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ABSTRACT 
DALE JOSEPH WILGER: Position-Dependent Energy Transfer Between Ruthenium(II) and 
Osmium(II) Modified Coiled-coil -Helical Peptides & Oligoproline Recognition by a -
Hairpin Peptide 
 
 Two different research projects are discussed throughout this dissertation. The first 
project relates to the study of position-dependent energy transfer between specially 
synthesized metallopeptides that contain RuII and OsII bipyridyl complexes. The second 
project relates to the measurement of aromatic-prolyl interactions in a model peptide system. 
 The study of excited-state energy transfer processes is of interest due to its 
implications in natural and artificial photosynthesis. In this work, a series of coiled-coil -
helical metallopeptides were designed, synthesized, and characterized. The metallopeptides 
contain RuII and OsII bipyridyl complexes that serve as excited-state energy donors and 
acceptors, respectively. 
Rates for energy transfer between the metallopeptides are position dependent and 
intimately linked with the structure of the peptide scaffold itself. The results indicate that 
energy transfer phenomena can be fine-tuned using peptide primary sequence and secondary 
structure. The metallopeptide system could be used to better understand the mechanisms of 
RuII to OsII excited-state energy transfer, and may potentially be applied to the construction 
of synthetic light-harvesting antenna, or as a sensitizer for dye-sensitized solar cells. 
As a second project, aromatic-prolyl interactions were studied in a model peptide 
system composed of a -hairpin peptide motif known as a tryptophan zipper (trpzip). 
Interactions between the amino acid proline and aromatic amino acids are of importance in 
iv 
 
the context of both protein folding and protein-protein interactions. The intermolecular 
recognition of the polyproline type II (PPII) helix peptide secondary structure by aromatic 
residues is important in a large number of cellular signaling events. Also, the cis-trans 
isomerization of amide bonds containing proline is often rate-limiting during protein folding. 
A disulfide exchange system was designed for studying aromatic-prolyl interactions between 
a trpzip peptide and a series of oligoproline peptides which adopt the PPII helix 
conformation. Favorable aromatic-prolyl interactions with energies up to 2.3 kcal·mol-1 were 
measured. A -hairpin peptide which also contains tryptophan, WKWK, does not have 
favorable interactions with the oligoproline peptides. The WKWK -hairpin peptide contains 
a different configuration of tryptophan residues and demonstrates the importance of structure 
when considering aromatic-prolyl interactions in the context of complex peptide 
environments. 
 
 
v 
 
ACKNOWLEDGEMENTS 
 
 First and foremost, I would like to thank Professor Marcey Waters for welcoming me 
into her lab and providing an environment where I could learn about a broad range of 
research topics. I have thoroughly enjoyed the developments I have made, both 
professionally and personally. They would not have been possible if I did not have her as an 
advisor, as a mentor, and as a friend. 
 I would like to thank my committee members, Professor Maurice Brookhart, 
Professor John Papanikolas, Professor Joseph Templeton, Professor Christopher Fecko, and 
the rest of the UNC chemistry faculty for their help. Professor Papanikolas has, in particular, 
provided me with considerable help, and even more patience during the whole process. 
 I would like to thank all the members of the Waters lab, both past and present. 
Without their help, none of this would have been possible. I would especially like to thank 
Dr. Alexander Riemen and Dr. Lauren Latshaw Cline for teaching me not only about 
chemistry, but also about how to be a good chemist. 
 I would like to thank Stephanie Bettis for her help with the energy transfer studies. 
She has helped us realize a goal we have both pursued for several years. Without her help, it 
might never have been possible. 
 I would like to thanks all of my friends throughout the department who have helped 
me along the way, especially Austin, Dan, Anne-Marie, Tim, and Jen. I can only hope that 
our paths cross frequently in the coming years. 
vi 
 
 I would like to thank my parents for their love and support, and for teaching me right 
from wrong. I would like to thank my sister Elizabeth and her husband Joe for always being a 
steady rock for me to rely on when I have come home. Lastly, I would like to thank Colleen 
for making my life so much better than I ever thought it could be. 
 
 
vii 
 
TABLE OF CONTENTS 
LIST OF TABLES........................................................................................................xi 
LIST OF FIGURES.....................................................................................................xii 
LIST OF ABBREVIATIONS.....................................................................................xvi 
Chapter 
     I. INTRODUCTION: 
  POSITION-DEPENDENT ENERGY TRANSFER BETWEEN   
  RUTHENIUM(II) AND OSMIUM(II) MODIFIED 
  COILED-COIL -HELICAL PEPTIDES.........................................................1 
 
 A.  Significance..................................................................................................1 
 B.  Background..................................................................................................2 
  i. Covalent and noncovalent scaffolds 
for studying energy transfer.......................................................2 
   
ii.  Photophysical properties of 
RuII and OsII bipyridyl complexes.............................................7 
 
  iii Previous studies on energy transfer between 
   RuII and OsII bipyridyl complexes...........................................12 
 
 C. Purpose of this work............................................................................17 
 
        II. DESIGN OF -HELICAL COILED-COILS FOR 
  THE STUDY OF ENERGY TRANSFER BETWEEN 
  RUII AND OSII BIPYRIDYL COMPLEXES.................................................21 
 
  A.  General design principles for coiled-coil peptides.....................................21 
 B.  Previous work of interest using coiled-coil peptides.................................25 
 C.  Current system design................................................................................26 
viii 
 
D.  Conclusions for system design...............................................................................28 
 III. Synthesis of metallopeptides............................................................................31 
  A.  Synthesis of [Ru(bpy)3]2+- and [Os(bpy)3]2+- 
        containing metallopeptides........................................................................31 
 
        i.       Background for [Ru(bpy)3]2+- and [Os(bpy)3]2+-   
   containing amino acids............................................................31 
 
   ii. Synthesis of [Ru(bpy)3]2+- and [Os(bpy)3]2+- 
    containing Fmoc-lysine derivatives.........................................33 
 
  iii. Development of the CuAAC reaction for 
   synthesizing metallopeptides...................................................36 
 
   iv. Conclusions..............................................................................42 
   
  B.  Experimental section..................................................................................44 
 
  i. Materials and general methods................................................44 
   ii. Synthesis of [Ru(bpy)3]2+- and [Os(bpy)3]2+- 
    containing Fmoc-lysine derivatives.........................................45 
 
  iii.  Synthesis of -Fmoc--azido-L-lysine.....................................48 
  iv.  Synthesis of RuII and OsII bipyridyl alkyne complexes 
   and the tris-(triazolylmethyl)amine ligand...............................49 
   
   v.  Synthesis of peptides and metallopeptides..............................52 
  vi.  1H and 13C NMR spectra..........................................................56 
      
IV. PHYSICAL CHARACTERIZATION OF THE 
  METALLOPEPTIDE DIMERS INCLUDING THE 
  DETERMINATION OF DISSOCIATION      
  CONSTANTS..................................................................................................63 
   
  A.  Introduction................................................................................................63 
   
  i. Choice of RuII and OsII donor/acceptor 
   positions for the metallopeptides.............................................63 
 
  ii.  Choice of metallopeptide pairs for analysis.............................64 
ix 
 
  
 B.  Circular dichroism analysis of the metallopeptide pairs............................67 
 
 C.  Guanidinium chloride denaturation of the metallopeptide pairs...............71 
  D.  All-atom molecular dynamics simulations................................................78 
  E. Conclusions.................................................................................................83 
   
  F. Experimental section...................................................................................83 
    
   i.  Circular dichroism and guanidinium 
    denaturation experiments........................................................83 
   
ii.  All-atom molecular dynamics simulations..............................84 
 
V.  THE STUDY OF POSITION-DEPENDENT ENERGY 
  TRANSFER WITHIN COILED-COIL 
  METALLOPEPTIDE HETERODIMERS.......................................................91 
 
  A.  Introduction................................................................................................91 
 
  B.  General energy transfer behavior and control experiments.......................92 
 
 C.  Titration experiments.................................................................................97 
  D.  Results and discussion.............................................................................102 
  E.  Conclusions..............................................................................................104 
  F.  Time-resolved emission experimental section..........................................105 
VI.  THE STUDY OF METALLOPEPTIDE SENSITIZERS 
  FOR NANOCRYSTALLINE SEMICONDUCTORS..................................108 
 
  A.  Introduction..............................................................................................108 
  
  B.  Background..............................................................................................108 
 
  C.  System design...........................................................................................112 
   
  D.  Photophysical measurements...................................................................116 
 
  E.  Conclusions..............................................................................................121 
   
 F.  Experimental section................................................................................122 
x 
 
VII.  OLIGOPROLINE RECOGNITION BY A 
  -HAIRPIN PEPTIDE...................................................................................125 
 
 A.  Introduction and significance...................................................................125 
 
  i.  Proline is a structurally unique amino acid............................125 
  ii. Proline-rich motifs.................................................................127 
    
   iii.  The polyproline type II (PPII) helix.......................................129 
   
 B.  The tryptophan zipper peptides as models for 
       aromatic-prolyl interactions.....................................................................131 
 
  i.  The tryptophan zipper peptides..............................................131 
 
  ii. System design........................................................................133 
   
   iii.  CD analysis of trpzip -hairpin and 
    oligoproline peptides..............................................................139 
 
  iv.  Analysis of the disulfide exchange experiments...................141 
 C.  Conclusions..............................................................................................145 
 D. Experimental Section................................................................................146 
   i.  Peptide synthesis and purification.........................................146 
   
  ii.    Circular dichroism measurements..........................................147 
   iii.  Disulfide exchange experiments............................................147 
 
  iv.  Sample chromatograms.........................................................150 
 
   v.  TOCSY and NOESY NMR experiments...............................154 
  
  BIBLIOGRAPHY..........................................................................................157 
 
 
 
 
 
 
xi 
 
  
LIST OF TABLES 
Table                                                                                                                         Page 
 
4.1 Folding parameters obtained from guanidinium 
 Denaturation experiments …………………….....………………….......…...74 
 
 4.2 Percent dimer for the analyzed metallopeptides…………..…................……77 
  
 5.1 Lifetimes and amplitudes generated from the titration experiments.....……102 
 
6.1 Photophysical properties of the phosphopeptides 3pS, 
 3pS-P0, and 3pS-P3.......................................................................................119 
 
 6.2 Photophysical properties of the phosphopeptides on ZrO2............................120 
 
 6.3 Photophysical properties of the phosphopeptides on TiO2............................121 
  
 7.1 Primary sequences for the peptides used in disulfide 
  exchange experiments....................................................................................139 
 
 7.2 Equilibrium constants generated from the disulfide 
  exchange experiments....................................................................................142 
 
 7.3 Corrected values for Gibb’s free energy change 
  of heterodimer formation...............................................................................144 
 
 7.4 Sample data set for trpzip/CWGG exchange experiment..............................149 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
LIST OF FIGURES 
Figure                                                                                                                        Page 
 
1.1 The structure of light-harvesting complex II ( LH2) from a  
 Photosynthetic bacteria……………………...…………………………….…..2 
 
1.2 Diagram representing the Förster and Dexter 
 mechanisms for energy transfer………………...……………………..………4 
 
1.3 Chemical structure of the synthetic constructs previously used for the 
 study of distance-dependent energy transfer…………………………………..7 
 
1.4 Chemical and ground-state electronic structure for the 
 Ru(bpy)32+molecular ion…………………………………………………...….8 
 
1.5 Jablonksi diagram showing all of the relevant photophysical 
 events for the Ru(bpy)32+ molecular ion……………………………………..10 
 
1.6 Latimer diagram showing the redox properties for the excited-  
 and ground-state Ru(bpy)32+ molecular ion………………………………….11 
 
1.7 Chemical structure of covalently linked 
 binuclear RuII and OsII complexes…………………………………..……….13 
 
1.8 Chemical structure of polystyrene-based systems used for the 
 study of energy transfer between RuII and OsII complexes…………………..15 
 
1.9 Chemical structure of the ethynyl- and ethylene-linked nucleosides 
 used for the study of energy transfer between RuII and OsII complexes……..17 
 
2.1 Crystal structures for several coiled-coil peptides indicating 
 different oligomerization states……………………………….……………...22 
 
2.2 Helical wheel diagram representing the stabilizing forces in a 
 dimeric coiled-coil peptide. Crystal structure showing the 
 relevant amino acid residues………………………………..………..…....…24 
 
2.3 The primary sequences for the P1 and P2 peptides. 
 Diagram showing the “blunt” ends and “sticky-ends” assembly 
 patterns for coiled-coil peptides……………………………………………...28 
 
3.1 Chemical structures of previously reported redox-active amino acids……....32 
 
3.2 Synthesis of Fmoc-protected amino acids (6a and 6b)....................................34 
 
xiii 
 
3.3 Synthesis of -Fmoc--azido-L-lysine (8).......................................................37 
 
3.4 Synthesis of complexes 11a and 11b……...…...…................................…….38 
 
3.5 Convergent synthesis of metallopeptides using the CuAAC reaction....….....39 
 
3.6 Absorbance and emission spectra for metallopeptides 
 synthesized using the convergent CuAAC reaction.........................................44 
 
3.7 1H and 13C NMR spectra for -Fmoc--azido-L-lysine (8).............................56 
 
3.8 1H and 13C NMR spectra for 
 4’-methyl-2,2’-bipyridine-4-propargylamide (10)..........................................57 
 
3.9 1H NMR spectra for bis-(2,2’bipyridine) 
       (4’-Methyl-2,2’-bipyridine-4-propargylamide)-ruthenium(II)    
 bis(hexafluorophosphate) (11a).......................................................................58 
 
3.10 1H NMR spectra for bis-(2,2’bipyridine) 
       (4’-Methyl-2,2’-bipyridine-4-propargylamide)-osmium(II)    
  bis(hexafluorophosphate) (11b).......................................................................59 
 
3.11 1H and 13C NMR spectra for the 
 tris-(triazolylmethyl)amine ligand (12)............................................................60 
 
4.1 The primary sequences for the P1 and P2 parent peptides and a 
 helical wheel diagram for the metallopeptide partners 
 examined throughout the study........................................................................64 
 
4.2 Crystal structure of a similar coiled-coil dimer...............................................66 
 
4.3 Circular dichroism (CD) spectra for all three metallopeptide pairs.................68 
 
4.4 Continuous variation experiments for all three metallopeptide pairs..............70 
 
4.5 GndHCl denaturation curves and Gibbs free energy of unfolding 
 for all three metallopeptide pairs.....................................................................73 
 
4.6 Histograms showing the simulated metal-center distance 
 Distributions for all three metallopeptide pairs...............................................81 
 
4.7 Simulated conformations of the bipyridyl complexes in the 2c/2b 
 and 2g/2e metallopeptide pairs........................................................................82 
 
4.8 Simulated metal-center displacement distances for all 
 Three metallopeptides......................................................................................88 
xiv 
 
 
5.1 Helical wheel diagram for the metallopeptide partners including 
 approximate distances between attachment points..........................................93 
 
5.2 The chemical structure of the osmium complex 13 and the relevant 
 time-resolved emission experiment with 2b-Ru..............................................95 
 
5.3 Time-resolved emission trace for the 2b-Ru/2c-Os and 2e-Ru/2g-Os 
 GndHCl denaturation experiments..................................................................96 
 
5.4 The time-resolved emission traces for the 2e-Ru/2g-Os, 2b-Ru/2c-Os, 
  and 2f-Ru/2f-Os metallopeptide pairs..............................................................99 
 
 5.5 Diagram showing the experimental set up for TCSPC..................................106 
 
6.1 Schematic representation of a DSSC.............................................................110 
 
6.2 Bipyridyl ligands functionalized with anchoring groups...............................112 
 
6.3 System design for the RuII-containing phosphopeptides...............................114 
 
6.4 Relative surface stability of the 2pS and 3pS phosphopeptides on TiO2.......116 
 
6.5 Structure of the phosphopeptides used to test the anchor length...................117 
 
6.6 Absorbance and emission spectra for the phosphopeptides...........................118 
 
7.1 The s-trans and s-cis amide bond conformations for 
 peptides and for Xaa-Pro amide bonds............................................................126 
 
7.2 A tryptophan-proline amide bond and an aromatic-prolyl interaction..........127 
 
7.3 The PRM-binding EVH1 domain from Homer 1a........................................129 
 
7.4 The conformation of the polyproline type II (PPII) helix..............................130 
 
7.5 The structure of a trpzip -hairpin peptide....................................................132 
 
7.6 The aromatic binding residues from the Homer 1a EVH1 
 domain overlaid with a trpzip peptide...........................................................133 
 
7.7 The trpzip -hairpin peptide redesigned for disulfide 
 exchange experiments....................................................................................135 
 
7.8 The WKWK -hairpin peptide redesigned for disulfide 
 exchange experiments....................................................................................138 
xv 
 
 
7.9 CD spectra of the oligoproline peptides, trpzip, and WKWK.......................140 
 
7.10 An HPLC chromatogram for a typical disulfide exchange reaction..............141 
 7.11 Sample chromatogram for the trpzip/CW-Pro5 disulfide 
  exchange experiment.....................................................................................150 
 
 7.12 Sample chromatogram for the trpzip/CW-Pro6 disulfide 
  exchange experiment.....................................................................................151 
  
 7.13 Sample chromatogram for the trpzip/CW-Pro7 disulfide 
  exchange experiment.....................................................................................151 
 
 7.14 Sample chromatogram for the WKWK/CW-Pro7 disulfide 
  exchange experiment.....................................................................................152 
 
 7.15 Sample chromatogram for the WKWK/CWGG disulfide 
  exchange experiment.....................................................................................152 
 
 7.16 Sample chromatogram for the trpzip/CWGG disulfide 
  exchange experiment.....................................................................................153 
 
 7.17 Sample chromatogram for the trpzip/C-Pro7-W disulfide 
  exchange experiment.....................................................................................153 
 
 
xvi 
 
LIST OF ABBREVIATIONS AND SYMBOLS 
 
Å  Angstrom 
A  Amplitude of a time-resolved emission measurement 
Ac  Acetyl group 
ACN  Acetonitrile 
AcOH  Acetic acid 
Arg, R  Arginine 
Asn, N  Asparagine 
ATP  Adenosine triphosphate 
AUC  Analytical ultracentrifugation 
  Preexponential factor for Dexter energy transfer 
BET  Back electron transfer 
Boc  tert-Butyloxycarbonyl group 
bpy  Bipyridyl ligand, bipyridine ligand 
BS  Beam splitter 
n-BuOH n-Butanol 
tBuOH  tert-Butanol 
c  Concentration in mol·L-1 
°C  Degrees Celsius 
CD  Circular dichroism spectroscopy 
cm  Centimeter  
Cm  Chemical denaturation midpoint 
CuAAC Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition 
xvii 
 
Cys, C  Cysteine 
DBU  1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCC  Dicyclohexylcarbodiimide 
deg  degrees of arc 
DIPEA Diisopropylethylamine 
DMF  N,N-Dimethylformamide 
dmol  decamole 
DMSO  Dimethylsulfoxide 
DNA  Deoxyribonucleic acid 
DSSC  Dye-sensitized solar cell 
e  Elementary charge 
  Molar extinction coefficient 
EDC  1-Ethyl-3-(3’-(dimethylamino)propyl)carbodiimide hydrochloride 
ES  Excited state 
ESI-MS Electrospray ionization mass spectrometry 
EtOAc  Ethyl acetate 
EtOH  Ethanol 
EVH1  Ena/VASP homology 1 domain 
Fmoc  Fluorenylmethyloxycarbonyl group 
fs  Femtosecond 
  Quantum yield 
ΔGD  Gibbs free energy change at a specific denaturant concentration 
ΔGF  Gibbs free energy change of unfolding 
xviii 
 
ΔGH20  Gibbs free energy change in water/buffer 
ΔΔGD Difference between ΔGD values at two different GndHCl concentrations 
Gln, Q  Glutamine 
Glu, E  Glutamic acid, or glutamate 
Gly, G  Glycine 
GndHCl Guanidinium hydrochloride 
GS  Ground state 
GYF  Glycine-tyrosine-phenylalanine domain 
HATU  7-Aza-benzotriazole-N,N,N’,N’,-tetramethyluronium hexafluorophosphate 
HBTU  O-Benzotriazole-N,N,N’,N’,-tetramethyluronium hexafluorophosphate 
His, H  Histidine 
HOBt  N-hydroxybenzotriazole 
HPLC  High pressure liquid chromatography 
Ile, I  Isoleucine 
IPA  Isopropanol, 2-propanol 
ISC  Intersystem crossing 
ITC  Isothermal titration calorimetry 
J  Spectral overlap integral 
K  Kelvin, absolute temperature scale 
2  Orientation factor 
kD  Rate of energy transfer (Dexter mechanism) 
kF  Rate of energy transfer (Förster mechanism) 
kcal  kilocalorie 
xix 
 
Kd  Dissociation constant 
kHz  Kilohertz 
L  Liter 
l  Optical path length 
  Wavelength 
LC-MS Liquid chromatography-mass spectrometry 
Leu, L  Leucine 
LH2  Light-harvesting complex II 
LHE  Light-harvesting efficiency 
Lys, K  Lysine 
M  Isotopic mass, exact mass 
m  Slope of a line 
μM  Micromolar 
mAU  Milliabsorbance unit 
MD  Molecular dynamics 
MeOH  Methanol 
MHz  Megahertz 
mL  Milliliter 
MLCT  Metal-to-ligand charge-transfer 
mM  Millimolar 
mol  Mole 
MRE  Mean molar residue ellipticity 
MS  Mass spectrometry 
xx 
 
m/z  Mass-to-charge ratio 
n  Refractive index 
η  Efficiency of a process 
nm  Nanometer 
NMP  N-Methylpyrrolidinone 
NMR  Nuclear magnetic resonance spectroscopy 
NOE  Nuclear Overhauser effect 
NOESY Nuclear Overhauser effect spectroscopy 
ns  Nanosecond 
Orn, O  Ornithine 
pdb  Protein data bank 
PDI  Polydispersity index 
PPII  Polyproline type II helix 
PRM  Proline-rich motif 
Pro, P  Proline 
D-Pro, P D-Proline 
ps  Picosecond 
R  Molar gas constant 
R0  Förster radius for a specific donor and acceptor 
R2  Coefficient of determination 
RESP  Restrained electrostatic potential 
RP-HPLC Reversed-phase high pressure liquid chromatography 
RT  Room temperature 
xxi 
 
SAF  Self-assembling fiber 
Ser, S  Serine 
SH3  Src-homology 3 domain 
SPPS  Solid-phase peptide synthesis 
SSE  Steady-state emission 
T  Temperature (Kelvin scale) 
  Lifetime of a time-resolved emission measurement 
[θ]  Mean molar residue ellipticity 
TCEP  Tris(2-carboxyethyl)phosphine 
TCSPC Time-correlated single photon counting 
TFA  Trifluoroacetic acid 
Thr, T  Threonine 
TIPS  Triisopropylsilane 
TLC  Thin layer chromatography 
TOCSY Total correlation spectroscopy 
Trp, W  Tryptophan 
trpzip  Tryptophan zipper peptide 
Tyr, Y  Tyrosine 
UEV  Ubiquitin E2 variant domain 
UV-vis Ultraviolet-visible spectroscopy 
V  Volt 
Val, V  Valine 
v:v  Volume-to-volume ratio 
xxii 
 
WW  Tryptophan-tryptophan domain 
Xaa  Any nonproline amino acid 
 
 
 
 
Chapter I 
INTRODUCTION: 
POSITION-DEPENDENT ENERGY TRANSFER BETWEEN RUTHENIUM(II) AND 
OSMIUM(II) MODIFIED COILED-COIL -HELICAL PEPTIDES 
  
A. Significance 
 Mankind currently faces the overwhelming task of meeting the ever-increasing 
energy demands of our developing global community.1 The expanding energy requirements 
of our developing world, coupled with worsening environmental and political issues related 
to energy use have animated new endeavors in the study of light absorption and energy 
transfer processes.1 These studies have been inspired by the simple observation that the vast 
majority of the energy required to sustain all life on earth is essentially supplied by solar 
radiation. Natural sunlight is diffuse and intermittent. Photosynthetic life forms have adapted 
to this by evolving complex light-harvesting antennae systems that absorb multiple photons 
at different chromophore sites and couple them to localized reactive centers through a series 
of highly synchronized excited-state energy transfer and electron transfer steps (Figure 1.1).2 
These processes have been optimized within photosynthetic organisms in order to increase 
effective molar absorptivity, broaden the spectral window for light absorption, and to couple 
multielectron redox processes to single-photon absorption processes. The basic mechanisms 
by which these energy transfer and electron transfer events occur are of interest if mankind is 
to ever mimic the complex energy conversion systems developed within natural 
photosynthetic organisms.3 
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Figure 1.1 The crystal structure for the light-harvesting complex II LH2 from Rhodobacter 
sphaeroides (pdb code: 2FKW).2a The peptide segments of the light-harvesting complex are 
shown in green. The protein complex has 27 different bacteriochlorophyll molecules (red) 
bound tightly along with 9 different carotenoid chromophores (rhodopsin glucoside, blue) 
that serve as primary and secondary light absorbing units, respectively. The peptide 
architecture of the complex holds many of the bacteriochlorophyll molecules within less than 
9 angstroms of each other. The distance between chromophore molecules has been optimized 
through evolution and allows for the rapid transfer of excited-state energy within the 
complex, and then ultimately to a photosynthetic reaction center (not shown). 
B. Background 
i. Covalent and noncovalent scaffolds for studying energy transfer 
A large number of covalent linkages, assemblies, and scaffolds have been used in 
order to study energy transfer phenomenon. These scaffolds vary in complexity from simple 
alkyl chains,4 to high molecular weight synthetic polymers,5 and extremely complex 
oligonucleotide molecules including duplex DNA.6 These synthetic architectures are all used 
to spatially preorganize excited-state energy donors and acceptors in order to facilitate, 
expedite, and in most cases study energy transfer. 
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The constant obsession for studying excited-state energy transfer between spatially 
preorganized partners has been motivated by a number of interwoven factors. The first 
consideration is practical in nature. Energy transfer is, fundamentally, always a distance-
dependent behavior. Energy transfer will in many cases occur more efficiently when excited-
state donors and acceptors are held in close proximity. Although this is not strictly true for all 
energy transfer processes, we have only to look at natural light-harvesting structures to see 
the concept at work. Natural light-harvesting protein complexes never rely on diffusion 
controlled energy transfer in order to couple light absorption and photosynthetic reactions.2 
Instead, chromophores are held in intimate contact with both spacing and orientation 
optimized for the vectoral transfer of excited-state energy (Figure 1.1). This elaborate energy 
transfer organization is certainly a design feature many researchers would like to mimic 
synthetically.3 
Another primary consideration for studying preorganized energy transfer is more 
academic in pursuit. While energy transfer is always distance-dependent to some extent, the 
exact mechanism of energy transfer has a pronounced effect on the degree of the observed 
distance-dependence. Indeed, the study of distance-dependent energy transfer for many 
systems has led to the general acceptance of the current excited-state energy transfer models. 
Excited-state energy transfer has historically been analyzed according to two distinct 
models (Figure 1.2). The dipole-dipole mechanism was originally described by Theodor 
Förster,7 while the electron exchange mechanism was originally described by David Dexter.8  
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Figure 1.2 Diagram representing the dipole-dipole mechanism (Förster, left) and the electron 
exchange mechanism (Dexter, right) for excited-state energy transfer. The Förster 
mechanism relies on a through space dipole-dipole coupling and typically occurs over greater 
distances than the Dexter mechanism. The Dexter mechanism relies on orbital overlap 
between the donor and acceptor and is typically operative over extremely short distances. 
The dipole-dipole mechanism of energy transfer describes a process where an 
excited-state electron can relax back to the ground state while simultaneously elevating an 
electron in another molecule to an electronically excited state through a nonradiative process. 
The coupled excitation/relaxation event occurs through the interaction of induced electronic 
dipoles on the donor and acceptor. Energy transfer through a Förster mechanism can occur 
over distances up to several nanometers (~10 nm), but requires an overlap of emission 
wavelengths for the donor molecule and absorption (excitation) wavelengths for the acceptor 
molecule. The extent of this overlap is measured by a spectral overlap integral (J) that 
determines the relative efficiency of energy transfer. The efficiency of energy transfer by the 
Förster mechanism also depends on the relative orientation of the donor and acceptor 
molecules (), the fluorescence quantum yield of the donor (D, the refractive index of the 
medium (n), and the distance between the donor and acceptor (r). The rate of energy transfer 
predicted by the Förster mechanism (kF) will vary with the distance (r) to the inverse sixth 
power according to Equation 1:9,10 
݇ி ൌ  0.592 ൉ 
ଶ ൉஽ ൉ ܬሺሻ
ܰ ൉ ݊ସ ൉ ߬஽ ൉ ݎ଺        ܧݍݑܽݐ݅݋݊ 1 
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where N is the Avogadro number. The orientational factor and is often taken to be 2/3, 
assuming the donor and acceptor undergo isotropic reorientation on a time scale shorter than 
the excited-state lifetime of the donor. The distance dependence of energy transfer by the 
Förster mechanism is often expressed as an efficiency quotient according to Equation 2:9,10 
ܧ ൌ   11  ൅ ሺ ݎ ܴ଴ሻൗ
଺        ܧݍݑܽݐ݅݋݊ 2 
where R0 is the distance at which energy transfer efficiency is 50%. This distance is known 
as the Förster radius and is specific for a donor/acceptor pair. If the spectroscopic parameters 
(Equation 1) are known for a desired donor, acceptor, and medium then the Förster radius 
(R0) can also be directly calculated. One consequence of Förster’s predicted energy transfer 
mechanism is the requirement that both donor and acceptor transitions be optically allowed 
in order for energy transfer to manifest. For example, singlet-singlet transitions are allowed 
by the Förster mechanism, while triplet-triplet transitions are typically forbidden. 
The electron exchange mechanism (Dexter) for energy transfer describes a process 
where an excited electron and hole (orbital vacancy) are simultaneously transferred from the 
donor molecule to the acceptor molecule. The movement of a combined electron and hole is 
often referred to as an exciton. The Dexter mechanism for energy transfer relies on orbital 
(wave function) overlap between the donor and acceptor molecules and occurs over much 
shorter distances compared to the Förster mechanism. The rate of energy transfer predicted 
by the Dexter mechanism (kD) will vary with the distance (r) according to Equation 3:10 
݇஽ ൌ  2ߨħ ൉ ߚ ൉ exp ൬െ
െ2ݎ
ܮ ൰       ܧݍݑܽݐ݅݋݊ 3 
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where L is the average van der Waals radius for the initial and final molecular orbitals of the 
donor/acceptor system and  is a parameter that depends on spectral overlap between the 
donor emission and acceptor absorbance spectra, similar to the Förster model. Unlike 
Förster’s predicted mechanism, the rate of energy transfer cannot be calculated directly from 
measured spectroscopic data, and the preexponential factor () must be experimentally 
determined. Another consequence of Dexter’s predicted mechanism is that energy transfer 
efficiency by electron exchange will decrease exponentially with the donor/acceptor distance 
(r). The Dexter theory of energy transfer can also be applied to formally forbidden processes, 
including triplet-triplet transitions.10 If the donor and acceptor molecules in question are 
covalently linked then Dexter energy transfer can also occur with a significant through-bond 
electronic coupling component in a process known as superexchange.10 
 Experimental studies on the distance dependence for energy transfer have long been 
the proving ground for the previously described mechanistic interpretations. The predicted 
distance dependence (r-6) for the Förster mechanism of energy transfer was experimentally 
confirmed by Stryer and Haugland using a series of oligoprolines as molecular spacers.11 The 
oligoproline bridges acted as rigid spacers that held the donor (naphthyl) and acceptor 
(dansyl) groups at known fixed distances (Figure 1.3a). These experiments confirmed the use 
of Förster energy transfer as a “spectroscopic ruler” for measuring distances on the 
nanometer scale.11 Similarly, Speiser and Katriel were able to show that the distance 
dependence for excited-state energy transfer in a series of covalently linked benzyl-biacetyl 
molecules followed an inverse exponential trend as predicted by Dexter (Figure 1.3b).12 In 
Speiser’s studies, aryl moieties served as energy donors, while biacetyl moieties served as the 
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energy acceptors. Both these examples serve to emphasize the intertwined roles that the 
theoretical and experimental disciplines have played in the field of energy transfer study. 
 
 
 
 
 
 
 
Figure 1.3. (a) The oligoproline system used by Stryer and Haugland to confirm the distance 
dependence (r-6) for the Förster mechanism of energy transfer. The naphthyl moiety (C 
terminus) served as the energy donor, while the dansyl moiety (N terminus) served as the 
energy acceptor. (b) Two molecular systems used by Speiser and Katriel to determine the 
distance dependence (exponential) for the Dexter mechanism of energy transfer (n = 1, 2, 3). 
The benzyl moiety served as the energy donor, while the biacetyl moiety served as the energy 
acceptor. 
ii. Photophysical properties of RuII and OsII bipyridyl complexes 
 The polypyridyl complexes of ruthenium (RuII), and to a lesser extent osmium (OsII), 
have been central to the study of excited-state energy transfer and solar energy conversion for 
many researchers due to a number of combined favorable properties including their: (a) 
relative chemical inertness in the ground state; (b) relatively long-lived excited state 
lifetimes; (b) useful redox properties in the excited sate; and (d) ease of synthesis with an 
often modular design.3a,b 
 
 
 
(a) 
 
(b) 
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Figure 1.4. (a) The chemical structure of Ru(bpy)32+, the tris(bipyridyl) ruthenium dication. 
(b) The ground-state electronic structure of Ru(bpy)32+, including the filled t2g orbitals (dxy, 
dxz, and dyz) and empty eg orbitals (dz2 and dx2-y2). The electronic transition corresponding to 
the excitation of a t2g electron to a * orbital on the bipyridyl ligand (MLCT) is shown in 
blue. 
The tris(bipyridyl) ruthenium cation (Ru(bpy)32+) has served as the prototypical 
model for the study of excited-state energy transfer (Figure 1.4a).13 Being a third row 
octahedral d6 transition metal complex, with chelating ligands, Ru(bpy)32+ is quite stable in 
the ground state. The crystal structure of Ru(bpy)32+ shows a decreased Ru-N bond length 
(2.06 Å) when compared to the Ru-N bond length (2.10 Å) in Ru(NH3)63+.14 Since the RuII 
ionic radius is expected to be larger than the RuIII ionic radius, the apparent decrease in the 
Ru-N bond length indicates significant -bonding between the filled Ru t2g orbitals and the 
empty bipyridyl * orbitals. The complex is kinetically stable towards racemization and 
ligand exchange, even at elevated temperatures, a property not similar to polypyridyl 
complexes of Fe.15 
The excited state of interest for the Ru(bpy)32+ dication arises through a metal-to-
ligand charge transfer  (MLCT) process whereby an electron occupying a t2g orbital on Ru is 
transferred to a * orbital localized on one of the bipyridyl ligands (Figure 1.4b). This MLCT 
(a) 
 
(b) 
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transition renders the complex a strong absorber of light in the visible region (max = ~450 
nm,  = 13,000 in acetonitrile,  = 14,600 in water).13 The strong absorbance of light over a 
range of wavelengths in the blue region of the visible spectrum gives Ru(bpy)32+ a 
characteristic red color. The MLCT band (max) is slightly sensitive to solvent polarity, 
indicating some instantaneous shielding of the dipolar excited state by solvent molecules.16 
The initial absorption of a photon at 450 nm leads to a 1MLCT state that undergoes 
intersystem crossing to the 3MLCT state (Figure 1.5). Intersystem crossing is extremely 
rapid, requiring approximately 300 fs, and proceeding with a quantum yield (ISC) that is 
essentially unity.17 Intersystem crossing occurs concomitantly with spin-allowed processes 
including vibrational relaxation and relaxation/reorientation of the solvent shell. Experiments 
using ultrafast absorption anisotropy measurements have shown that, while the Ru(bpy)32+ 
excited-state electron is initially delocalized over all three bipyridyl ligands, localization of 
this electron on one of the bipyridyl ligands occurs within several hundred femtoseconds.18 
The 3MLCT state for Ru(bpy)32+ may be the most extensively studied electronically 
excited molecule to date. The 3MLCT excited state contains about 2.1 eV (~ 48 kcal·mol-1) 
excess energy relative to the ground state, and actually exists as a manifold of triplet exited 
states that are mixed with higher-lying singlet excited states. An attractive feature for 
studying the Ru(bpy)32+ (3MLCT) excited state is its persistent lifetime, which is several 
hundred nanoseconds in water, and more than a microsecond in acetonitrile.19 This slow 
decay back to the ground state has allowed for any number of  energy and electron transfer 
phenomena to be studied. The excited-state lifetime of the molecular ion can be monitored 
using its phosphorescent emission (max = ~630 nm). 
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Figure 1.5 Jablonksi diagram showing all of the relevant photophysical events for 
Ru(bpy)32+ excitation. Initial absorption of light at 450 nm produces a short lived 1MLCT 
state. Intersystem crossing to the 3MLCT state occurs within several hundred femtoseconds 
and has a quantum yield (ISC) close to unity. The 3MLCT configuration can last several 
hundred nanoseconds and is the excited state of interest for many chemists. Relaxation from 
the 3MLCT state occurs via a combination of phosphorescence (max = ~630 nm) and 
radiationless transitions. The quantum yield for phosphorescence is typically less than 10% at 
room temperature, regardless of solvent.  
The excess energy contained within the electronic configuration of the 3MLCT state 
manifests as an increased willingness to undergo redox chemistry (Figure 1.6). Oxidation and 
reduction are disfavored for Ru(bpy)32+ in the ground-state, but reducing and oxidizing 
potentials are both enhanced in the excited-state complex (Figure 1.6).3b The excited-state 
redox potentials for the Ru(bpy)32+ molecular ion imply the thermodynamic ability to oxidize 
water (E° (pH = 8) = -0.76 V), a property that has pushed the molecular ion into the artificial 
photosynthesis limelight.3a Also of high interest is the fact that the excited-state Ru(bpy)32+ 
molecular ion has an energy appropriate for electron injection into wide-bandgap oxide 
semiconductors, including titanium dioxide (TiO2).20 
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Figure 1.6. Latimer diagram showing the redox properties for the excited- and ground-state 
Ru(bpy)32+ molecular ion. Values are reported for acetonitrile at 25 °C. The complex does 
not have a potent oxidizing or reducing potential in the ground state, but excitation to the 
3MLCT state results in favorable potentials for both oxidation and reduction. 
 The excited-state Ru(bpy)32+ molecular ion is capable of not only electron transfer 
reactions, but also energy transfer phenomena if an appropriate acceptor is selected. A full 
account of energy transfer and electron transfer partners studied for Ru(bpy)32+ would be 
needlessly long, but the tris(bipyridyl) osmium cation (Os(bpy)32+) used throughout the 
current study deserves mention. The Os(bpy)32+ molecular ion also absorbs light strongly in 
the visible region (max = ~480 nm,  = 12,000 in water) due to a 1MLCT excitation band.19 
Unlike the ruthenium analog, Os(bpy)32+ has a significant absorbance above 600 nm 
associated with the direct  excitation to a triplet (3MLCT) state. This normally optically 
forbidden transition is allowed for Os due to spin-orbit coupling in the heavier metal. The 
initial excited state dynamics of Os(bpy)32+ are similar to Ru(bpy)32+, with vibrational 
relaxation, solvent shell relaxation, and excited-state localization all occurring in a matter of 
femtoseconds.21 The 3MLCT state for Os(bpy)32+ is, however, considerably lower in energy 
compared to ruthenium, and an increased Stokes shift for the complex (max = ~730 nm) is 
apparent in the emission spectrum. The Os(bpy)32+ molecular ion also has a much shorter 
excited-state lifetime ( = 19 ns in water).19 The 3MLCT state for Os(bpy)32+ is roughly 0.40 
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eV lower in energy compared to Ru(bpy)32+ and can serve as an efficient energy transfer 
acceptor for the complex. Both Dexter and Förster energy transfer mechanisms are 
theoretically possible for RuII to OsII energy transfer. Emission spectra for Ru(bpy)32+ 
overlap with absorption spectra for Os(bpy)32+ from 550-690 nm, a requirement for both 
mechanisms of energy transfer.19 While the relaxation of the RuII 3MLCT requires a spin flip 
that would normally be forbidden by Förster’s predicted mechanism, spin-orbit coupling in 
the heavier Os atom could allow for triplet-triplet energy transfer to occur. 
   iii. Previous studies on energy transfer between RuII and OsII bipyridyl 
complexes 
Researchers have previously studied energy transfer between RuII and OsII bipyridyl 
complexes attached to short covalent tethers,4 high molecular weight polymers,5 and complex 
oligonucleotides.6 The coiled-coil peptide scaffold employed throughout this work has not 
been previously studied, and represents a very different chemical environment for studying 
energy transfer processes. 
Furue and coworkers studied RuII to OsII energy transfer by linking a series of 
bipyridyl complexes through short covalent tethers (Figure 1.7).4 All of the heterobinuclear 
complexes exhibited intramolecular energy transfer based on a quenching of RuII emission at 
610 nm that was accompanied by an enhancement in OsII emission at 800 nm. Time-
correlated single-photon counting (TCSPC) measurements indicated that RuII to OsII energy 
transfer in these bridged complexes occurred with first-order rate constants varying from 1.2 
x 108 to 1.2 x 109 s-1 in water ( = 0.86 to 8.1 ns). Furue attributed energy transfer to a 
Förster-type mechanism based on the distance-dependence (to the inverse sixth power) 
observed for the quenching rates. 
13 
 
 
 
 
Figure 1.7 Covalently linked binuclear RuII and OsII complexes used by Furue to study 
energy transfer. Excitation of the RuII center results in energy transfer to OsII, as indicated by 
TCSPC experiments. The binuclear complexes exhibit first-order rate constants varying from 
1.2 x 108 s-1 (n = 7) to 1.2 x 109 s-1 (n = 2) in water. 
 Meyer and coworkers have used a series of polystyrene-based polymers derivatized 
with bipyridyl complexes of RuII and OsII to study energy transfer and light-harvesting 
phenomena (Figure 1.8).5 The polymers typically contained 16 to 30 repeat units and were 
synthesized using specialized techniques. After polymerization, RuII and OsII bipyridyl 
complexes were conjugated to the polystyrene molecules using different chemical methods. 
The authors showed that polystyrene molecules derivatized with ether linkages were efficient 
promoters of RuII to OsII energy transfer with first-order rate constants greater than 2 x 108 s-1 
( < 5 ns) (Figure 1.8a).23a While RuII to OsII excited-state energy transfer was fast in the 
ether-linked polymers, energy migration from RuII to RuII (G = 0) was comparably slow 
with measured rate constants less than 1 x 106 s-1( > 1 s). Polystyrene molecules 
derivatized with amide linkages had similar RuII to OsII energy transfer rates, but vastly 
improved RuII to RuII energy migration rates (Figure 1.8b).23c The marked increase of the 
RuII to RuII energy migration rates (greater than 2 x 108 s-1, similar to energy transfer rates) 
was attributed to the fact that in these amide-linked systems the charge transfer electron 
resides on the bipyridyl-amide ligand. In contrast to the ether-linked systems where the 
excited-state electron resides on an exterior bipyridyl ligand, the amide substituent orients the 
excited-state dipole towards the polymer backbone. Later generation polystyrene molecules 
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with mixed ligand designs were studied using ultrafast spectroscopy techniques (Figure 
1.8c).5e The average rate of RuII to RuII energy migration in these systems was measured as 
2.5 x 108 to 1.0 x 109 s-1 ( = 1-4 ns), with RuII to OsII energy transfer rates averaging to 2.5 x 
109 s-1 ( = 400 ps). Although this analysis indicated an efficient energy transfer to OsII from 
a number of RuII donors, interpretation was difficult due to the statistical composition of the 
polymers. Specialized polymerization techniques were used to control the polydispersity 
(PDI = 1.08) of the samples, but some degree of nonhomogeneity for polymer length, 
donor/acceptor loading, and acceptor distribution were still typical. The authors use Monte 
Carlo simulations in order to rationalize donor/acceptor spacing and the energy transfer 
kinetics. A Dexter mechanism for energy transfer was discussed for these polymer systems 
based on the close donor/acceptor spacing predicted by molecular modeling. Any 
contribution from a through-bond superexchange mechanism was considered negligible due 
to the large number of intervening saturated bonds between donor/acceptor complexes. A 
Förster mechanism for energy transfer was also generally discounted due to the low degree of 
singlet character in the phosphorescent MLCT states for RuII (~11) and OsII (~30%). 
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Figure 1.8. Polystyrene-based systems used to study energy transfer between RuII and OsII 
(MII = RuII and OsII). (a) The ether-linked polymers are efficient promoters of RuII to OsII 
energy transfer, but were less efficient at promoting RuII to RuII energy migration. (b) 
Second-generation amide-linked polymers were more efficient promoters of RuII to RuII 
energy migration. (c) RuII and OsII derivatized polystyrenes with mixed bipyridyl ligand 
designs were later used to study energy migration/transfer dynamics using ultrafast time-
resolved emission spectroscopy (ps-ns). 
 Tor and coworkers studied RuII to OsII energy transfer in a series of modified 
oligonucleotides.6 A series of ethynyl-linked and ethylene-linked bipyridyl complexes 
containing RuII and OsII were developed for incorporation into DNA during standard solid-
phase oligonucleotide synthesis (Figure 1.9). Tor performed a systematic study of RuII to OsII 
energy transfer in a series of DNA duplexes in order to define the relationship between 
donor/acceptor distance and energy transfer efficiency. The donor/acceptor separation 
(a) 
 
(b) 
 
(c)
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distances were determined based on the helical model for B-form DNA. The ethynyl-linked 
bipyridyl complexes were designed to project the donor/acceptor complexes away from the 
DNA base stack (Figure 1.9a) since intercalation phenomena have a dramatic affect on 
energy transfer rates in similar systems.22 The DNA duplexes incorporating the ethynyl-
linked donor/acceptor complexes displayed a shallower distance dependence than would be 
expected for a Förster-type mechanism. As previously mentioned (Section B), the orientation 
factor for Förster energy transfer (2) is typically assumed to be 2/3, although it has been 
shown that this approximation can lead to gross misinterpretation of energy transfer rates.9 A 
series of DNA duplexes incorporating the ethylene-linked RuII donor were studied in an 
attempt to ameliorate any undesired orientation effects. Duplexes incorporating the more 
flexibly linked donor gave similar results however, and the observed distance dependence 
was again shallower than would be expected based on a Förster-type mechanism. The authors 
conclude that a Förster-type mechanism could account for a significant component of the 
observed energy transfer, with some contribution of “Dexter-like behavior” under certain 
circumstances. The simple helical model used to interpret the donor/acceptor distances in 
these systems may have provided a significant source of error, and the authors admit that end 
fraying, conformational changes, or other nondescript duplex dynamics may be the source of 
the anomalous distance-dependent behaviors. Tor excluded any role of the DNA duplex in 
mediating energy transfer beyond providing the structurally defined spatial organization. 
This conclusion was based on the observation that the ethynyl-linked and ethylene-linked 
bipyridyl complexes gave similar distance dependences. This conclusion is in contrast to the 
results of Barton and coworkers who demonstrated a significant role for the DNA duplex 
during energy transfer processes.22 
17 
 
 
 
 
 
Figure 1.9 (a) Ethynyl-linked nucleosides containing RuII and OsII bipyridyl complexes. The 
rigid alkyne bridge was designed to project the bipyridyl complexes away from the DNA 
base stack. (b) The ethylene-linked nucleoside containing RuII was designed to allow 
isotropic motion of the donor moiety prior to energy transfer.  
 C. Purpose of this work 
 We have studied RuII to OsII energy transfer using a designed coiled-coil -helical 
peptide scaffold. The positional dependence for energy transfer in these systems has been 
established and corroborated with the appropriate control experiments. The design of the 
coiled-coil scaffold used throughout this work is described in Chapter II. The synthetic 
techniques required to access these metallopeptides are described in Chapter III. The physical 
characterization of these metallopeptides, including binding constants required for 
interpretation during energy transfer studies, is described in Chapter IV. A full evaluation of 
the RuII to OsII energy transfer behaviors for these coiled-coil metallopeptides, including the 
positional dependence, is described in Chapter V. A new strategy for attaching RuII-
containing metallopeptides to nanocrystalline semiconductors, including TiO2, is described in 
Chapter VI. 
The ultimate goal for the development and study of these coiled-coil metallopeptides 
is to provide a new platform for the study of energy transfer. The coiled-coil peptide scaffold 
represents a new chemical environment for the study of RuII to OsII energy transfer 
processes. We hope that this metallopeptide system will be used to further the understanding 
(a) 
 
(b) 
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of energy transfer mechanisms between RuII and OsII bipyridyl complexes. The individual 
roles of synthetic chemists, spectroscopists, and theoreticians have never been truly discrete 
within the field of energy transfer study. We hope that our coiled-coil metallopeptide system 
will contribute to the field of energy transfer study in the same manner the research discussed 
throughout Chapter I already has. 
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Chapter II 
DESIGN OF -HELICAL COILED-COILS FOR THE STUDY OF ENERGY TRANSFER 
BETWEEN RUII AND OSII BIPYRIDYL COMPLEXES 
  
 A. General design principles for coiled-coil peptides 
The coiled-coil structural motif is comprised of multiple -helical peptides wrapped 
around each other in a left-handed supercoiled arrangement.1 Coiled-coil domains typically 
contain between two and seven -helical peptide segments and are perhaps the most widely 
studied group of protein structural units (Figure 1.1). A significant portion of what we know 
about natural protein folding behavior has been established based on the exhaustive study of 
thermodynamic driving forces and structure-determining elements for coiled-coil 
association.2 Coiled-coil assemblies now represent arguably the most complex class of de 
novo designed proteins.3 Different coiled-coil motifs hold promise for application in affinity 
tagging, surface functionalization, supramolecular chemistry, and biotechnology applications 
including tissue engineering.4,5 
The coiled-coil motif was originally identified by Francis Crick to be the primary 
structural element of -keratin, the well known scleroprotein .6 At the time, several 
researchers had identified that -helices, the common secondary structural element 
discovered by Linus Pauling only one year earlier,7 constituted an important part of -
keratin. Crick realized that certain X-ray diffraction patterns for -keratin could only be 
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rationalized if the -helical segments present in -keratin were tilted and wrapped around 
each other in a tangled arrangement.6 Crick also put forth a simple model for coiled-coil 
sidechain packing arrangements known as the “knobs-into-holes” rationale that is still the 
currently accepted model. Since that initial discovery, coiled-coil structures have been 
identified in any number of proteins including transcription factors that regulate gene 
expression,8 chaperone proteins that promote the correct folding of other proteins,9 and actin-
binding proteins that regulate muscle contraction.10 
   (a)                                        (b)                                           (c)  
  
 
 
 
 
 
Figure 2.1. Crystal structures are shown for several coiled-coil peptides indicating the 
variety of oligomerization states available. (a) A dimeric coiled-coil structure (pdb code: 
1A93). (b) A trimeric coiled-coil structure (pdb code: 3GJP). (c) A heptameric coiled-coil 
structure (pdb code: 2HY6). A single -helical subunit in each structure is highlighted in 
blue for clarity. 
All of the coiled-coil structures described to date, both natural and synthetically 
designed, contain a common seven residue repeating sequence known as a heptad unit.1 The 
amino acid positions of the heptad unit are typically designated with the letters a, b, c, d, e, f, 
and g. This common heptad repeat sequence is a consequence of the -helical structures 
found within coiled-coil subunits. Since -helices have approximately 3.6 residues per turn, 
an amino acid residue will repeat along the vertical axis of the helix every seven residues. 
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Placing hydrophobic residues at the a and d positions (first and fourth within the heptad) 
creates a highly nonpolar surface that provides the primary driving force for association via 
solvent exclusion. Ile and Leu residues are often specifically chosen for the a and d sites, 
respectively, when a parallel dimeric coiled-coil structure is desired.11 -Branched aliphatic 
residues at the a positions (typically Val or Ile), in combination with Leu residues at the d 
positions, are superior promoters for parallel dimeric structures due to geometric packing 
requirements.11 The intermolecular interactions that commonly stabilize the coiled-coil 
structure can be schematically represented using a helical wheel diagram (Figure 1.2a). 
Amino acids corresponding to the e and g positions are directly adjacent to the coiled-
coil interface and are capable of making secondary interactions during folding (Figure 
1.2a,c). These positions are typically designed (or evolved) with oppositely charged residues, 
most often Lys and Glu, in order to provide complementary charge-charge interactions.12 
These residue positions not only serve to positively reinforce a desired folding pattern, but 
additionally serve as negative control elements since many undesired folding arrangements 
may be disfavored by charge-charge repulsions.12 The remaining b, c, and f positions within 
a coiled-coil structure do not typically provide favorable interhelix interactions (Figure 1.2a). 
These residues are typically hydrophilic in nature and serve to reinforce the general 
amphipathic nature of the coiled-coil. High helical propensity is quite common, but not 
absolutely required, for most amino acids in coiled-coil structures. Based on the previously 
described design principles, it is of no surprise that Gly, Cys, and Pro occur much less 
frequently the coiled-coil secondary structure when compared to protein sequences in 
general.2  
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Figure 2.2. (a) A typical helical wheel diagram used to represent the stabilizing forces 
present in a dimeric coiled-coil. Hydrophobic contacts (between a and d positions) are shown 
as solid black lines. Salt bridges between charged residues (e and g) are shown as dashed 
lines. The single solid red line represents the Asn-Asn hydrogen bond present within a single 
a layer of the coiled-coil. (b) Crystal structure (pdb code: 2ZTA) showing the hydrophobic 
packing arrangement of the a and d positions (blue spheres). The hydrogen bonded Asn-Asn 
pair is also shown (red stick model). Amino acid sidechains are only shown for a and d 
position amino acids in order to improve clarity. (c) Two heptads of the crystal structure 
(structure was truncated and rotated 90° along the longitudinal axis of the coiled-coil) are 
shown in order to highlight four distinct salt bridges. All four ionic interactions are made 
between Lys (blue) and Glu (red). 
Perhaps the most important negative design principle that has been established for 
coiled-coil sequences is the selective inclusion of buried polar residues within the 
hydrophobic interface. Like most coiled-coil design principles, the strategy is based on 
(a)  
 
(b) 
(c) 
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observations of natural coiled-coil domains in proteins.13 Polar residues, such as Asn, when 
included at two complementary a positions must satisfy their hydrogen bonding potential, 
and impart folding specificity through mutual alignment (Figure 1.2a,b). Although the 
incorporation of two asparagine residues within the hydrophobic core of a parallel coiled-coil 
dimer interface is slightly destabilizing, alternative arrangements required for the undesired 
structures including trimers, tetramers, antiparallel dimers, and misaligned dimers are far 
more destabilizing. 13 Oakley and Kim were able to measure an energetic cost of 2.3 
kcal·mol-1 for the antiparallel alignment of two sequences including Asn at complementary a 
positions. 
B. Previous work of interest using coiled-coil peptides 
A coiled-coil structure has not previously been used to study the mechanism or 
distance dependence of energy transfer between RuII and OsII bipyridyl complexes. Ogawa 
and coworkers studied both ground state and photoexcited state electron transfer in a series of 
dimeric coiled-coil peptides.14 These designed metallopeptides were typically constructed 
using ruthenium pentaammine [Ru(NH3)5-] derivatized His residues as electron donors and 
ruthenium polypyridyl ([Ru(bpy)(Im)-], [Ru(trpy)(bpy)-], or [Ru(bpy)2(phen)-]) derivatized 
His residues as electron acceptors. Ogawa’s work demonstrated that peptide primary 
sequence and secondary structure can be used to direct intermolecular electron transfer 
between dimers.14c Ogawa also showed that biomimetic electron transfer could be directed 
across the hydrophobic interface within a single coiled-coil metallopeptide.14b Ogawa used 
similarly designed coiled-coil metallopeptides to probe the effects of -helix dipole on 
intramolecular electron transfer, but was unable to determine an effect on rate due to the 
coiled-coil macrodipole.14e 
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Ogawa’s examples of intradimer electron transfer all employed nonspecific 
homodimeric coiled-coil sequences. The peptides were chemically derivatized differentially, 
but peptide primary sequence was identical and was not designed to favor donor/acceptor 
assembly. As a result, these donor/acceptor mixtures contained statistical quantities of the 
desired donor/acceptor partners along with undesired partners (donor/donor and 
acceptor/acceptor) incapable of electron transfer behavior. 
Ogawa investigated a heterodimer metallopeptide system, presumably in order to 
induce a more specific donor/acceptor interaction.14c The designed heterodimer contained 
Glu residues at all of the e and g positions within one peptide sequence, and Lys residues 
within all of the e and g positions of the complementary sequence. As previously described, 
this arrangement favors a partnering of the heterodimer with complementary charge-charge 
interactions, but disfavors homodimers where significant repulsions between like charges 
will result. Interestingly, electron transfer in this designed heterodimer did not occur across 
the coiled-coil scaffold, but instead occurred between coiled-coil heterodimers in solution. 
This drastic change in behavior was attributed to complementary charges surrounding the 
donor/acceptor complexes on the exterior surfaces of the heterodimer. None of Ogawa’s 
coiled-coil sequences included an Asn-Asn interaction as a negative control feature. 
C. Current system design 
 A designed heterodimeric coiled-coil structure was selected as the scaffold for 
studying energy transfer in the current system. The primary sequences were adopted and 
modified from the heterodimeric self-assembled fiber (SAF) system originally reported by 
Woolfson and coworkers (Figure 1.3a).15 Woolfson’s SAF peptides were designed with a 
primary sequence meant to provide complementary interactions that promote a staggered 
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heterodimer structure referred to as the “sticky-ends” design (Figure 1.3b).15 These staggered 
interactions, or “sticky ends”, promote dimer-dimer association and subsequent fiber 
formation. The P1 and P2 peptides are both 28 residue sequences, and the P2 peptide remains 
unchanged from several of Woolfson’s publications.15b-e Both peptide sequences contain two 
positively charged heptad repeat units (Lys at all e and g positions) and two negatively 
charged heptad repeat units (Glu at every e and g position). The P1 peptide has these charged 
heptads rearranged from Woolfson’s sequence in order to discourage longitudinal 
association, and therefore fiber formation (Figure 1.3a). Natural coiled-coil peptides all share 
this “blunt” end assembly. Woolfson demonstrated that this simple permutation fails to 
oligomerize beyond the dimer state, and therefore does not form fibers.15a As previously 
described, Asn substitutions at a positions play a critical role within both systems. These 
substitutions prevent the two peptides from associating in an antiparallel fashion, an 
undesired arrangement where charge-charge interactions would remain favorable. 
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Figure 2.3 (a) The primary sequences for the P1 and P2 peptides are given using single letter 
amino acid codes in capitals. The letter designations for the heptad positions are labeled 
(lower case) for the first heptad only. Hydrophobic contacts made by Ile and Leu residues are 
represented as solid black lines. The hydrogen bonded Asn-Asn brace is represented as a red 
line. The complementary charge-charge interactions between Lys and Glu residues are 
represented as dashed lines. For a schematic representation of these interactions see Figure 
1.2a. The “blunt” ends assembly pattern that the P1 and P2 peptide sequences produces is 
also represented as a simple diagram below the primary sequences. (b) The “sticky-ends” 
assembly produced by Woolfson’s original sequence is schematically represented. 
 D. Conclusions for the system design 
The P1 and P2 sequences were selected in order to form the most desirable coiled-coil 
structures suitable for the study of energy transfer. The heterodimeric design was chosen to 
favor conditions where donor/acceptor structures can be easily examined with minimal 
influence due to homodimer formation. The sequences contain both positively charged and 
negatively charged heptad repeat units, so no single electrostatic potential dominates the 
surfaces of either peptide. Because studying the mechanisms, including any observable 
(a) 
 
 
(b) 
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position dependence, was the governing intent of this research, two Asn residues are included 
in order to enforce the alignment of the two peptides. This strict conformational preference 
should make the identification of any position dependence simpler, since subtle yet undesired 
conformational isomers will be strongly discouraged. 
Woolfson’s established route towards micro-feature protein fibers served as further 
encouragement for the selection of this sequence. It was anticipated that if an efficient energy 
transfer system were developed on the molecular level, it could potentially be expanded 
towards functional materials for use as light harvesting antennae in solar cells and artificial 
photosynthetic constructs.15e 
The coiled-coil peptide structure represents an interesting, and previously 
uninvestigated, scaffold for studying energy transfer between RuII and OsII containing 
bipyridyl complexes. A multitude of positions could have potentially been modified for the 
study of energy transfer. The P1 peptide was ultimately modified with an OsII bipyridyl 
complex at the 2c, 2f, and 2g positions in order to study energy transfer. The OsII-containing 
metallopeptides are referred to as 2c-Os, 2f-Os, and 2g-Os throughout the rest of the report. 
The P2 peptide was similarly modified with a RuII bipyridyl complex at the 2b, 2e, and 2f 
positions in order to produce the 2b-Ru, 2e-Ru, and 2f-Ru metallopeptides. The development 
of the chemistry used to modify the coiled-coil scaffold and synthesize the metallopeptides is 
described in Chapter III. The choice of substitution positions and how they relate to both 
coiled-coil structure and the study of energy transfer is described in Chapter IV. The 
metallopeptides exhibit position-dependent energy transfer behavior that is related to their 
design and structure. The full characterization of this position-dependent energy transfer is 
described in detail within Chapter V. 
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Chapter III 
SYNTHESIS OF METALLOPEPTIDES 
  
 A. Synthesis of [Ru(bpy)3]2+- and [Os(bpy)3]2+-containing metallopeptides 
 i. Background for [Ru(bpy)3]2+- and [Os(bpy)3]2+-containing amino acids 
A number of redox-active amino acids containing RuII and OsII bipyridyl complexes 
have previously been reported.1 Meyer and coworkers developed a method for the acylation 
of lysine at the -N using bipyridyl-4-carboxylic acid complexes of RuII and OsII (Figure 
3.1a).1a The [Ru(bpy)3]2+-modified lysine complex could be incorporated into polyalanine -
helices and other simple peptides for the study of photoinduced electron transfer. Geisser and 
coworkers extended this method to prepare shorter chemical analogs with fewer methylene 
spacers (Figure 3.1b).1b Kise and Bowler developed a method for synthesizing a 
[Ru(bpy)3]2+-containing amino acid with a single methylene group linking the bipyridyl 
complex to the amino acid -carbon (Figure 3.1c).1c,d Their method relied on a 
cinchonidinium bromide catalyst under phase-transfer conditions. The [Ru(bpy)3]2+-
containing amino acid developed by Kise and Bowler could also be incorporated into -
helices, although specialized coupling conditions were required. Meyer and coworkers also 
prepared several [Ru(bpy)3]2+-containing proline derivatives for incorporation in polyproline 
helices, another common type of protein secondary structure.1e All of the amino acid 
derivatives discussed are convenient because they can be incorporated into metallopeptides 
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in a site-specific manner using routine solid-phase peptide synthesis (SPPS) protocols. 
Common drawbacks for these amino acid derivatives include the need for longer coupling 
times, more exotic coupling reagents, and often diminished yields relative to standard amino 
acids. All of these redox-active amino acids suffer from the fundamental drawback that they 
can only be used in the context of linear synthetic approaches. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Previously reported redox-active amino acids. (a) Meyer and coworkers 
developed procedures for preparing [Ru(bpy)3]2+- and [Os(bpy)3]2+-containing lysine 
derivatives (MII = RuII or OsII). (b) Geisser and coworkers prepared similar (RuII only) amino 
acids with shorter linkers (n = 1, 2, and 3). (c) Kise and Bowler developed a [Ru(bpy)3]2+-
containing amino acid with a single methylene group as the linker to the amino acid 
backbone. (d) Meyer and coworkers also developed a [Ru(bpy)3]2+-containing proline 
derivative. 
 
33 
 
Meyer’s method of employing -N derivatized lysine amino acids was anticipated to 
be the most amenable for incorporating RuII and OsII bipyridyl complexes in coiled-coil 
peptide structures. As discussed in Chapter II, a [Ru(bpy)3]2+-containing proline would 
almost certainly be destabilizing towards a coiled-coil peptide structure due to the inherently 
low helix propensity of the amino acid proline. The shorter amino acids (Figure 3.1b,c) were 
also initially disregarded due to the potentially destabilizing effect they may have on the 
coiled-coil peptide structure. To the best of our knowledge, all reported [Ru(bpy)3]2+-
containing amino acids are Boc-protected at the -N for use with Boc/benzyl synthetic 
strategies. 
 ii. Synthesis of [Ru(bpy)3]2+- and [Os(bpy)3]2+-containing Fmoc-lysine derivatives 
 RuII- and OsII-containing Fmoc-protected amino acids were developed for use with 
Fmoc-based synthetic strategies. Fmoc-based SPPS does not require the use of anhydrous 
hydrofluoric acid, or the specialized equipment associated with it, in order to cleave peptide 
products from the solid support,.2 Fmoc-based chemistry is generally considered safer 
compared to Boc-based SPPS chemistry for these reasons.  
The developed synthetic strategy started with the commercially available ligand, 4,4’-
dimethyl-2,2’-dipyridine (1) (Figure 3.2). Selective oxidation of 1 to the monoaldehyde (2) 
using selenium dioxide, has been reported by Bergstrom and by Peek.3a,b Oxidation to the 
carboxylic acid (3) can be affected using silver oxide.3b The succinimidyl ester can be 
produced using standard coupling conditions (4).3c Diisopropylcarbodiimide was typically 
the coupling reagent of choice, although DCC or EDC could both be used as well. The 
succinimidyl ester could subsequently be reacted with -N-Fmoc-L-lysine in order to 
produce the desired bipyridyl ligand (5). Reaction of 5 with either Ru(bpy)2Cl2 or 
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Os(bpy)2Cl2 by heating at reflux in H2O/EtOH (1:1, v:v) yielded the desired RuII- and OsII-
containing Fmoc-protected amino acids 6a and 6b, respectively.4 The amino acids were 
typically isolated as the hexafluorophosphate salts in good yield. 
 
Figure 3.2 Synthesis of Fmoc-protected amino acids containing both RuII and OsII bipyridyl 
complexes (6a, 6b). Conditions: (a) SeO2 (1.01 equiv), 1,4-dioxane, 100 °C, 24 hours. (b) 
AgNO3 (1.1 equiv), NaOH, H2O/EtOH, RT, 15 hours. (c) N-Hydroxysuccinimide (1.0 
equiv), DIC (1.2 equiv), DMF, 8 hours. (d) -N-Fmoc-L-Lysine (1.1 equiv), N-
methylmorpholine (2.5 equiv), DMF, RT, 6 hours (77%). (e) Ru(bpy)2Cl2 or Os(bpy)2Cl2, 
H2O/EtOH, 90 °C, HPF6 (6a 70%, 6b 60%). 
The amino acids 6a and 6b could be incorporated into metallopeptides during 
standard SPPS using procedures typical for Fmoc-protected amino acids. Yields for 
metallopeptides synthesized in this manner were somewhat lower compared to peptides 
containing only the canonical amino acids. Multiple attempts were made to couple the redox-
active Fmoc-protected amino acids using HATU at 50 °C. Although this procedure had been 
35 
 
useful for other researchers trying to couple large [Ru(bpy)3]2+-containing amino acids, in the 
authors hands it produced no noticeable improvement in peptide yield.1c Fmoc-deprotection 
reactions are typically performed under highly basic conditions in the presence of 
nucleophilic scavenger for dibenzofulvene.2 Piperidine can serve as both base and scavenger 
in these reactions. After the coupling of 6b, washing the SPPS resin did not lead to any 
coloring of the wash solvent after several wash aliquots. However, it was observed that 
solutions used for the deprotection reactions became slightly colored in a manner 
characteristic to OsII bipyridyl complexes. This observation was apparent whether 
deprotection reactions were performed using 20% piperidine or 2% piperidine/2% DBU. 
Despite the high level of kinetic stability reported for RuII and OsII bipyridyl compounds 
(Chapter I),5 it is not unreasonable to conclude that inefficiencies observed when trying to 
incorporate 6a or 6b during SPPS resulted from an intolerance to the deprotection reaction 
conditions, and not from incomplete coupling reactions. This conclusion is supported by 
reports from other researchers who employed similar coupling condition for the 
incorporation of sterically hindered [Ru(bpy)3]2+-containing amino acids, but did not require 
Fmoc-deprotection during synthesis.1c 
 The metallopeptides 2f-Os* and 2f-Ru* were synthesized by incorporating 6b and 6a, 
at the 2f positions within P1 and P2, respectively. The asterisk label is used to differentiate 
these metallopeptides from those described below which contain different linkers to the 
peptide scaffold. Although the 2f-Os* and 2f-Ru* peptides did form stable coiled-coil 
structures, this approach towards synthesizing metallopeptides was abandoned for the more 
convergent synthetic strategy described below. 
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iii. Development of the CuAAC reaction for synthesizing metallopeptides  
A convergent synthetic strategy allows peptide, chemical linker, and bipyridyl 
complex to be easily varied for systematic optimization and study. The criteria for a 
convergent synthetic strategy were considered as follows: (1) is the synthetic process high 
yielding?; (2) is the process orthogonal to the chemistry normally used to synthesize peptides 
(e.g. SPPS conditions)?; (3) can the byproducts of the process be removed from the product 
easily?; and (4) can the reactants and materials needed throughout the process be easily 
synthesized or obtained commercially? 
There were a number of conjugation reactions that could have met the criteria for a 
more convergent synthesis of [Ru(bpy)3]2+- and [Os(bpy)3]2+-containing metallopeptides. The 
Staudinger reaction, nucleophilic addition to a Michael acceptor, and palladium catalyzed 
coupling reactions were all considered possible routes for the attachment of [Ru(bpy)3]2+ and 
[Os(bpy)3]2+ complexes convergent with traditional SPPS.6 The Cu(I)-catalyzed azide-alkyne 
1,3-dipolar cycloaddition (the CuAAC, or “click” reaction) provides general and robust 
conditions for bioconjugation.7 The CuAAC reaction typically yields one exclusive 
regioisomer (1,4-triazole) in an extremely high yield with no resultant stereocenters. Both the 
alkyne and azide functional groups are tolerant to all of the chemical conditions used during 
routine SPPS, as is the triazole product. It was known from the outset that introducing azide 
functionality into amino acids was quite general,8 and that several alkyne-functionalized RuII 
and OsII bipyridyl complexes had previously been reported.9 It was also anticipated that Cu(I) 
and other reagents used for the CuAAC could be easily removed using purification 
techniques typical for peptide isolation. 
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 -Fmoc--azido-L-lysine (8) was chosen as the azido amino acid for the CuAAC 
reaction based on the desire to maintain a flexible four methylene linker (Figure 3.3).10 The 
azido amino acid (8) could be easily synthesized by the Cu(II)-catalyzed diazotransfer 
reaction with the -amino acid (7). Imidazole-1-sulfonyl azide (9) was typically employed as 
the diazotransfer reagent,11 although triflyl azide could also be used to affect the same 
transformation. The diazotransfer reagent (9) provided the advantage that it could be stored 
for months without losing potency, while triflyl azide must be prepared and used within a 
short a period of time. Both reagent have the potential for highly exothermic reactions and 
must be treated as detonation hazards.12 
 
Figure 3.3 Synthesis of -Fmoc--azido-L-lysine (8) by diazotransfer from sulfonyl-
imidazole-azide (9). Conditions: (a) sulfonyl-1-imidazole azide (9) (1.2 equiv), potassium 
carbonate (2.0 equiv), copper(II) sulfate pentahydrate (0.01 equiv), MeOH, RT, 18 hours 
(81%). 
 The alkyne functionalized ligand (10) could be easily synthesized from the previously 
described monocarboxylic acid (3) using standard coupling conditions. Reaction of 10 with 
either Ru(bpy)2Cl2 or Os(bpy)2Cl2 by heating at reflux in H2O/EtOH yielded the desired 
alkyne functionalized bipyridyl complexes 11a and 11b, respectively (Figure 3.4). Bipyridyl 
complexes of RuII and OsII containing the propargyl amide group (10) have spectroscopic 
properties very similar to those of the parent compounds, [Ru(bpy)3]2+ and [Os(bpy)3]2+.9f 
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Figure 3.4 Synthesis of the alkyne-containing bipyridyl complexes 11a and 11b using the 
propargyl amide ligand 10. Conditions: (a) N-Hydroxysuccinimide (1 equiv), EDC (1.1 
equiv), ACN, 4 hours, propargyl amine (1.1 equiv), 12 hours. (b) Ru(bpy)2Cl2 or 
Os(bpy)2Cl2, H2O/EtOH, 90 °C, HPF6 (11a 98%, 11b 84%). 
Metallopeptides could be easily prepared by first synthesizing azidopeptides with -
Fmoc--azido-L-lysine incorporated at the desired point of (11a/11b) attachment during 
SPPS (Figure 3.5). The azido group is completely orthogonal to both the extremely basic 
(piperidine, DBU, DIPEA) and extremely acidic conditions (TFA) used during SPPS. 
Azidopeptides could be cleaved from the solid-phase support using standard procedures. 
Purification was performed using RP-HPLC. Yields for azidopeptides were comparable to 
yields for peptides containing only the standard amino acids. 
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Figure 3.5 Convergent synthesis of metallopeptides starting with the synthesis of 
azidopeptides using -Fmoc--azido-L-lysine (8). Conditions: (a) Standard SPPS with m 
residues; Coupling steps: Fmoc-amino acid (5 equiv), HBTU (4 equiv), HOBt (4 equiv), 
DIPEA (5 equiv), DMF/NMP, 2 x 1 hour; Deprotection steps: 20% piperidine, DMF, 2 x 15 
minutes; -Fmoc--azido-L-lysine (8) (1.5-2 equiv), HBTU (2 equiv), HOBt (2 equiv), 
DIPEA (4 equiv), DMF, 1 x 3 hours; Standard SPPS with n residues. (b) Cleavage from the 
SPPS support: TFA:TIPS:water (95:2.5:2.5), 3 hours; purification: RP-HPLC. (c) CuAAC 
reaction: 11a or 11b (2 equiv), [Cu(CH3CN)4]PF6 (2 equiv), tris(triazolyl)methylamine 
ligand (12) (1 equiv), buffer (10 mM phosphate buffer, pH 8.5)/DMF (1:1; v:v), 24-48 hours; 
purification: size exclusion chromatography, RP-HPLC. (d) The tris(triazolyl)methylamine 
ligand (12) could be prepared from tripropargylamine by reaction with methyl azidoacetate 
(4 equiv), DIPEA (3 equiv), [Cu(CH3CN)4]PF6 (0.3 equiv), 24 hours, 83%. 
Conjugation of 11a and 11b to the azidopeptides required optimization of the CuAAC 
reaction (Figure 3.5). The CuAAC reaction can proceed under acidic or neutral conditions, 
but is typically promoted by the addition of an exogenous base, or by the use of alkaline 
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buffered media.7 Reaction pH was critical in the developed metallopeptide system. The 
CuAAC reaction proceeded much more quickly when a basic (pH 8.5) phosphate buffer was 
used compared to neutral (pH 7) buffered solutions. The parent peptide sequences and the 
azidopeptides had solubility properties that varied considerably with pH. Under acidic 
conditions the peptides were readily soluble in water, methanol, and acetonitrile to a lesser 
extent. Purification by RP-HPLC under acidic conditions was not met with difficulty. 
However, attempts to determine the azidopeptide concentration using the molar absorptivity 
of tyrosine in 5M guanidinium hydrochloride (pH 7) failed to give reliable results, 
presumably due to insolubility of the azidopeptides in the highly concentrated stock 
solutions. Alternatively, CuAAC reactions could be performed simply by massing out 
azidopeptide solids, or by solution transfer to a tared vial using methanol as the transfer 
solvent. Azidopeptides were considerably less soluble in the basic aqueous media required 
for the CuAAC reaction. Cosolvents such as DMF were typically employed in order to 
solubilize the azidopeptides. The cosolvents DMSO and tBuOH could also be used to 
solubilize the azidopeptides in water. Interestingly, while methanol and acetonitrile were 
good solvents for the azidopeptides under acidic conditions, these solvents were extremely 
inept under the basic reaction conditions. 
Any number of copper(I)-catalysts have been shown competent in the CuAAC 
reaction.7c The in situ reduction of copper(II) sulfate to copper(I) using sodium ascorbate has 
perhaps been the most widely employed catalysts system. Tetrakis(acetonitrile)copper(I) 
hexafluorophosphate was typically employed as the precatalyst in the metallopeptide 
syntheses, and therefore did not require any in situ reduction process, although the 
copper(II)/ascorbate system has been employed by other researchers within the laboratory for 
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similar CuAAC reactions. It was commonly observed that reaction mixtures containing a 
tris-(triazolylmethyl)amine ligand (12) demonstrated shorter reaction times, and increased 
yields compared to reaction mixtures lacking the ligand.13 The reaction will proceed without 
the ligand (12) if higher equivalents of the copper(I)-catalysts are used (~ 10 equiv of 
copper(I)), but byproducts of peptide oxidation were observed under these conditions. 
Tetravalent ligands such as the tris-(triazolylmethyl)amines have been proposed to protect 
the copper(I)-catalyst metal center from oxidation and therefore maintain higher 
concentrations of active catalyst during reaction.13 Indeed, cyclic voltammetry studies 
showed that tris-(triazolylmethyl)amine ligands can increases the Cu(I)/Cu(II) redox couple 
by close to 0.3 V.13 Other researchers have proposed the effect of these ligands is not on the 
copper oxidation state, but on the copper aggregation state.7c In the absence of accelerating 
ligands the CuAAC reaction, under certain circumstances, demonstrates kinetics that are 
second order in Cu(I) and sometimes higher than first order in alkyne.14 Many copper(I) 
compounds exist as assortments of aggregates in solution. For example, CuI in acetonitrile 
exists as number of aggregated species, ranging from Cu2I2 to Cu7I7 .7c Complexes of 
copper(I) and tris-(triazolylmethyl)amine ligands crystallize as bimetallic dimers where each 
copper center shares one triazole ring with the other.15 The concept that bimetallic (or higher 
order) copper(I) aggregates are the true catalytic species in the CuAAC reaction would help 
to explain many of the observations made regarding the reaction. The optimized CuAAC 
conditions for metallopeptide synthesis employed one equivalent of the tris-
(triazolylmethyl)amine ligand, while two equivalents of the copper(I) catalyst and alkyne 
were used (11a or 11b). This was done to prevent the accidental addition of excess tris-
(triazolylmethyl)amine ligand, since this has been shown to inhibit other CuAAC reactions,16 
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and also because one equivalent of the ligand was sufficient to promote the desired reaction. 
The CuAAC reactions between the azidopeptides and 11a or 11b were often complete in 
several hours, although reaction times of at least one day were typically employed. After the 
conjugation reactions were complete, the reaction mixtures were diluted tenfold with water, 
frozen, and lyophilized. The desired metallopeptides could be purified using a combination 
of size-exclusion chromatography and RP-HPLC as described in the experimental section. 
iv. Conclusions 
Several methods for synthesizing [Ru(bpy)3]2+- and [Os(bpy)3]2+-containing 
metallopeptides have been presented throughout this chapter. Methods for the synthesis of 
Ru(bpy)3]2+- and [Os(bpy)3]2+-containing amino acids have been presented, along with 
techniques for their incorporation during SPPS. Also presented in this chapter is a convergent 
method for metallopeptide synthesis where alkyne functionalized RuII (11a) and OsII (11b) 
complexes could be conjugated to azidopeptides by way of a CuAAC reaction. The use of a 
tris-(triazolylmethyl)amine ligand (12) to accelerate the conjugation reaction was also 
described. As mentioned in Chapter II, the 2b, 2e, and 2f positions within the P2 peptide 
sequence were selected for the incorporation of -Fmoc--azido-L-lysine and modification 
with 11a in order to produce metallopeptides that could serve as excited-state energy donors. 
These donor metallopeptides are from here on out referred to as the 2b-Ru, 2e-Ru, and 2f-Ru 
metallopeptides. The P2 designation corresponding to the original parent sequence that was 
modified is implied, but not explicitly listed. The 2c, 2f, and 2g positions within the P1 
peptide sequence were similarly modified with 11b in order to produce metallopeptides that 
could serve as excited-state energy acceptors. These acceptor metallopeptides are from here 
on out referred to as the 2c-Os, 2f-Os, and 2g-Os metallopeptides. The synthetic procedures 
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required to synthesize the parent peptides (P1 and P2), azidopeptides, metallopeptides, and 
all needed precursors described throughout Chapter III are presented within the following 
experimental section. 
The spectroscopic properties of the synthetic metallopeptides were similar to those of 
Ru(bpy)32+ and Os(bpy)32+ (Figure 3.6a). Absorbance bands due to the -*, 1MLCT, and 
3MLCT transitions of the bipyridyl complexes dominate the spectra. The metallopeptide 
steady-state emission spectra also resemble those of the parent complexes (Figure 3.6b). The 
emission maxima for the RuII- and OsII-containing metallopeptides, approximately 660 and 
800nm, respectively, are both hypsochromically shifted relative to Ru(bpy)32+ and 
Os(bpy)32+. The photophysical properties of mixtures of the metallopeptides indicate a 
position-dependent energy transfer between the donor (RuII) and acceptor (OsII) 
metallopeptides. The study of this energy transfer is reported later in Chapter V. The physical 
characterization of the coiled-coil metallopeptides is described beforehand in Chapter IV. 
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Figure 3.6 (a) Absorbance spectra for the 2f-Ru metallopeptide show -* and 1MLCT 
transitions characteristic to RuII bipyridyl complexes. Absorbance spectra for the 2f-Os 
metallopeptide show -*, 1MLCT, and also 3MLCT transitions characteristic only to OsII 
bipyridyl complexes. Absorbance spectra were recorded at 25°C in 10 mM PO43-, pH 7, 
buffer. (b) Normalized steady-state emission spectra for the 2e-Ru and 2g-Os metallopeptides 
with emission maxima at approximately 660 and 800 nm. Emission spectra were recorded at 
25°C in 10 mM PO43-, pH 7, buffer that was deoxygenated with Ar for 30 minutes. 
 B. Experimental section 
i. Materials and general methods 
Solvents were purchased from Fisher Scientific and were used as received unless 
noted otherwise. cis-Dichlorobis(2,2’-bipyridine)ruthenium(II) dihydrate was purchased from 
Strem Chemicals. All -N-Fmoc-amino acids, including -N-Fmoc-lysine, were purchased 
from Novabiochem. Tetrakis(acetonitrile)copper(I) hexafluorophosphate, 2,2’-bipyridine, 
(a) 
 
(b)
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and 4,4’-dimethyl-2,2’-bipyridine were purchased from Aldrich. The compounds 4’-methyl-
2,2’-bipyridine-4-carboxaldehyde, 4’-methyl-2,2’-bipyridine-4-carboxylic acid, and 
succinimidyl-4-carboxy-4’-methyl-2,2’-bipyridine were synthesized according to reported 
procedures.3 cis-Dichlorobis(2,2’-bipyridine)osmium(II) was synthesized using the procedure 
reported by Meyer.4 Deuterated solvents were purchased from Cambridge Isotope 
Laboratories. 1H and 13C NMR spectra were recorded at 400 and 100 MHz, respectively, on 
Bruker spectrometers. Chemical shifts were given in ppm relative to solvent peaks 
corresponding to residual protons for the deuterated solvents. These values were taken as δ 
7.26, 1.93, 2.49, 5.32 and 4.67 for CDCl3, CD3CN, (CD3)2SO, CD2Cl2, and D2O, 
respectively. Coupling constants are given in hertz. The details for peptide synthesis and 
purification are provided below. High-resolution and low-resolution mass spectra were 
obtained using a Bruker Biotof instrument.  
ii. Synthesis of [Ru(bpy)3]2+- and [Os(bpy)3]2+-containing Fmoc-lysine derivatives 
4'-Methyl-2,2'-bipyridine-4-carboxylic acid (3). The bipyridyl monocarboxylic acid 
was prepared according to the literature procedure by Peek and Erickson.3b 
Succinimidyl-4-carboxy-4'-Methyl-2,2'-bipyridine (4). The succinimidyl ester was 
prepared according to the literature procedure by Telser and Netzel.3c 
 -Fmoc--(4'-methyl-2,2'-bipyridine-4-carboxamido-)-L-Lysine (5). A suspension of 
succinimidyl-4-carboxy-4’-methyl-2,2’-bipyridine (.767 g, 2.5 mmol), N-methylmorpholine 
(0.75 mL, 6.8 mmol, 2.7 equiv), and -N-Fmoc-lysine (1.00 g, 2.7 mmol, 1.1 equiv) was 
stirred in 25 mL of anhydrous DMF for 8 hours. The solvent was removed in vacuo and the 
remaining solid residue was suspended in 0.1 M ammonium chloride and extracted into ethyl 
acetate (4 x 100 mL). The organic fractions were freed of solvent and recrystallized from 
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hexanes/diethyl ether (1:1, v:v) to give the product as a white solid (1.07 g, 1.9 mmol, 77 %). 
1H NMR (400 MHz, (CD3)2SO): δ 8.96 (s, 1H), δ 8.76 (s, 1H), δ 8.57 (s, 1H), δ 8.25 (s, 1H), 
δ 7.99-7.85 (m, 3H), δ 7.81 (s, 1H), δ 7.80-7.60 (m, 3H), δ 7.40-7.35 (m, 2H),  δ 7.32 (m, 
3H), δ 5.76 (s, 1H), δ 4.25 (m, 3H), δ 3.78 (m, 1H), δ 2.74 (m, 2H), 2.43 (s, 3H), δ 1.70-1.30 
(m, 6H); 13C NMR (150 MHz, CDCl3/CD3OD) δ 174.8, 166.0, 156.1, 155.6, 154.5, 150.2, 
150.0, 148.1, 143.8, 143.7, 143.1, 141.2, 127.6, 127.0, 125.5, 125.0, 123.0, 122.2, 119.9, 
118.0, 77.21 + 77.0 + 76.8 (CDCl3), 66.8, 53.6, 53.4, 50.4 (CD3OD), 47.1, 38.9, 31.2, 29.6, 
27.6, 26.4, 25.5, 21.6, 21.3. High-resolution ESI-MS: m/z calculated for C33H33N4O5 (M + 
H+), 565.2478; found 565.2478. 
Bis-(2,2’bipyridine)(-Fmoc--(4’-Methyl-2,2’-bipyridine-4-carboxamido-)-L-
lysine)ruthenium(II) bis(hexafluorophosphate) (6a). A small round bottom, equipped with a 
condenser, was charged with cis-dichlorobis(2,2’-bipyridine)ruthenium(II) dihydrate (0.793 
g, 1.52 mmol), and -Fmoc--(4'-methyl-2,2'-bipyridine-4-carboxamido-)-L-Lysine (5) (1.03 
g, 1.82 mmol, 1.2 equiv), and then heated at reflux in 70% aqueous ethanol for 24 h. The 
mixture was allowed to cool to room temperature, filtered, and then acidified with several 
drops of 60% aqueous HPF6. The mixture was placed in a freezer or 1 hour while a turbid 
orange precipitate formed. The solid orange product was collected on a medium frit. The 
collected product was dissolved in a minimum amount of ACN, and then added drop wise to 
a round bottom cooled in an ice bath and containing 150 mL IPA. The orange precipitate 
reformed, and was collected on a medium frit to afford the title product (1.42 g, 1.12 mmol, 
74%). TLC (n-BuOH/EtOAc/AcOH/water, 1:1:1:1); Rf: 0.48. 1H NMR (400 MHz, CD3CN): 
δ 8.91 (m, 1H), δ 8.55 (s, 1H), δ 8.48-8.40 (m, 5H), δ 8.06-8.03 (m, 5H), δ 7.91-7.74 (m, 
3H), δ 7.74-7.64 (m, 5H), δ 7.64-7.51 (m, 3H), δ 7.39-7.33 (m, 6H), δ 7.26-7.22 (m, 2H),  δ 
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6.17 (m, 1H), δ 4.23 (m, 2H), δ 4.15 (m, 1H), δ 4.08 (m, 1H), δ 3.40 (m, 2H), 2.31 (m, 3H), 
1.62 (m, 2H), 1.45 (m, 2H), 1.26 (m, 2H); UV-vis (CH3CN) max (): 235 (28,000), 255 
(31,000), 288 (70,000), 456 (14,000); High-resolution ESI-MS: m/z calculated for 
C53H48N8O5Ru (M2+), 489.1396; found 489.1333. 
Bis-(2,2’bipyridine)(-Fmoc--(4’-Methyl-2,2’-bipyridine-4-carboxamido-)-L-
lysine)osmium(II) bis(hexafluorophosphate) (6b). A small round bottom, equipped with a 
condenser, was charged with cis-dichlorobis(2,2’-bipyridine)osmium(II) (0.026 g, 0.046 
mmol), and -Fmoc--(4'-methyl-2,2'-bipyridine-4-carboxamido-)-L-Lysine (5) (0.045 g, 
0.080 mmol, 1.73 equiv), and then heated at reflux in 50% aqueous ethanol for 24 h. The 
mixture was allowed to cool to room temperature, filtered, and then acidified by several 
drops of 60% aqueous HPF6. The green mixture was extracted with EtOAc (50 mL). The 
EtOAc fraction was dried with anhydrous magnesium sulfate and freed of solvent. The solid 
product was reconstituted in a minimum volume of ACN and added drop wise to a stirring 
solution of 10 mM NH4PF6 that was cooled in an ice bath.  The green precipitate was 
collected on a medium frit to afford the title product (0.037 g, 0.027 mmol, 60%). TLC (n-
BuOH/EtOAc/AcOH/water, 1:1:1:1); Rf: 0.48. 1H NMR (400 MHz, CD3CN): δ 8.76 (s, 1H), 
δ 8.51-8.44 (m, 5H), δ 7.91-7.83 (m, 6H), δ 7.77 (d, J = 6.4, 1H), 7.67-7.62 (m, 6H), 7.58 (s, 
1H), 7.48 (d, J = 6.4, 1H), 7.41-7.38 (m, 2H), 7.34-7.29 (m, 6H), 7.22-7.29 (m, 1H), 6.10 (d, 
J = 8.4, 1H), 4.32 (d, J = 6.8, 1H), 4.22 (m, 1H), 4.14 (m, 1H), 3.57 (m, 1H), 3.45 (m, 2H), 
3.31 (m, 1H), 2.63 (s, 1.5H), 2.54 (s, 1.5 H), 1.6 (m, 3H), 1.47 (m, 3H). UV-vis (CH3CN) 
max (): 255 (29,000), 291 (60,000), 440, (10,000), 483 (10,000); High-resolution ESI-MS: 
m/z calculated for C53H48N8O5Os (M2+), 533.6642; found 534.1480. 
 
48 
 
iii. Synthesis of -Fmoc--azido-L-lysine 
-Fmoc--azido-L-lysine (8). A 100 mL round bottom was charged with α-N-Fmoc-
L-lysine (4.547 g, 12.3 mmol), imidazole-1-sulfonyl azide (9) (3.104 g, 14.81 mmol, 1.20 
equiv), and potassium carbonate (3.411 g, 24.68 mmol, 2.0 equiv). The mixture was stirred in 
MeOH (60 mL) while copper(II) sulfate pentahydrate (30.8 mgs, 123.4 μmol, 1 mol %) was 
added. A precautionary blast shield was employed while the mixture stirred under N2 for 18 
h. The reaction mixture was concentrated under vacuum, diluted with H2O (400 mL), and 
acidified via the addition of 6M aqueous HCl. The precipitate that formed was extracted with 
EtOAc (3 x 400 mL). The combined organic fractions were washed with H2O (1 L), dried 
over anhydrous Na2SO4, and concentrated under vacuum.  The product 8 was obtained as a 
white solid after chromatography on silica gel using 5% (v/v) MeOH in CH2Cl2 (3.96 g, 10.0 
mmol, 82%).  1H NMR (400 MHz, CD3OD): δ 7.69 (d, J = 7.6, 2H), δ 7.60 (t, J = 8.0, 2H), δ 
7.31 (t, J = 7.2, 2H), δ 7.24 (t, J = 7.2, 2H), δ 4.30 (d, J = 6.8, 2H), δ 4.19 (m, 1H), δ 4.13 (t, 
J = 6.8, 1H), δ 3.17 (m, 2H),  δ 1.90-1.35 (m, 6H); 13C NMR (100 MHz, CD3OD) δ 174.4, 
157.3, 143.8, 141.2, 127.4, 126.8, 124.8, 119.5, 66.6, 55.1, 53.8, 50.9, 30.9, 28.0, 22.8. High-
resolution ESI-MS: m/z calculated for C53H48N8O5Os (M2+), 533.6642; found 534.1480. 
Imidazole-1-sulfonyl azide hydrochloride (9). Imidazole-1-sulfonyl azide 
hydrochloride was synthesized according to the procedure by Goddard-Borger and Stick.11 
Warning: Potentially explosive intermediates formed during reaction.12 Synthetic operations 
were conducted behind a blast shield whenever possible. A 100 mL round bottom charged 
with sodium azide (5.47 g, 84.1 mmol) and ACN (85 mL) was cooled in an ice bath and 
stirred magnetically while sulfuryl chloride (6.81 mL, 1 equiv) was added drop wise. The 
addition was performed behind a blast shield where the reaction remained while it was stirred 
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overnight (18 h) and slowly returned to room temperature. The mixture was again cooled in 
an ice bath with stirring while imidazole (11.45 g, 168.4 mmol, 2 equiv) was added in small 
portions over the course of 20 minutes. Behind a blast shield, the mixture was allowed to 
slowly warm to room temperature while stirring for 4.5 hours. The mixture was transferred to 
a 500 mL separatory funnel and diluted with EtOAc (170 mL). The organic solution was 
washed using water (2 x 170 mL) and then saturated sodium bicarbonate (2 x 170 mL). After 
drying with anhydrous sodium sulfate, the organic portion was filtered through a cotton plug. 
An acidic solution was prepared by adding acetyl chloride (22 mL) to anhydrous EtOH (75 
mL). The addition was performed slowly (over 20 minutes) under a nitrogen atmosphere 
while the alcoholic solution was cooled in an ice bath. The filtered EtOAc solution was 
cooled in an ice bath while a portion of the acidic EtOH solution (40 mL) was added slowly. 
A white precipitate formed and the mixture was placed in a freezer (1 h) before the solid was 
collected. Drying the solid under vacuum overnight provided the title compound (10.4 g, 
49.7 mmol, 59%). 1H NMR (400 MHz, D20): δ 9.31 (s, 1H), δ 7.89 (s, 1H), δ 7.49 (s, 1H). 
iv. Synthesis of RuII and OsII bipyridyl alkyne complexes and the tris-
(triazolylmethyl)amine ligand 
4’-Methyl-2,2’-bipyridine-4-propargylamide (10). The bipyridyl propargyl amide was 
prepared according to the procedure by Khan and Grinstaff.9d The monocarboxylic acid 3 
(189 mg, 0.881 mmol) was suspended in acetonitrile (ACN) (5 mL) along with N-
hydroxysuccinimide (101 mg, 0.881 mmol).  EDC (185.9 mg, 0.9697 mmol, 1.10 equiv) was 
added. The mixture was sonicated and became more translucent while stirring for 4 h.  The 
addition of propargyl amine completely homogenized the reaction which was allowed to stir 
overnight.  The reaction was concentrated under vacuum.  The oily residue was suspended in 
50 
 
20 mL of 1 M aqueous Na2CO3, and extracted with 3 x 20 mL of ethyl acetate. The combined 
organic portions were washed with saturated aqueous NaHCO3, dried over anhydrous 
Na2SO4, filtered, and freed of solvents under vacuum. The product 10 was obtained as a 
white solid after chromatography on silica gel using 10% (v/v) MeOH in CH2Cl2 (178 mg, 
80%).  1H NMR (400 MHz, CDCl3): δ 8.79 (d, J = 4.8, 1H), δ 8.63 (s, 1H), δ 8.53 (d, J = 4.8, 
1H), δ 8.26 (s, 1H), δ 7.77 (dd, J = 4.8, 1.4, 1H), δ 7.17 (d, J = 4.8, 1H), δ 6.85 (br s, 1H), δ 
4.29 (m, 2H),  δ 2.45 (s, 3H), δ 2.30 (t, 1H); 13C NMR (100 MHz, CDCl3) δ 165.3, 157.1, 
155.0, 150.1, 149.0, 148.4, 141.9, 125.2, 122.2, 121.7, 117.4, 72.3, 29.87, 21.2.  High-
resolution ESI-MS: m/z calculated for C15H13N3O (M + H+), 252.1137; found 252.1137. 
Bis-(2,2’bipyridine)(4’-Methyl-2,2’-bipyridine-4-propargylamide)-ruthenium(II) 
bis(hexafluorophosphate) (11a). The propargyl amide derivatized RuII complex was prepared 
according to the procedure by Khan and Grinstaff.9d A small round bottom, equipped with a 
condenser, was charged with cis-dichlorobis(2,2’-bipyridine)ruthenium(II) dihydrate (101.0 
mg, 0.1941 mmol), and bipyridyl ligand 2 (55.5 mg, 0.2209 mmol, 1.14 equiv). The reagents 
were heated at reflux in 70% aqueous ethanol for 7 h, and then concentrated in vacuo. The 
residue was dissolved in water (25 mL), and then washed with EtOAc (50 mL). The aqueous 
portion was treated with several drops of concentrated aqueous NH4PF6. The microcrystalline 
product that formed was extracted into CH2Cl2 (50 mL), and washed with 10 mM aqueous 
NH4PF6. Concentration afforded the product as dark red solid (180.8 mg, 98%). 1H NMR 
(400 MHz, CD3CN): δ 8.79 (s, 1H), δ 8.54-8.52 (m, 5H), δ 8.10-8.06 (m, 4H), δ 7.90 (d, J = 
5.6 Hz, 1H), δ 7.75 (m, 5H), δ 7.66 (dd, J = 6.0, 1.6 Hz, 1H), δ 7.60 (d, J = 5.6 Hz, 1H), δ 
7.44-7.41 (m, 4H),  δ 7.31 (d, J = 5.6 Hz, 1H), δ 4.19 (m, 2H), δ 2.57 (s, 3H), δ 2.54 (m, 1H); 
51 
 
UV-vis (CH3CN) max (): 246 (26,000), 288 (60,000), 455 (13,400); High-resolution ESI-
MS: m/z calculated for C35H29N7ORu (M2+), 332.5738; found 332.5716. 
Bis-(2,2’bipyridine)(4’-Methyl-2,2’-bipyridine-4-propargylamide)-osmium(II) 
bis(hexafluorophosphate) (11b). The propargyl amide derivatized OsII complex was prepared 
according to the procedure by Khan and Grinstaff.9d A small round bottom, equipped with a 
condenser, was charged with cis-dichlorobis(2,2’-bipyridine)osmium(II) (39.7 mg, 0.069 
mmol), and bipyridyl ligand 10 (19.1 mg, 0.076 mmol, 1.1 equiv). The reagents were heated 
at reflux in 50% aqueous EtOH for 24 h, and then concentrated under vacuum. The residue 
was suspended in H2O (100 mL), and filtered to remove unreacted cis-dichlorobis(2,2’-
bipyridine)osmium(II). The aqueous filtrate was washed with DCM (2 x 100 mL). A portion 
of saturated NH4PF6 was added to the aqueous solution and a green precipitate formed. The 
precipitate was extracted into EtOAc and then concentrated to a solid under vacuum. The 
solid was partially dissolved in DCM, filtered, and then concentrated to provide the product 
as a dark green solid (18.4 mg, 26%). 1H NMR (400 MHz, CD2Cl2): δ 8.80 (d, J = 1.2 Hz, 
1H), δ 8.48 (s, 1H), δ 8.43-8.40 (m, 4H), δ 7.90-7.84 (m, 4H), δ 7.78 (t, J = 5.6 Hz, 1H), δ 
7.70-7.65 (m, 4H), δ 7.63-7.59 (m, 4H), δ 7.41-7.34 (m, 4H), δ 7.44-7.41 (m, 4H),  δ 7.21 
(dd, J = 5.8, 1.0 Hz, 1H), δ 4.20 (dd, J = 5.6, 2.4 Hz, 2H), δ 2.69 (s, 3H), δ 2.28 (t, J = 2.4 Hz 
, 1H); UV-vis (CH3CN) max (): 247 (22,000), 291 (50,000), 485 (10,000), 593 (3,000); 
High-resolution ESI-MS: m/z calculated for C35H29N7OOs (M2+), 337.6024; found 337.5952. 
tris-(triazolylmethyl)amine ligand (12). A solution of tripropargylamine (233.0 mg, 
1.777 mmol), methyl azidoacetate (805.4 mg, 6.998 mmol, 3.94 equiv), and 
tetrakis(acetonitrile)copper(I) hexafluorophosphate (21.9 mg, 58.8 μmol), and DIPEA (1 mL, 
5.741 mmol, ~3 equiv to alkyne) in ACN (4 mL) was stirred under N2 for 24 h. The reaction 
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warmed considerably when DIPEA was added and was cooled in an ice bath. The reaction 
was concentrated in vacuo, and the residue was suspended in saturated aqueous NaHCO3 (50 
mL), extracted with CH2Cl2 (3 x 50 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated. The product (5) was obtained as an off white solid after chromatography on 
silica gel using 5% (v/v) MeOH in CH2Cl2.  Yield, 701 mg (83%).  1H NMR (400 MHz, 
CDCl3): δ 7.84 (s, 1H), δ 5.18 (s, 2H), δ 3.79 (s, 2H), δ 3.78 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 166.8, 144.6, 125.2, 52.9, 50.7, 47.4. High-resolution ESI-MS: m/z calculated for 
C18H24N10O6 (M + Cs+), 609.0935; found 609.0920. 
Bis-(2,2’bipyridine)(4’-Methyl-2,2’-bipyridine-4-methyl-aceto-1,2,3-triazolo-
methylacetamide)-osmium(II) bis(trifluoroacetate) (13). A solution of 11b (6.95 mgs, 8 
mol), methyl azidoacetate (1.42 mg, 10 mol, 1.7 equiv) and DIPEA (3 L) in ACN (1.5 
mL) was stirred in a round bottom and cooled in an ice bath before tetrakis 
(acetonitrile)copper(I) hexafluorophosphate (0.56 mgs, 1.5 mol, 20 mol %) was added. The 
solution was allowed to warm to room temperature slowly and stirred for 2 days under inert 
atmosphere. The OsII complex was purified by RP-HPLC using methods identical to those 
described below for the metallopeptides. ESI-MS: m/z calculated for C38H34N10O3Os (M2+), 
435.12; found 435.1. The complex is discussed briefly in Chapter V during the description of 
a control experiment. 
 v. Synthesis of peptides and metallopeptides 
SPPS of the peptide parent sequences P1 and P2. Peptides were typically synthesized 
by standard automated SPPS using a Thuramed tetras synthesizer. Fmoc-protected amino 
acids were used along with a CLEAR-Amide resin from Peptides International, Inc.  Amino 
acid residues were activated with HBTU, HOBt, and DIPEA in DMF. Amino acids were 
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deprotected twice with 2% DBU and 2% piperidine in DMF for 15 minutes each step. 
Commercially available amino acids were coupled using double coupling cycles of 30-60 
minutes each. Couplings for the unnatural amino acids 6a, 6b, and 8 have specific procedures 
described below. The N-terminus of each peptide was acetylated using 5% acetic anhydride 
and 6% lutidine in DMF for 30 minutes. Cleavage of the peptides from the resin was 
performed in 95.0% TFA, 2.5% water, and 2.5% TIPS. TFA was evaporated with a stream of 
nitrogen and diethyl ether was added to precipitate the cleavage products. The peptides were 
extracted with water or collected as solids by centrifugation and lyophilized to dryness. 
Peptides were purified by RP-HPLC using an Atlantis Prep OBD dC-18 semi-preparative 
column, with a gradient of 0-100% solvent B over 40 minutes, where solvent A was 95:5 
water:ACN, 0.1% TFA, and solvent B was 95:5 ACN:water, 0.1% TFA. Purified samples 
were lyophilized and the peptide sequence was confirmed by ESI-MS. M was calculated as 
3212.73 (exact) for P1 (C142H237N37O47). MS m/z observed: 1608.4 ([M + 2H+]2+), 1072.6 
([M + 3H+]3+), 804.7 ([M + 4H+]4+); M was calculated as 3363.95 (exact) for P2 
(C149H258N46O42). MS m/z observed: 1123.0 ([M + 3H+]3+), 842.5 ([M + 4H+]4+), 674.0 ([M + 
5H+]5+). 
Synthesis of the metallopeptides 2f-Os* (P1) and 2f-Ru* (P2). Metallopeptides were 
typically synthesized according to the primarily automated procedures described above. At 
times the metallopeptides were synthesized by hand. The [Ru(bpy)3]2+- and [Os(bpy)3]2+-
containing Fmoc-protected amino acids 6a and 6b were typically coupled by hand using one 
of two sets of conditions: (a) 2 equiv of HBTU, 2 equiv of HOBt, 3 equiv of DIPEA, 3-5 h. 
(b) 2 equiv of HATU, 3 equiv of DIPEA, 50 °C, 24 hours. Amino acid deprotection reactions 
were performed using two sets of conditions: (a) 2% DBU, 2% piperidine, DMF, 15 minutes. 
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(b) 20% piperidine, DMF, 15 minutes. Traditional Kaiser tests using ninhydrin were useful 
for estimating the extent coupling and deprotection for metallopeptides containing 6a, but 
were often more ambiguous for metallopeptides containing 6b due to the high molar 
absorptivity of the [Os(bpy)3]2+-containing amino acid. M was calculated as 3912.93 (exact) 
for 2f-Os*-P1 (C175H265N43O47Os). MS m/z observed: 1304.7 ([M2+ + H+]3+), 978.9 ([M2+ + 
2H+]4+), 783.2 ([M2+ + 3H+]5+); M was calculated as 3974.09 (exact) for 2f-Ru*-P2 
(C182H286N52O42Ru). MS m/z observed: 1325.3 ([M2+ + H+]3+), 994.2 ([M2+ + 2H+]4+), 795.8 
([M2+ + 3H+]5+). 
Synthesis of azidopeptides using -Fmoc--azido-L-lysine. Peptides containing 
azidolysine residues at desired positions were synthesized using an automated synthesizer as 
described above. -Fmoc--azido-L-lysine 8 was injected manually and a single 3 hour 
coupling reaction was performed. The azidopeptides were cleaved from the resin, and 
purified in an identical fashion. Azidopeptide identities were confirmed by ESI-MS. M was 
calculated as 3238.76 (exact) for 2f-N3-P1 (C143H239N39O46). MS m/z observed: 1620.9 ([M + 
2H+]2+), 1081.0 ([M + 3H+]3+), 811.0 ([M + 4H+]4+); M was calculated as 3295.78 (exact) for 
2c-N3-P1 (C145H242N40O47). MS m/z observed: 1649.3 ([M + 2H+]2+), 1099.9 ([M + 3H+]3+), 
825.2 ([M + 4H+]4+); M was calculated as 3237.77 (exact) for 2g-N3-P1 (C143H240N40O45). 
MS m/z observed: 1620.3 ([M + 2H+]2+), 1080.6 ([M + 3H+]3+), 810.7 ([M + 4H+]4+); M was 
calculated as 3389.97 (exact) for 2f-N3-P2 (C150H260N48O41). MS m/z observed: 1131.0 ([M + 
3H+]3+), 848.5 ([M + 4H+]4+), 679.1 ([M + 5H+]5+); M was calculated as 3447.00 (exact) for 
2b-N3-P2 (C152H263N49O42). MS m/z observed: 1150.3 ([M + 3H+]3+), 863.0 ([M + 4H+]4+), 
690.6 ([M + 5H+]5+); M was calculated as 3389.94 (exact) for 2e-N3-P2 (C149H256N48O42). 
MS m/z observed: 1131.0 ([M + 3H+]3+), 848.5 ([M + 4H+]4+),  679.0 ([M + 5H+]5+). 
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Synthesis of metallopeptides using the CuAAC reaction. In a typical procedure 8-15 
mgs (~2-4 µmol) of azidopeptide would be partially dissolved in 1-3 mL 50% (v/v) DMF in 
10 mM PO43-, pH 8.5, buffer that was deoxygenated with N2 for 30 minutes. The peptide was 
reacted with (2 equiv) either the RuII complex 11a or the OsII complex 11b in the presence of 
tetrakis(acetonitrile)copper(I) hexafluorophosphate (2 equiv), and tris-(triazolylmethyl)amine 
ligand (12, 1 equiv). The mixtures were allowed to stir overnight for at least 12 h, typically 
longer, and then diluted with water (10 mL).  The aqueous solution was frozen and 
lyophilized.  The fully lyophilized residue was dissolved in water and filtered through a 0.22 
µm PVDF syringe filter.  The final metallopeptide was obtained after purification by 
reversed-phase HPLC using the conditions listed above.  The molecular weight was 
confirmed by LC-MS. M2+ was calculated as 3993.96 (exact) for 2f-Os (C178H268N46O47Os). 
MS m/z observed: 1997.0 ([M2+]2+), 1331.8 ([M2+ + H+]3+), 999.0 ([M2+ + 2H+]4+), 799.4 
([M2+ + 3H+]5+), 666.4 ([M2+ + 4H+]6+); M2+ was calculated as 4050.98 (exact) for 2c-Os 
(C180H271N47O48Os). MS m/z observed: 2025.8 ([M2+]2+), 1350.7 ([M2+ + H+]3+), 1013.2 
([M2+ + 2H+]4+), 810.8 ([M2+ + 3H+]5+), 679.5 ([M2+ + 4H+]6+); M2+ was calculated as 
3992.98 (exact) for 2g-Os (C178H269N47O46Os). MS m/z observed: 1996.5 ([M2+]), 1131.3 
([M2+ + H+]3+), 998.7 ([M2+ + 2H+]4+), 799.2 ([M2+ + 3H+]5+), 666.2 ([M2+ + 4H+]4+); M2+ 
was calculated as 4055.12 (exact) for 2f-Ru (C185H289N55O42Ru). MS m/z observed: 1352.0 
([M2+ + H+]3+), 1014.1 ([M2+ + 2H+]4+), 811.6 ([M2+ + 3H+]5+), 676.5 ([M2+ + 4H+]6+), 580.0 
([M2+ + 5H+]7+); M2+ was calculated as 4112.14 (exact) for 2b-Ru (C187H292N56O43Ru); MS 
m/z observed: 1371.7 ([M2+ + H+]3+), 1029.0 ([M2+ + 2H+]4+), 823.6 ([M2+ + 3H+]5+); M2+ 
was calculated as 4055.09 (exact) for 2e-Ru (C184H285N55O43Ru). MS m/z observed: 1352.6 
([M2+ + H+]3+), 1014.5 ([M2+ + 2H+]+4). 
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vi. 1H and 13C NMR spectra. 
 
 
 
Figure 3.7. -Fmoc--azido-L-lysine (8). 1H: CD3OD, 400 MHz; 13C CD3OD, 100 MHz. 
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Figure 3.8  4’-Methyl-2,2’-bipyridine-4-propargylamide (10). 1H CDCl3, 400 MHz 13C 
CDCl3, 100 MHz. 
58 
 
 
Figure 3.9 Bis-(2,2’bipyridine)(4’-Methyl-2,2’-bipyridine-4-propargylamide)-ruthenium(II) 
bis(hexafluorophosphate) (11a). 1H CD3CN, 400 MHz. 
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Figure 3.10 Bis-(2,2’bipyridine)(4’-Methyl-2,2’-bipyridine-4-propargylamide)-osmium(II) 
bis(hexafluorophosphate) (11b). 1H CD2Cl2, 400 MHz. 
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Figure 3.11 tris-(triazolylmethyl)amine ligand (12).1H CDCl3, 400 MHz. 13C CDCl3, 100 
MHz. 
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Chapter IV 
PHYSICAL CHARACTERIZATION OF THE 
METALLOPEPTIDE DIMERS INCLUDING THE DETERMINATION OF  
 DISSOCIATION CONSTANTS 
 
A. Introduction 
i. Choice of RuII and OsII donor/acceptor positions for the metallopeptides 
The importance of, and general considerations for, studying RuII to OsII energy 
transfer were described in detail in Chapter I. The use of a dimeric coiled-coil peptide motif 
as a scaffold for studying RuII to OsII energy transfer was introduced within Chapter II, along 
with the relevant design principles used for the selection of the parent sequences. The 
synthetic manipulations required for the preparation of the 2b-Ru, 2e-Ru, 2f-Ru, 2c-Os, 2f-
Os, and 2g-Os metallopeptides were described in Chapter III. The specific substitution 
positions were chosen to provide a range of distances for the study of energy transfer, while 
not disrupting the coiled-coil structure of interest. The substitutions were made within the 
second heptad repeat unit of each coiled-coil parent sequence (Figure 4.1a). Substitutions 
near the peptide termini were avoided in order to prevent further disruption of the secondary 
structure due to end fraying (Chapter II). Avoiding RuII- and OsII-substitution at the termini 
was also expected to provide more reliable donor/acceptor displacements during the energy 
transfer studies. The choices for the second heptad repeat unit versus the third heptad repeat 
unit were arbitrary. The choice to use the P2 parent sequence for the donor (RuII) 
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metallopeptides and the P1 parent sequence for the acceptor (OsII) metallopeptides was also 
arbitrary. 
ii. Choice of metallopeptide pairs for analysis 
Throughout the energy transfer studies discussed in Chapter V, the metallopeptides 
are examined as specific coiled-coil pairs. In this chapter the folding and association of the 
metallopeptides is examined for the same pairs in order to facilitate direct comparisons. 
Coiled-coil association and intermolecular energy transfer were studied for the 2f-Ru/2f-Os, 
2b-Ru/2c-Os, and 2e-Ru/2g-Os metallopeptide pairs (Figure 4.1b). Although other 
metallopeptide partners could have potentially associated and facilitated energy transfer 
between the RuII and OsII bipyridyl complexes, they were not specifically studied within this 
work. 
The relative two-dimensional positioning of the different metallopeptide pairs is 
represented as a helical wheel diagram (Figure 4.1b). The relative three-dimensional 
positioning of the donor/acceptor bipyridyl complexes involves there longitudinal 
displacement as well, and may be roughly estimated from crystal structures of similar coiled-
coil peptides (Figure 4.2). The 2f-Ru/2f-Os metallopeptide pair could be expected to provide 
the greatest donor/acceptor displacement with an approximate distance of 14.3 Å measured 
between the respective -carbons. Distance measurements made between -carbons could 
however be misleading due to the individual bond vectors (-) linking the bipyridyl 
complexes to the coiled-coil structure. For example, the 2f-Ru/2f-Os C-C bonds would 
project the donor/acceptor pairs even further apart. The expected distance between the 2f-
Ru/2f-Os -carbon atoms would increase to roughly 16.2 Å.  
 
65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 (a) The primary sequences for the P1 and P2 parent peptides showing the 
positions of modification for the 2g-Os, 2c-Os, 2f-Os, 2b-Ru, 2e-Ru, and 2f-Ru 
metallopeptides. Natural amino acids are designated using single letter codes. These 
positions are substituted with azidolysine in the azidopeptides, and in the metallopeptides 
they have been altered by attachment of either RuII (P2) or OsII (P1) bipyridyl complexes as 
described in Chapter III. (b) A helical wheel diagram for the metallopeptide partners 
examined throughout the study. The 2f-Ru/2f-Os (blue), 2b-Ru/2c-Os (red), and 2e-Ru/2g-Os 
(green) metallopeptide pairs are shown, although the two-dimensional diagram is not 
necessarily representative of the actual donor/acceptor positions within the three-dimensional 
coiled-coil peptide scaffold. 
 
(a) 
 
(b) 
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Figure 4.2 Crystal structure of a similar coiled-coil dimer (pdb code: 2ZTA). The relative 
positions corresponding to the 2f-Ru/2f-Os (blue), 2b-Ru/2c-Os (red), and 2e-Ru/2g-Os 
(green) metallopeptide pairs are shown. 
The 2b-Ru/2c-Os metallopeptide pair could be expected to have a donor/acceptor 
displacement ranging from 12.7 to 14 Å, depending on whether the distance was measured 
from the - or -carbons. In the case of the 2e-Ru/2g-Os metallopeptide pair, the relative 
donor/acceptor displacement could be expected to decreases from 9.9 Å measured between 
the -carbons to 9.1 Å measured between the -carbons. This is due to the 2g-Os C-C bond 
directing the side chain towards the helical interface. 
The -azido-L-lysine linker described in Chapter III was designed to provide a 
flexible four methylene tether for the RuII and OsII bipyridyl complexes. The length and 
conformational freedom of the linker was predicted to prevent destabilization of the coiled-
coil peptide structure, but also introduces a greater extent of ambiguity in determining precise 
donor/acceptor distances. For this reason the relative distances discussed above could not be 
assumed entirely representative of the donor/acceptor distances provided by the coiled-coil 
peptide scaffold until further analysis was performed. 
The specific attachment points for the different metallopeptide pairs all have subtle 
effects on their observed structural stabilities. Circular dichroism spectroscopy and chemical 
denaturation analysis experiments are described throughout Chapter IV, in order to provide 
an understanding of the structural differences between the metallopeptide pairs. 
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Also described within this chapter is the computational modeling of the 
conformational states for the coiled-coil peptide backbones, the attached bipyridyl 
complexes, and the azido-L-lysine linkers for all three metallopeptide pairs using high-level 
molecular dynamics simulations. This work was performed in collaboration by Dr. 
Christopher Materese under the advisement of Professor Garyk Papoian. 
B. Circular dichroism analysis of the metallopeptide pairs 
Since the folding behavior of the coiled-coil metallopeptides is bimolecular, each pair 
has a related dissociation (Kd) constant that can be used to quantify and predict equilibrium 
concentrations of folded coiled-coil dimer and unfolded peptide monomer for any given 
preequilibrium concentration. Determination of a Kd for each metallopeptide pair is required 
to interpret the energy transfer behavior described in Chapter V. 
Circular dichroism (CD) is a spectroscopic technique where the differential 
absorption of right and left circularly polarized light is measured for a sample.1 Since right 
and left circularly polarized light are chiral, many biomolecules including peptides and 
oligonucleotides, interact differently with the polarized forms of light. These interactions 
lead to characteristic CD features that are typically expressed in terms of concentration 
corrected molar ellipticity values at specific wavelengths (θx).1 For peptides these ellipticity 
measurements are also corrected for the number of amino acid residues and the measurement 
is referred to as the mean molar residue ellipticity ([θ]x). The standard ellipticity designation 
is bracketed to express this quantity with the units deg·cm2·dmol-1. 
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Figure 4.3. Circular dichroism (CD) spectra for all three metallopeptide pairs. (a) CD spectra 
for the 2f-Os (green) and 2f-Ru (red) peptides at 50 M concentrations. A 1:1 mixture of the 
two peptides (black, 50 M combined peptide concentration) shows a more intense negative 
signal at 222 nm indicating an increase in the -helicity for the two peptides. (b) A similar 
analysis for the 2c-Os (green) and 2b-Ru (red) peptides at 50 M concentrations. (c) A 
similar analysis for the 2g-Os (green) and 2e-Ru (red) peptides at 50 M concentrations. All 
spectra were recorded at 25°C in 10 mM PO43-, pH 7, buffer. 
(a) 
(b)  
(c)  
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The CD spectra for all three heterodimeric metallopeptide pairs display features 
characteristic of -helices, and more specifically to -helical coiled-coils (Figure 4.3). These 
features include maxima below 200 nm, and pairs of minima at 208 and 222 nm.1,2 The CD 
signals associated with the -helical peptide secondary structure are concentration dependent 
for the metallopeptide pairs since folding and dimerization are coupled in these peptide 
structures. This concentration dependence qualitatively indicates that the metallopeptide pairs 
form coiled-coil structures when mixed in low M concentrations. The ellipticity at 222 nm 
([θ]222) corresponds to an n-* transition and can be used as a quantitative measure of -
helicity, and therefore dimerization.2 The ratio of the CD signals at 208 and 222 nm 
([θ]222/[θ]208) also gives evidence for dimeric coiled-coil structures. The CD signal at 208 nm 
([θ]208) is due to a -* transition parallel to the helix axis and is sensitive to whether the 
helix is single stranded or is part of a greater helical bundle.2 The ellipticity ratio [θ]222/[θ]208 
for the 2f-Os/2f-Ru metallopeptide pair is equal to 1.00. The 2c-Os/2b-Ru and 2g-Os/2e-Ru 
peptide pairs both have [θ]222/[θ]208 ratios equal to 1.03. Ratios of 1.0 or greater are 
characteristic of dimeric coil coil peptides, as single-stranded -helices typically have values 
closer to 0.85.3 
All three metallopeptide pairs were analyzed using continuous variation experiments. 
The different metallopeptides all display maximum -helicity (minimum at [θ]222) when 
equimolar mixtures of the donor/acceptor metallopeptides are examined, indicating that 
heterodimeric coiled-coil structures are being formed in a 1:1 ratio (Figure 4.4). This is not 
unexpected since the sequences were designed to form dimeric species, but still important to 
confirm since trimeric species are often the default structure for -helical coiled-coils when 
design features favoring the dimeric structure are not strongly reinforcing.4 
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Figure 4.4 Continuous variation experiments (Job plot) for the metallopeptide pairs 
measured using the [θ]222 CD signal. (a) The 2f-Ru/2f-Os metallopeptide pair examined at a 
continuous concentration of 50 M with variations made in the 2f-Os mole fraction. (b)  The 
2b-Ru/2c-Os metallopeptide pair examined at a continuous concentration of 50 M with 
variations made in the 2c-Os mole fraction. (c) The 2e-Ru/2g-Os metallopeptide pair 
examined at a continuous concentration of 50 M with variations made in the 2g-Os mole 
fraction. All spectra were recorded at 25°C in 10 mM PO43-, pH 7, buffer. 
(a)
(b)
(c)
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C. Guanidinium chloride denaturation of the metallopeptide pairs 
Chemical denaturation using guanidinium chloride (GndHCl) provides a reliable tool 
for measuring coiled-coil dissociation constants.5 The method has been used to compare 
minute structural changes within families of similarly designed coiled-coils.5c Dissociation 
constants can also be measured directly from the concentration dependence of the [θ]222 
signal,6 however measuring dissociation constants by this method does have several 
disadvantages. Firstly, the ellipticity ([θ]222) must be accurately measured over a broad range 
of concentrations both above and below the dissociation constant. This requirement 
introduces technical complications since extremely high or low concentrations of peptides 
may not have the same solubility and/or may require cuvettes of different path lengths. 
Secondly, the method assumes that the individual monomers have a very low helical content 
and contribute only minimally to the [θ]222 signal. This assumption may not necessarily be 
true since many of the relevant amino acid residues may have a high helical propensity 
outside of the context of a coiled-coil peptide structure.4 Alternatively, chemical denaturation 
experiments using GndHCl are performed at a single peptide concentration that is well above 
the dissociation constant for the coiled-coil pair. The assumption made during a GndHCl 
denaturation experiment is that at high peptide concentrations the coiled-coil is entirely 
associated and -helical monomer concentrations are well below the detectable limit. 
Additionally, any peptide monomers that are not associated within a coiled-coil structure will 
be fully unfolded in the denaturing medium and will not contribute significantly to the 
observed [θ]222 signal. 
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 Performed as a titration, GndHCl denaturation experiments track the unfolding of the 
coiled-coil structure as a function of the denaturant concentration. The fraction folded (FF) at 
any denaturant concentration can be calculated using Equation 1 (Figure 4.5a):5c 
ܨி ൌ ሺሾߠሿ െ ሾߠሿ஽ሻ/ሺሾߠሿி െ ሾߠሿ஽ሻ       ܧݍݑܽݐ݅݋݊ 1       
where [θ] is the observed CD signal, [θ]F is the CD signal for the fully folded coiled-coil at a 
denaturant concentration of zero, and [θ]D is the CD signal for the fully denatured mixture. 
The fraction unfolded (FU) can be calculated using Equation 2:5c 
ܨ௎ ൌ 1 െ ܨி       ܧݍݑܽݐ݅݋݊ 2 
Once the fraction folded and fraction unfolded have been calculated, the free energy of 
unfolding (GD) can be measured for all denaturant concentrations using Equation 3:5c 
߂ܩ஽ ൌ  െܴ݈ܶ݊ ቆ2 ்ܲܨ௎
ଶ
ܨி ቇ        ܧݍݑܽݐ݅݋݊ 3 
where PT is the total peptide concentration, R is the molar gas constant in units of cal·mol-
1·K-1 (1.986), and T is the temperature in Kelvin (298). The method of linear extrapolation is 
used to calculate the free energy of unfolding in the absence of denaturant (GH20), using 
Equation 4:5c 
Δܩ஽ ൌ  Δܩுଶை െ  ݉ሾܩ݀݊ܪܥ݈ሿ       ܧݍݑܽݐ݅݋݊ 4 
where [GdnHCl] is the GndHCl denaturant concentration in units of molarity, m is the slope, 
and GH20 is the y-intercept. The method of linear extrapolation is used to measure the y-
intercept (GH20).5a The method assumes that the dependence of GD on the denaturant 
concentration observed throughout the transition period continues to be linear at denaturant 
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concentrations approaching zero. The GndHCl denaturation midpoint (Cm) is included in the 
linear extrapolation, along with adjacent points which produce a reliable linear fit (R2 values 
close to unity). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 (a) GndHCl denaturation curves at 25 C in 20 mM PO43-, 100 mM NaCl, pH 7.4 
buffer. Data shown for the 2f-Ru/2f-Os pair (black circles, 300 M), the 2b-Ru /2c-Os pair 
(red squares, 200 M), and the 2e-Ru/2g-Os pair (blue diamonds, 200 M). The fraction 
folded (FF) values were calculated using Equation 1. (b) Gibbs free energy of unfolding 
(GD) was calculated using Equation 3. Linear extrapolation using Equation 4 gives the 
value of the free energy of unfolding at zero denaturant concentration (GH20). Data shown 
for the 2f-Ru/2f-Os pair (black circles, m = -1.7 kcal·mol-1·M-1, R2 =0.997), the 2b-Ru /2c-Os 
pair (red squares, m = -1.5 kcal·mol-1·M-1, R2 =0.999), and the 2e-Ru/2g-Os pair (blue 
diamonds, m = -1.7 kcal·mol-1·M-1, R2 =0.997). 
 
(a)
 
(b)
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Dissociation constants (Table 4.1.) for all three metallopeptide pairs were determined 
using the GH20 values and Equation 5: 
ܭௗ ൌ  10 ଺ ൉ ݁ିሺ
೩ಸಹమೀ
ೃ೅ ሻ       ܧݍݑܽݐ݅݋݊ 5  
Dissociation constants could not be determined for the coiled-coil parent sequences due to 
solubility issues during the analysis. The 2f-Ru/2f-Os metallopeptide pair appeared to form 
the most thermodynamically stable coiled-coil peptide structure. The value of GH20 
measured for the 2f-Ru/2f-Os pair (8.6 ± 0.10 kcal·mol-1) corresponds to a Kd of 0.49 ± 0.09 
M (Table 4.1). 
Table 4.1. Folding parameters obtained from guanidinium denaturation experiments 
Peptide 
Pair 
ΔGH2O 
(kcal·mol-1)a 
Kd 
(M)b 
Cm 
(M)c 
% 
-helicityd 
2f-Ru/2f-Os 8.6 0.49 ± 0.09 2.2 80% 
2b-Ru/2c-Os 8.2 0.97 ± 0.2 2.0 74% 
2e-Ru/2g-Os 8.0 1.4 ± 0.3 1.8 72% 
aValues for GH20 were calculated by the method of linear extrapolation using Equation 4. 
The error in the measurement of GH20 was estimated to be less than 0.10 kcal·mol-1 for all. 
bThe Kd values were calculated using Equation 5. Error estimates are included with the 
values and were calculated based on the observed error for GH20. cThe GndHCl denaturation 
midpoints (Cm) were calculated based on the linear relationship between folded (FF) and 
denaturant concentration ([GndHCl]) within the transition region and typically had an error 
of less than 0.05 M. dThe percent -helicity values are based on a value of -35,900 
deg·cm2·dmol-1 calculated for all three pairs using Equation 6. 
The calculation of -helical content has previously been described for similar de novo 
designed coiled-coils. The -helical content can be estimated based on the theoretical 
maximum -helicity for a 28-residue peptide. The maximum -helicity for a peptide of any 
chain length can be calculated using Equation 6:7  
ሾߠሿଶଶଶ௡ ൌ ሺሾߠሿଶଶଶ∞ሻቀ1 െ ݇ ݊ൗ ቁ      ܧݍݑܽݐ݅݋݊ 6 
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where n is the number of amino acid residues, [θ]222∞ is the mean molar residue ellipticity of 
an -helix of infinite length taken to be -39,500 deg·cm2·dmol-1, and k is a wavelength-
dependent factor taken to be 2.57 at 222 nm. Based on Equation 6, the maximum -helicity 
for all three metallopeptide pairs would be -35,900 deg·cm2·dmol-1. The fully folded 2f-
Ru/2f-Os dimer was calculated to be 80% -helical based on the observed [θ]222 (-28,600 ± 
800 deg·cm2·dmol-1). These values were measured at peptide concentrations where the 
fraction folded closely approaches unity. Measured values less than 100% do not imply the 
presence of monomeric species, but instead imply that the peptides within the coiled-coil 
dimer adopt nonideal -helical conformations. The -helical content reported for the 2f-
Ru/2f-Os dimer falls within the range reported for peptides of similar length and sequence 
structure with values from 69-96% being common in the literature.6,8  
The 2b-Ru/2c-Os peptide pair displays minor destabilization when compared to the 
2f-Ru/2f-Os pair. The difference in GH20 measured (8.2 ± 0.10 kcal·mol-1) for the 2b-Ru/2c-
Os dimer corresponds to an increase in the extrapolated Kd (0.97 ± 0.2 M). The maximum 
ellipticity for the 2b-Ru/2c-Os peptide pair (-26,400 ± 700 deg·cm2·dmol-1) corresponded to 
74% -helicity, indicating slightly less -helical character when compared to the 2f-Ru/2f-Os 
pair. The 2e-Ru/2g-Os peptide pair was found to be the most destabilized heterodimer, 
although the magnitude of the destabilization was again quite minimal. The extrapolated 
GH20 (8.0 ± 0.10 kcal·mol-1) value for the 2e-Ru/2g-Os peptide pair was within error of that 
reported for the 2b-Ru/2c-Os pair. The calculated Kd (1.4 ± 0.3 M) value for 2e-Ru/2g-Os 
peptide pair was therefore also within error. The maximum ellipticity (-25,900 ± 300 
deg·cm2·dmol-1) for the 2e-Ru/2g-Os peptide pair corresponded to 72% -helicity. Although 
the thermodynamic parameters (GH20, Kd, and % -helicity) for the 2b-Ru/2c-Os and 2e-
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Ru/2g-Os metallopeptide pairs are all within error, the GndHCl denaturation midpoints (Cm = 
2.0 M for the 2b-Ru/2c-Os and 1.8 M for the 2e-Ru/2g-Os) for the two pairs analyzed at the 
same total peptide concentrations are well outside of error. Chemical denaturation midpoints 
are often used to compare structurally similar peptide sequences since GH20 values are 
extrapolated and inherently prone to large errors.5c The difference in free energy of unfolding 
between two peptides (ΔGD) can be calculate using Equation 7:9 
Δ߂ܩ஽ ൌ ሺܥ௠஺ െ ܥ௠஻ሻሺ݉஺ െ݉஻ሻሺ0.5ሻ      ܧݍݑܽݐ݅݋݊ 7 
where CmA and CmB are the GndHCl denaturation midpoints for two peptides A and B, and 
mA and mB are the slope values from Equation 4 applied to peptide A and B, respectively. 
The value of ΔGD calculated for the 2b-Ru/2c-Os and 2e-Ru/2g-Os metallopeptide pairs is 
0.3 kcal·mol-1. This observation does indicate that the 2e-Ru/2g-Os peptide pair is somewhat 
destabilized when compared to the 2b-Ru/2c-Os pair. This result is not entirely unsurprising 
since the 2e-Ru and 2g-Os metallopeptides are substituted with bipyridyl complexes at the e 
and g positions, respectively. As discussed in Chapter II, amino acid residues at these 
positions are typically close to the hydrophobic core and are designed to provide attractive 
charge-charge interactions,10 while the RuII and OsII bipyridyl complexes may behave 
repulsively due to their identical positive charges. 
 The determination of Kd values for all three metallopeptide pairs is important for 
accurately measuring energy transfer in these systems since only the properties of 
donor/acceptor dimers are of interest. The energy transfer studies (Chapter V) for the 
different metallopeptide pairs were typically performed as titrations with the RuII peptide 
concentration fixed at 25 M. The OsII peptide concentrations employed were 6.25, 12.5, 
18.75, 25.0, and 50.0 M corresponding to 0.25, 0.5, 0.75, 1.0 and 2.0 equivalents compared 
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to the RuII peptide. Given the extinction coefficients of the bipyridyl complexes (~14,600 at 
452 nm for Ru(bpy)32+, and ~12,000 at 480 nm for Os(bpy)32+) in water,11,12 this 
concentration regime was appropriate for emission studies using a 0.2 cm optical path length 
cell. The Kd values allow for percent dimer and percent monomer to be calculated for each 
metallopeptide pair at the concentrations used during the energy transfer studies (Table 4.2). 
These values will be used later for comparison during the energy transfer studies. 
Table 4.2. Percent dimer for the analyzed metallopeptides 
OsII Peptide 
Equivalents 
OsII Peptide 
Concentrationa 
(M) 
2f-Ru/2f-Os 
Percent 
Dimerb 
2b-Ru/2c-Os 
Percent 
Dimerc 
2e-Ru/2g-Os 
Percent 
Dimerd 
0.00 0.00 0 0 0 
0.25 6.25 24 24 23 
0.50 12.5 48 47 45 
0.75 18.75 70 66 65 
1.00 25.0 87 82 79 
2.00 50.0 98 96 95 
aThe RuII peptide concentration is 25 M for all three metallopeptide pairs. bThe dimer 
concentration was calculated based on a Kd value of 0.49 M for the 2f-Ru/2f-Os peptide 
pair. cThe dimer concentration was calculated based on a Kd value of 0.97 M for the 2b-
Ru/2c-Os peptide pair. dThe dimer concentration was calculated based on a Kd value of 1.4 
M for the 2e-Ru/2g-Os peptide pair. The percent dimer for each metallopeptide pair is 
calculated relative to the total RuII peptide concentration (25 M). 
 Any equilibrium that can be described using a dissociation constant (Kd) can also be 
described as a ratio of association and  dissociation rates as shown in equation 8:6 
ܭௗ ൌ  ݇௢௡ ݇௢௙௙൘        ܧݍݑܽݐ݅݋݊ 8 
where kon is the rate of association to form the complex and koff is the rate of dissociation that 
destroys the peptide-peptide complex. Although we have not directly measured the rates of 
kon or koff, comparison to other coiled-coil systems with low M Kd values would imply that 
association occurs on the microsecond timescale and dissociation most likely occurs on the 
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millisecond to second timescale.6 Since the decay of the Ru(bpy)32+ 3MLCT excited state 
(discussed in Chapter I) decays on the time scale of several hundred nanosecond in water,11 
one can tentatively conclude that coiled-coil strand exchange is unlikely to affect any energy 
transfer studies. 
 D. All-atom molecular dynamics simulations 
 As mentioned in the introductory section, the -azido-L-lysine amino acid residue 
used to incorporate the RuII and OsII bipyridyl complexes is quite flexible. The length and 
flexibility of the linker may allow the metallopeptides to adopt a number of different 
conformational states in solution. A general trend may be anticipated based on the crystal 
structure analysis presented above (Figure 4.2), but an accurate depiction of metal complex 
displacement distances is certainly missing. All-atom molecular dynamics simulations were 
performed to better understand the possible solution-phase behaviors of the synthetic 
metallopeptide pairs. This work was performed by Dr. Christopher Materese under the 
advisement of Professor Garyk Papoian. 
 Similar to the structural analysis, the theoretical analysis was performed separately 
for the 2f-Ru/2f-Os, 2b-Ru/2c-Os, and 2e-Ru/2g-Os metallopeptide pairs. Both bipyridyl 
complexes were modeled as RuII in order to save computing space, and also because 
metallopeptide dynamics were of interest and energy transfer itself was not modeled. The 
designation for the metal identity is dropped throughout this section, and the metallopeptide 
pairs 2f-Ru/2f-Os, 2b-Ru/2c-Os, and 2e-Ru/2g-Os are instead referred to as the 2f/2f, 2b/2c, 
and 2e/2g pairs. The exact details for the simulations are provided within the experimental 
section. 
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The different simulations did indeed demonstrate dynamic behaviors for the 
metallopeptides, with many small local perturbations in the coiled-coil structure occurring at 
a very fast rate. These localized structural changes occur within the coiled-coil peptide 
scaffold, and also within the -azido-L-lysine linker. The vast majority of the dynamic 
movements did not lead to substantial displacement of the bipyridyl complexes, and would 
not be expected to affect energy transfer rates. In addition to the small structural changes the 
metallopeptide dimers experience, there are large scale movements of the bipyridyl 
complexes that do result in substantial changes in the displacements of the bipyridyl 
complexes. These larger scale movements allowed the metallopeptide pairs to occupy 
specific conformational states for extended periods of time during the simulation experiment. 
Histograms representing the relative time that the different metallopeptide pairs occupy 
different conformational states are presented below (Figure 4.6). 
 The simulation for the 2f/2f metallopeptide pair shows a relatively large metal-center 
displacement throughout the experiment. The metal-center distance distributions are very 
broad and non-Gaussian. The 2f/2f peptide pair exhibits the broadest range of metal-center 
distance distributions when compared to the 2b/2c and 2e/2g pairs (Figure 4.6a). Most of the 
conformations for the 2f/2f peptide pair place the bipyridyl complexes at distances greater 
than 2 nm. The relatively large metal-center displacements would imply that the 2f/2f peptide 
pair would be inefficient at promoting energy transfer compared to the 2b/2c and 2e/2g pairs, 
although it is possible that conformations with smaller metal-center displacements could 
exist and were simply not observed during the simulated time frame. One observation 
involving metallopeptide stability was made for the 2f/2f peptide pair. During the simulation 
experiment, conformations that brought the bipyridyl complexes and peptide termini in 
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proximity appeared to destabilize the coiled-coil structure. The interaction between the 
bipyridyl complexes and peptide scaffold would imply that the two have complementary 
attractive forces. Whether those interactions are hydrophobic, dipole-dipole, Van der Waals, 
Coulombic, or other in nature is difficult to determine but they do seem to affect coiled-coil 
stability near the peptide termini were the propensity for fraying is already increased. 
 The 2b/2c and 2e/2g metallopeptide pairs both exhibited conformations with 
significantly shorter metal-center displacements, demonstrating that some degree of 
positional control is exerted by the coiled-coil scaffold. The simulation for the 2b/2c pair 
shows the metallopeptides persistently occupying a conformation where the bipyridyl 
complexes are in close contact (Figure 4.6b). This conformation is characterized by a small 
metal-center displacement, close to 0.8 nm, and a close stacking of the bipyridyl ligands 
placing them in Van der Waals contact with each other (Figure 4.7a). The simulation for the 
2e/2g pair shows the metallopeptide persistently occupying a conformation with a metal-
center displacement closer to 1.2 nm (Figure 4.6c). This conformation is also characterized 
by fewer Van der Waals contacts between bipyridyl ligands coordinated to the metal centers 
(Figure 4.7b). The 2e/2g pair certainly is capable of accessing conformations similar to those 
observed almost exclusively for the 2b/2c pair, so it is unclear whether the preference for the 
conformation with the larger metal-center displacement would persist over longer periods of 
simulation. Both the 2b/2c and 2e/2g metallopeptide pairs occupy conformational states that 
allow the donor/acceptor bipyridyl complexes to access each other in solution, and are most 
likely both sufficient promoters of energy transfer when compared to the 2f/2f peptide pair. 
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Figure 4.6. (a) Histogram showing the simulated metal-center distance distribution for the 
2f-Ru/2f-Os peptide pair. (b) Histogram showing the simulated metal-center distance 
distribution for the 2b-Ru/2c-Os peptide pair. (c) Histogram showing the simulated metal-
center distance distribution for the 2e-Ru/2g-Os peptide pair. The x-axis is the distance 
between the metal centers for the two metallopeptides for all. The y-axis is normalized for all 
and represents relative amounts of time that metal-center distances exist within the 
simulation. 
(a) 
(b) 
(c) 
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Figure 4.7 (a) The conformation that is a persistent arrangement in the 2c/2b metallopeptide 
pair only. The conformation is characterized by a small metal-center displacement (0.8 nm) 
and close contacts between bipyridyl ligands. The conformation appears only briefly in the 
simulation of the 2g/2e metallopeptide pair. (b) The conformation that is a persistent 
arrangement in the 2g/2e metallopeptide pair. The conformation is characterized by a slightly 
larger metal-center displacement (1.2 nm) and fewer contacts between bipyridyl ligands. 
 The simulations for the 2b/2c and 2e/2g metallopeptide pairs displayed an increasing 
destabilization of the coiled-coil structure, respectively, when compare to the 2f/2f peptide 
pair. This result is interesting when compared to the stability measurements made in section 
D, and probably relates to the attachment of the bipyridyl complexes closer to the termini of 
the metallopeptides. The observed trend for coiled-coil destabilization: 2e/2g > 2b/2c > 2f/2f 
matches the trend observed for all of the thermodynamic parameters measured previously 
(GH20, Kd, and % -helicity) and implies that interactions between the bipyridyl complexes 
and the coiled-coil scaffold itself are most destabilizing, while steric interactions between 
bipyridyl complexes are less important in determining coiled-coil stability. 
 
(a) 
(b) 
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 E. Conclusions 
 The selection of metallopeptides for energy transfer studies was discussed within 
Chapter IV. These selections, designed to provide a range of distances for energy transfer 
studies, were related to the current understanding of coiled-coil structure. The effects of RuII 
and OsII substitution on coiled-coil structure was evaluated for the 2f-Ru/2f-Os, 2b-Ru/2c-Os, 
and 2e-Ru/2g-Os metallopeptide pairs using CD spectroscopy and chemical denaturant 
techniques. The flexible -azido-L-lysine amino acid residue used to incorporate the RuII and 
OsII bipyridyl complexes was shown to allow coiled-coil formation for all three 
metallopeptide pairs, with only minor degrees of destabilization between them. A theoretical 
approach for understanding metallopeptide stability and dynamics is also presented in 
Chapter IV, performed by Dr. Christopher Materese. The RuII to OsII energy transfer 
behaviors for the 2f-Ru/2f-Os, 2b-Ru/2c-Os, and 2e-Ru/2g-Os metallopeptide pairs is fully 
evaluated in Chapter V, using the structural analysis detailed within Chapter IV to reinforce 
the conclusions. 
 F. Experimental section 
 i. Circular dichroism and guanidinium denaturation experiments 
CD spectra were recorded on a chirascan circular dichroism spectrometer. CD spectra 
were recorded from 185 to 260 nm using 10 mM sodium phosphate buffer, pH 7. CD spectra 
taken for GndHCl denaturation experiments were taken from 200 to 260 nm. All spectra 
were recorded at 25 C (298.15 K) with an optical path length of 0.1 cm. All scans were 
corrected by subtracting the spectrum of the respective buffer used in the experiment. The 
results are expressed as mean molar residue ellipticity [] values with units of 
degrees·cm2·dmol-1 as calculated using Equation 9: 
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ሾߠሿ ൌ   ሺߠ௢௕௦ሻ10 ൉ ݈ ൉ ܿ ൉ ݊        ܧݍݑܽݐ݅݋݊ 9    
where θobs is the observed ellipticity at a specific wavelength in millidegrees, l is the path 
length in cm, c is the concentration in mol·L-1, and n is the number of amino acid residues. 
 GndHCl denaturation experiments were conducted by monitoring [θ]222 as a function 
of GndHCl concentration. Samples were prepared from stock peptide solutions, buffer (20 
mM sodium phosphate, 100 mM sodium chloride, pH 7.4), and 8M stock solutions of 
GndHCl. The GndHCl stock solution was prepared in the same buffer and adjusted to pH 7.4 
before use. The GndHCl stock solution concentration was determined by mass using 
volumetric glassware. The concentrations for the RuII peptide stock solutions (2b-Ru, 2e-Ru, 
and 2f-Ru) were determined using the extinction coefficient for Ru(bpy)32+ in water (14,600 
at 452 nm).11 The concentrations for the OsII peptide stock solutions were determined using 
the extinction coefficient for Os(bpy)32+ in water (12,000 at 480 nm).12 All buffers and 
peptide stock solutions were prepared using MilliQ water. Metallopeptides used for the 
GndHCl denaturation experiments could typically be purified and used again after the 
removal of salts using polyacrylamide size-exclusion columns and separation using RP-
HPLC. 
The values for fraction folded (FF) were calculated using Equation 1. The values for 
fraction unfolded (FU) were calculated using Equation 2. The values for the free energy of 
unfolding (GD) were calculated using Equation 3. The values for the free energy of 
unfolding in the absence of denaturant (GH20) were extrapolated using Equation 4.  
ii. All-atom molecular dynamics simulations 
 The computational details for the all-atom molecular dynamics simulations were 
provided by Dr. Christopher Materese. Since no crystal structure was available for the 
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system, the initial structure was generated using PyMOL,13 which is a molecular 
visualization tool capable of constructing simple peptides. The P1 and P2 peptides were 
initially generated independently using PyMOL's helical parameters and were then manually 
aligned with care taken to avoid steric clashes and satisfy the hydrophobic interface. The -
triazolo-L-lysine linker segment was constructed using Gaussview, part of the Gaussian 03 
suite.14 Ruthenium and osmium are very similar from an MD perspective. Since the primary 
focus of these simulations is peptide dynamics, ruthenium was used as the central atom in 
both chromophores and osmium was not explicitly included. In order to examine the effect of 
linker positioning on the chromophores, the following three systems were created: System 1, 
which corresponds to the 2f-Ru/2f-Os metallopeptide pair, System 2 which corresponds to 
the 2b-Ru/2c-Os metallopeptide pair, and System 3 which corresponds to the 2e-Ru/2g-Os 
metallopeptide pair. 
 The simulations were prepared using we use the AMBER15 force field with the 
ff99SB16 parameter set. Since the AMBER libraries do not possess parameters for the 
artificial amino acids used as tethers, or for the chromophores themselves, these values 
needed to be collected from literature or obtained through quantum calculations. Partial 
charges for the linker and chromophores were obtained from Gaussian calculations using 
restricted B3LYP17 with the LANL2DZ18 basis set. Charges derived using the restricted 
electrostatic potential (RESP) technique19 gave spurious results for Ruthenium and the 
chelating nitrogen atoms in the bipyridyl ligands. RESP has difficulty predicting the correct 
charge for buried atoms since the charges are assigned in an effort to reproduce the external 
electrostatic potential.19 Because of this, Mulliken charges were used in lieu of RESP 
charges. In general, Mulliken charges tend to be slightly more exaggerated than RESP 
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charges with an average difference in predicted charge of 0.1(0.1)e for all atom excluding 
from the Ruthenium and those atoms immediately surrounding it. There was insufficient 
memory to compute partial charges for the entire linker and chromophore. In order to deal 
with this issue, the partial charges for the base of the peptide up to the -carbon of the side 
chain were extracted from the standard lysine amino acid residue. Force constants for Ru-N 
stretches, N-Ru-N (cis/trans) bends, C-C-N-Ru dihedrals, H-C-N-Ru dihedrals and van der 
Waals parameters were obtained from Brandt et al.20 Since AMBER does not explicitly 
support Octahedral geometry, chelating nitrogen atoms were divided into three distinctly 
named but chemically identical types in order to establish different bending force constants 
for cis and trans positions. Each of the three simulations were performed with ~13000 
explicit TIP3P water molecules in a box with the dimensions ~ 75  75  75 Å under 
periodic boundary conditions. The charge of each system was neutralized by the addition of 
sodium counter ions, followed by the subsequent introduction of an additional 10mM NaCl. 
Each system was held at constant volume, and the peptides were frozen in place while the 
water and ions were minimized for 200,000 steps. Subsequently, all constraints were 
removed from the systems and they were minimized for an additional 200,000 steps. The 
systems were gradually heated via Langevin temperature control to 300 K in incremental 
steps of 5 K every 50 ps. The production runs proceeded under the constant pressure, 
moderated by Langevin piston (set to 1 atm), with 2 fs time steps using the SHAKE 
algorithm and Ewald summation for long-range interactions. Short-range non-bonded 
interactions were calculated at each step, long-range interactions were only calculated on 
even steps and the pair list was updated every 10 steps. System coordinates were saved every 
1000 steps (2 ps) for analysis for a total simulation length of 500 ns. 
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 The individual trajectories of the RuII bipyridyl complexes for each simulation are 
shown (Figure 4.7). The trajectories serve only as an oversimplified report of the peptide 
dynamics. They represent the relatively metal-center displacements but do represent other 
dynamic portions of the metallopeptide scaffolds. The histograms shown in Figure 4.6 were 
generated from these trajectories, with the first 20 ns being discarded as relaxation time for 
the system. 
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Figure 4.8 (a) Metal-center displacement distance for the 2f/2f metallopeptide pair as a 
function of time. (b) Metal-center displacement distance for the 2b/2c metallopeptide pair as 
a function of time. (c) Metal-center displacement distance for the 2e/2g metallopeptide pair 
as a function of time. The red lines signify the cutoff point before which data is discarded as 
part of the system relaxation. 
 
 
(a) 
 
(b) 
 
(c) 
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Chapter V 
THE STUDY OF POSITION-DEPENDENT ENERGY TRANSFER 
WITHIN COILED-COIL METALLOPEPTIDE HETERODIMERS 
  
 A. Introduction 
 As mentioned in Chapter 1, the phenomena of RuII to OsII energy transfer has been 
studied using a number of covalent linkages,1 high molecular weight polymers,2 and DNA 
scaffolds.3 The coiled-coil peptide motif has not previously been used as an organizational 
structure for RuII to OsII energy transfer. The general structure and dynamic monomer-dimer 
equilibrium behavior of these novel coiled-coil metallopeptides were presented in Chapter IV 
using a combination of CD spectroscopy and GndHCl denaturation experiments. General 
trends that may be expected for the displacement distances of RuII and OsII bipyridyl 
complexes attached at different positions within the coiled-coil peptide scaffold were also 
discussed. The discussion was based on reported crystal structures for similar coiled-coil 
dimers, and on existing knowledge within the field of de novo protein design.4 Another 
interpretation of the coiled-coil peptide structure was provided by Dr. Christpher Materese 
using all-atom molecular dynamics simulations under the advisement of professor Garyk 
Papoian. 
Despite the extensive characterization provided within Chapter IV, the exact energy 
transfer behavior that should have been expected for the coiled-coil metallopeptides was not 
intuitively obvious at the outset. The metallopeptides that form the 
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focus of the preceding chapter do indeed exhibit position-dependent RuII to OsII energy 
transfer. The steps taken to determine and fully characterize this energy transfer are described 
throughout Chapter V. This work was performed in collaboration with Stephanie Bettis under 
the advisement of Professor John Papanikolas. All time-resolved emission measurements 
were collected by Stephanie Bettis. 
 B. General energy transfer behavior and control experiments 
 
 Similar to the measurements of thermodynamic stability made in Chapter IV, energy 
transfer studies were performed specifically on the 2f-Ru/2f-Os, 2b-Ru/2c-Os, and 2e-Ru/2g-
Os coiled-coil metallopeptide heterodimers (Figure 5.1). Based on the equilibrium behavior 
described in Chapter IV, energy transfer within the coiled-coil metallopeptides would be 
expected to be concentration dependent. Energy transfer from the RuII-containing 
metallopeptides was expected to vary with the concentration of the OsII-containing 
metallopeptide. For this reason, all of the energy transfer experiments were performed as 
titrations where the RuII metallopeptide concentration was held constant and the lifetime of 
RuII excited-state emission was examined as a function of both substoichiometric and 
superstoichiometric concentrations of the OsII metallopeptide. Time-resolved measurements 
of the RuII metallopeptide emission allowed correlations to be made with the physical model 
of the coiled-coil system that would have been more difficult using steady-state emission 
techniques alone. The emissive lifetimes were measured using time-correlated single photon 
counting (TCSPC)2e experiments. The metallopeptide samples were excited at 450 nm and 
emission data was collected at 660 nm. The general spectroscopy setup used to make the 
TCSPC measurements is diagramed in the experimental section. 
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Figure 5.1. A helical wheel diagram for the metallopeptide partners examined throughout the 
study. The 2f-Ru/2f-Os (blue), 2b-Ru/2c-Os (red), and 2e-Ru/2g-Os (green) metallopeptide 
pairs are shown. The approximate distances between attachment points based on crystal 
structures (pdb code: 2ZTA) measured between the the respective -carbons are 14.3,  12.7, 
and 9.9  Å for the 2f-Ru/2f-Os, 2b-Ru/2c-Os, and 2e-Ru/2g-Os metallopeptide pairs, 
respectively. 
 
 When considering potential energy transfer behaviors, the 2b-Ru/2c-Os and 2e-
Ru/2g-Os metallopeptide pairs were expected to provide the most favorable energy transfer if 
any were observed at all. Indeed, titration of the 2b-Ru or 2e-Ru metallopeptides with the 2c-
Os or 2g-Os peptides, respectively, resulted in a significant decrease in the observed lifetime 
of RuII emission. Quenching of the Ru(bpy)32+ excited-state emission by Os(bpy)32+ was 
reported by Cruetz and coworkers, although the bimolecular rate constant (1.5 x 109 M-1·s-1) 
would imply that diffusional quenching would be inefficient at the concentrations the 2b-Ru 
and 2e-Ru peptides were titrated at (low M for both donor and acceptor).5 Although it was 
believed that diffusion controlled quenching was unlikely in the absence of the peptide 
scaffold, a control experiment was designed to test such an occurrence. The 2b-Ru peptide 
was titrated with an OsII complex (13) designed to mimic the attachment linker, while not 
providing any strong noncovalent interactions that would encourage association with the 
peptide scaffold (Figure 5.2a). The addition of OsII complex 13 to the 2b-Ru peptide had no 
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measurable effect on the RuII excited-state lifetime at concentrations greater than those 
required for measurable quenching compared to the 2c-Os metallopeptide (Figure 5.2b). This 
result indicates that noncovalent association is required for quenching and is in contrast to the 
report by Tor and coworkers where the addition of Os(bpy)2(phen)2+ to solutions containing a 
RuII-modified oligonucleotide resulted is subtle quenching of the RuII-based 
phosphorescence, even at much lower concentrations.3c Tor’s result could be due to the 
longer emissive lifetime of the RuII-modified oligonucleotide used in the study. The result 
could also be attributed to the fact that, while oligonucleotides are polyanionic molecules, the 
2b-Ru peptide contained a net positive (+5) charge at pH 7. The 2b-Ru peptide may have had 
repulsive charge-charge interactions with 13 that were less important or even attractive when 
compared to Tor’s oligonucleotide system. It is also possible that the Os(bpy)2(phen)2+ 
complex used as a control in Tor’s study interacted with the DNA scaffold via classical 
intercalation or surface binding, both phenomena known for RuII complexes that contain 
phenanthroline ligands.6 
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Figure 5.2 (a) The chemical structure of the osmium complex 13 is shown. (b) The time-
resolved emission experiment showing that the 2b-Ru monoexponential lifetime  (red: 25 
M 2b-Ru peptide and 50 M P1 peptide) at 660 nm is not measurably affected by either one 
(blue: 25 M 2b-Ru peptide and 25 M 13), or two (black: 25 M 2b-Ru peptide and 50 M 
13) equivalents of 13. 
  
 A second control experiment was designed to demonstrate that the coiled-coil 
structure was directly responsible for promoting the observed quenching behavior in the 
manner predicted. The GndHCl denaturation experiments used to determine dissociation 
constants within Chapter IV provided a convenient strategy for disrupting the structure of the 
coiled-coil scaffold, even when the complementary OsII-containing peptide was present in 
excess. The emissive lifetimes for both the 2b-Ru and 2e-Ru metallopeptides increased 
considerably when examined in buffered media containing 5 M GndHCl (Figure 5.3). 
However, the lifetimes for RuII decay in both the 2b-Ru/2c-Os or 2e-Ru/2g-Os 
(a) 
 
(b) 
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metallopeptide heterodimers were identical to those for the 2b-Ru and 2e-Ru peptides, 
respectively, when examined in the denaturing media. Both experiments were good 
indicators of the role the coiled-coil scaffold performed during energy transfer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 (a) Time-resolved emission trace for the 2b-Ru/2c-Os GndHCl denaturation 
experiment (blue: 25 M 2b-Ru peptide and 50 M 2c-Os peptide in 10 mM sodium 
phosphate buffer, pH 7, red: 25 M 2b-Ru peptide and 50 M 2c-Os peptide in 5 M GndHCl 
buffer, pH 7). The emission lifetime of the 2b-Ru peptide is longer in the denaturing buffer 
(black: 25 M 2b-Ru peptide only in 5 M GndHCl buffer, pH 7), but is unaffected by the 
presence of the 2c-Os peptide. (b) Time-resolved emission trace for the 2e-Ru/2g-Os 
GndHCl denaturation experiment (blue: 25 M 2e-Ru peptide and 50 M 2g-Os peptide in 
10 mM sodium phosphate buffer, pH 7, red: 25 M 2e-Ru peptide and 50 M 2g-Os peptide 
in 5 M GndHCl buffer, pH 7). The emission lifetime of the 2e-Ru peptide is longer in the 
denaturing buffer (black: 25 M 2e-Ru peptide only in 5 M GndHCl buffer, pH 7), but is 
unaffected by the presence of the 2g-Os peptide. 
  
 
(a) 
 
(b) 
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C. Titration experiments 
 Once control experiments had confirmed that the observed RuII-based emission 
quenching was due to coiled-coil formation with the OsII-containing metallopeptides, 
detailed analyses of the different heterodimers were performed. Interestingly, all three RuII 
metallopeptides have excited-state lifetimes that differ slightly when measured in isolation 
from the OsII-containing peptides. This fact demonstrates the sensitivity of the RuII excited-
state lifetime to environment, a phenomenon typically observed in the context of 
solvatochromism.7 The lifetimes of the 2b-Ru, 2e-Ru, and 2f-Ru metallopeptides are, 
however, unaffected by the presence of the P1 parent peptide, even in an excess. This too is 
in contrast to the reports by Tor and coworkers who observed a significant change in the 
emissive lifetime of RuII-containing oligonucleotides when duplexed with complementary 
DNA oligonucleotides which did not contain OsII bipyridyl complexes.3c This observation 
was attributed to the fact that DNA oligonucleotides are highly disordered in isolation and go 
through a considerable degree of structural reorganization when they are duplexed with 
complementary oligonucleotides. In contrast, peptides designed to form coiled-coil structures 
can contain a considerable degree of -helical character in the monomeric state, and may 
also be bound to a small extent as -helical homodimers in the absence of the 
complementary unit. Both characteristics could explain why the 2b-Ru, 2e-Ru, and 2f-Ru 
metallopeptides are insensitive to complementary peptide sequences which did not contain 
OsII.  
 The excited state decay of the 2b-Ru, 2e-Ru, and 2f-Ru metallopeptides are all 
monoexponential in isolation, but became biexponential when the complementary 2c-Os, 2g-
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Os, or 2f-Os metallopeptides are added (Figure 5.3). In all cases, the biexponential behavior 
can be described using Equation 1: 
ۦ߬ۧ ൌ ܣଵ  ൉ ߬ଵ ൅ ܣଶ  ൉ ߬ଶ       ܧݍݑܽݐ݅݋݊ 1 
where ۦۧ is the weighted average lifetime observed for the mixture, 1 is the lifetime of the 
slower component, 2 is the lifetime of the faster component, and A1 and A2 are the 
amplitudes of the slower lifetime and faster lifetime components, respectively. The slower 
lifetime component for each metallopeptide pair corresponds to the lifetime of the RuII 
peptide in isolation. For example, the 2e-Ru/2g-Os metallopeptide pair has a slower excited-
state decay component (1) that corresponds to the lifetime of the 2e-Ru peptide measured in 
isolation. By implication, the amplitude (A1) of this slower component is found to be unity 
when no 2g-Os metallopeptide was added. While the 1 component measured for the different 
RuII-containing peptides vary by less than 10%, the 2 components measured for the different 
metallopeptide pairs vary to a greater extent. The amplitude of the faster lifetime component 
(A2) varies with the concentration of the OsII-containing peptide and was assigned as RuII to 
OsII energy transfer. The results of the time-resolved emission experiments are shown 
(Figure5.4). 
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Figure 5.4 (a) The time-resolved emission trace at 660 nm for the 2e-Ru/2g-Os 
metallopeptide pair. (b) The time-resolved emission trace at 660 nm for the 2b-Ru/2c-Os 
metallopeptide pair. (c) The time-resolved emission trace at 660 nm for the 2f-Ru/2f-Os 
metallopeptide pair. The concentration of the RuII-containing peptide was 25 M for each. 
The following titration experiments are shown for each: 0 M (black), 6.25 M (blue, 0.25 
equiv), 12.5 M (red, 0.5 equiv), 18.75 M (green, 0.75 equiv), 25 M (grey, 1.0 equiv), and 
50 M (violet, 2.0 equiv) OsII-containing peptide concentration. All samples analyzed at 
25°C in 10 mM PO43-, pH 7, buffer. The computer generated fit is shown as a solid line in 
each. 
(a) 
 
(b) 
 
(c) 
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The concentration-dependence of the faster lifetime component can be described 
using a dissociation constant (Kd) similar to that measured for the metallopeptide pairs by 
GndHCl denaturation (Chapter IV). The dissociation constants for the different 
metallopeptide pairs can all be expressed using Equation 2: 
 
ܭௗ ൌ   ሾܴݑሿሾܱݏሿሾܴݑ ൉ ܱݏሿ        ܧݍݑܽݐ݅݋݊ 2 
 
where [Ru] is the concentration of the RuII-containing peptide at equilibrium, [Os] is the 
concentration of the OsII-containing peptide at equilibrium, and [Ru·Os] is the concentration 
of the coiled-coil metallopeptide dimer at equilibrium. The quantities, [Ru] and [Os], can be 
expressed in terms of the dimer concentration [Ru·Os] using Equation 3 and Equation 4: 
 
ሾܴݑሿ ൌ ሾܴݑሿ଴ െ ሾܴݑ ൉ ܱݏሿ      ܧݍݑܽݐ݅݋݊ 3 
ሾܱݏሿ ൌ ሾܱݏሿ଴ െ ሾܴݑ ൉ ܱݏሿ       ܧݍݑܽݐ݅݋݊ 4 
 
where [Ru]0 is the total RuII-containing peptide concentration and [Os]0 is the total OsII-
containing peptide concentration. Substitution of Equation 3 and Equation 4 into Equation 2 
gives Equation 5: 
 
ܭௗ ൌ  
ሺሾܴݑሿ଴ െ ሾܴݑ ൉ ܱݏሿሻሺሾܱݏሿ଴ െ ሾܴݑ ൉ ܱݏሿሻ
ሾܴݑ ൉ ܱݏሿ        ܧݍݑܽݐ݅݋݊ 5 
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where the dissociation constant (Kd) is expressed in terms of the known quantities [Ru]0 and 
[Os]0. Equation 5 was rearranged to express the metallopeptide heterodimer concentration 
([Ru·Os]) in terms of the Kd, [Ru]0, and [Os]0 resulting in Equation 6: 
 
ሾܴݑ ൉ ܱݏሿ ൌ ሾܴݑሿ଴ ൅ ሾܱݏሿ଴ ൅ ܭௗ െ ඥሺሾܴݑሿ଴ ൅ ሾܱݏሿ଴ ൅ ܭௗሻ
ଶ െ 4ሾܴݑሿ଴ሾܱݏሿ଴
2    ܧݍݑܽݐ݅݋݊ 6 
 
The relative emission intensity (I) measured for the emission experiments can be expressed 
as a time-dependent function using Equation 7: 
 
ܫሺݐሻ ൌ ቈቆሾܴݑ ൉ ܱݏሿሾܴݑሿ଴ ቇ ݁
ିሺ௞ೃೠା௞ಶ೙೅ሻ௧ ൅ ቆሾܴݑሿ଴ െ ሾܴݑ ൉ ܱݏሿሾܴݑሿ଴ ቇ ݁
ି௞ೃೠ௧቉        ܧݍݑܽݐ݅݋݊ 7 
 
where kRu is the emission lifetime for the RuII-containing peptide in isolation, kEnT is the rate 
of energy transfer to the OsII-containing peptide, and t is time. Since the preexponential terms 
[Ru·Os]/[Ru]0 and ([Ru]0-[Ru·Os])/[Ru]0 represent the fractions of the RuII peptide contained 
in the heterodimer and monomer states (FF and FU), respectively, they can be used to 
calculate the Kd values of interest. The lifetimes and dissociation constants derived from 
these titration experiments are given in Table 5.1. The Kd values determined for the 
metallopeptides by time-resolved emission (Table 5.1) agree extremely well with the Kd 
values determined by chemical denaturation (Chapter IV). The correlation between the 
values is important to our hypothesis that the structure of the coiled-coil peptide scaffold is 
responsible for promoting the observed energy transfer since chemical denaturation is 
monitored by CD signal ([θ]222) and is dependent only on the peptide secondary structure.  
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Table 5.1. Lifetimes and amplitudes generated from the titration experiments 
 2e-Ru/2g-Os 2b-Ru/2c-Os 2f-Ru/2f-Os 
1a (ns) 468.2 ± 0.4 450.0 ± 0.5 478.7 ± 0.5 
EnTb (ns) 42.0 ± 0.2 304 ± 2 816 ± 14 
Kdc (M) 1.127 ± 0.001 1.088 ± 0.002 1.101 ±0.006 
Kd (GndHCl)d (M) 1.4 ± 0.3 0.97 ± 0.2 0.49 ± 0.09 
aThe slower excited-state decay component 1 is attributed to RuII emission in the absence of 
quenching. bThe rates of energy transfer for the metallopeptide heterodimers are reported as 
lifetimes (EnT = 1/kEnT) for comparison. cThe dissociation constants were calculated using 
Equation 6 and Equation 7. dThe dissociation constants were measured in Chapter IV. 
  
 D. Results and discussion 
The 2e-Ru/2g-Os metallopeptide pair is predicted to be the best promoter of RuII to 
OsII energy transfer based on the discussion of coiled-coil structure presented in Chapter IV. 
Indeed, the lifetime of energy transfer (EnT) measured for the 2e-Ru/2g-Os metallopeptide 
pair is 42 ns. This value was considerably faster than that for either the 2b-Ru/2c-Os or 2f-
Ru/2f-Os pairs. The molecular dynamics simulations of the 2e-Ru/2g-Os pair presented in 
Chapter IV showed a number of conformations where the bipyridyl complexes were able to 
come in close contact with each other. 
Comparing EnT for the 2e-Ru/2g-Os metallopeptide pair to the subnanosecond rates 
observed within the RuII- and OsII-modified polystyrene systems studied by Fleming and 
coworkers indicated that the metallopeptide system is a less efficient promoter of RuII to OsII 
energy transfer.2e This is almost certainly due to the RuII and OsII bipyridyl complexes 
occupying, on average, conformations that are less conducive (greater metal complex 
displacement) to excited-state energy transfer compared to the polystyrene-based systems 
where the donor and acceptor complexes are forced into van der Waals contact with each 
other.2e There is also the possibility that the effect is due to the different chemical structure of 
the RuII-bipyridyl complexes used within the polystyrene-based system. 
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 Based on the discussion presented in Chapter IV, a number of results could be 
expected for the 2b-Ru/2c-Os metallopeptide system. The 2b-Ru/2c-Os pair could be 
expected to promote energy transfer less efficiently than the 2e-Ru/2g-Os pair based on an 
analysis of the helical positions within similar coiled-coil peptide structures (Figure 5.1). 
Conversely, the molecular dynamics simulation of the 2b-Ru/2c-Os metallopeptide pair 
implies that it could promote energy transfer in a manner very similar to the 2e-Ru/2g-Os 
pair. The titration experiments using time-resolved emission indicated that the 2b-Ru/2c-Os 
metallopeptide pair give an energy transfer lifetime of 304 ns. Although the 2b-Ru/2c-Os 
metallopeptide pair is less efficient at promoting energy transfer compared to the 2e-Ru/2g-
Os pair, the structural differences between the two metallopeptide heterodimers may not be 
that great.  As described in Chapter I, the efficiency of Dexter energy transfer decreases 
exponentially with distance and the displacement between metal centers in the two 
metallopeptide systems may therefore be similar.8 It is reasonable to assume a Dexter 
mechanism is operative in both the 2b-Ru/2c-Os and 2e-Ru/2g-Os metallopeptide systems 
since the analysis of coiled-coil crystal structures presented in Chapter IV indicate that the 
attachment positions for the two scaffolds are very similar in distance to the radius of the 
metal complexes themselves and would likely allow for the RuII and OsII bipyridyl 
complexes to come in van der Waals contact.9 Tor and coworkers concluded that RuII to OsII 
energy transfer in the oligonucleotide-based system was primarily due to a Förster 
mechanism with contributions from the Dexter mechanism being important at smaller 
donor/acceptor separations. A similar conclusion could likely be made for the 2b-Ru/2c-Os 
and 2e-Ru/2g-Os metallopeptide sytems where both Dexter and Förster mechanisms may 
play a role in determining energy transfer rates, but to different extents.3c  
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 The 2f-Ru/2f-Os metallopeptide pair was, not surprisingly, the least efficient promoter 
of RuII to OsII energy transfer energy. At the outset it was difficult to even predict that the 2f-
Ru/2f-Os metallopeptide pair would promote energy transfer. The different analyses of the 
coiled-coil structures presented in Chapter IV all imply that the attachment positions on the 
peptide scaffold are sufficiently displaced to prevent any contact between the bipyridyl 
complexes. The energy transfer lifetime for the 2f-Ru/2f-Os metallopeptide system (816 ns) 
is fairly long compared to the 2b-Ru/2c-Os and 2e-Ru/2g-Os systems, but the fact that energy 
transfer is observed at all is likely an indicator that a Förster mechanism is involved. Again, 
this would agree with the conclusion reached both by Tor and by other researchers where a 
Förster mechanism is operative at greater donor/acceptor distances, but a Dexter mechanism 
is possible for the same energy transfer pair at closer distances.1,3 
 E. Conclusions 
 The coiled-coil peptide scaffold presented throughout this report has been shown to 
be an efficient promoter of RuII to OsII energy transfer. The 2e-Ru/2g-Os, 2b-Ru/2c-Os, and 
2f-Ru/2f-Os metallopeptide systems exhibit different energy transfer rates that correlate with 
the structural model presented for the coiled-coil peptide scaffold. Control experiments 
performed on the systems indicate the peptide scaffold is critical for promoting energy 
transfer. Equilibrium constants for the metallopeptides, measured by time-ressolved emission 
titration experiments, agree extremely well with those measured by chemical denaturation 
(Chapter IV), and reinforce the importance of the peptide scaffold for promoting RuII to OsII 
energy transfer. Although the mechanism of energy transfer could not be assigned exactly, 
the analyses of the metallopeptide system would imply that both Dexter and Förster 
components may play a role in determining the observed energy transfer rates. The exact 
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mechanism may be identified if additional metallopeptides representing a wider range of 
donor-acceptor displacements were examined. It is important to recognize that the position-
dependent energy transfer observed for the different metallopeptide pairs most likely does 
not represent a static displacement of bipyridyl complexes but instead is a measure of the 
average distances observed for the systems as a result of dynamic solution conformations. 
Inspired by the widespread use of the coiled-coil peptide scaffold throughout natural systems, 
a number of researchers have already investigated them for potential materials applications.10 
The metallopeptide systems described throughout this report could be applied to a number of 
productive applications including the construction of synthetic light-harvesting antenna,11 or 
as a sensitizer for dye-sensitized solar cells.12 It is the latter that forms the focus of Chapter 
VI where the initial efforts for developing RuII-containing peptides capable of performing 
excited-state electron injection with metal-oxide semiconductors is described.  
 F. Time-resolved emission experimental section 
 Ground state absorbance measurements were conducted with a Hewlett Packard 8453 
UV-VIS-NIR absorption spectrophotometer. Steady state emission (SSE) data were collected 
using an Edinburgh Instruments FLS920 equipped with a 450 W Xenon lamp and 
photomultiplier tube (Hamamatsu 2658P). SSE data were collected using a bandwidth no 
larger than 4.0 nm and, once collected, were corrected for the emission spectrophotometer’s 
spectral response.  The FLS920 was also used for time-resolved measurements by the time-
correlated single photon counting (TCSPC) technique with an instrument response of <100 
ps.  TCSPC excitation came from a 444.2 nm diode laser (Edinburgh Instruments EPL- 445, 
73 ps FWHM pulsewidth) operated at 200 kHz. A 495 nm long pass color filter was used for 
emission experiments. A diagram showing the basic experimental set up for time-resolved 
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emission measurements by time-correlated sinlge photon counting (TCSPC) is shown (Figure 
5.5). 
 The samples were placed in a 2.0 mm cuvette and placed at 45 degree angle from the 
incident laser beam. The samples were purged in Argon for >25 minutes prior to emission 
experiments. All experiments were performed with Abs444 nm< 0.2 OD. The solvent for each 
sample was 10 mM phosphate buffer at pH 7.  
 
Figure 5.5. Diagram showing the experimental set up for time-resolved emission 
measurements by time-correlated sinlge photon counting (TCSPC). 
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Chapter VI 
THE STUDY OF METALLOPEPTIDE SENSITIZERS 
FOR NANOCRYSTALLINE SEMICONDUCTORS 
  
 A. Introduction 
 Chapter I described the importance and general considerations for studying excited-
state energy transfer phenomena. The chemistry required to synthesize RuII-containing 
metallopeptides for the study of RuII to OsII energy transfer was described within Chapter III. 
Chapter VI will now describe the utilization of that synthetic chemistry to developed a series 
of metallopeptide-based sensitizers for nanocrystalline semiconductors. This work focused 
on synthesis, surface attachment, photophysics and excited-state electron transfer dynamics 
of these metallopeptide-based sensitizers on nanocrystalline semiconductor surfaces. This 
work was performed in close collaboration with Dr. Kenneth Hanson using the EFRC 
spectroscopy facility under the advisement of Professor Thomas J. Meyer. 
 B. Background 
Interest in excited-state electron transfer across heterogeneous surfaces has 
accelerated since the invention of the dye-sensitized solar cell (DSSC).1 Although the exact 
mechanisms of action for DSSCs differ, several key steps are generally involved (Figure 
6.1).2 These elementary steps include: (a) the absorption of light which creates an 
electronically-excited state localized on the sensitizer molecule; (b) electron injection from 
the excited state molecule into the semiconductor conduction band known as photoinjection;
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(c) the reduction of the oxidized sensitizer molecule by a charge-transporting electrolyte; and 
(d) the return of the injected electron through an external circuit, performing useful work on a 
load, with reduction of oxidized electrolyte occuring at a counter electrode. In addition to the 
processes described above that are required for efficient DSSC performance there are 
competitive detrimental processes that include but are not limited to back electron transfer 
(BET, e). BET is the process of charge recombination between the oxidized sensitizer and 
electrons localized in the semiconductor. The process described above is, as a whole, 
completely regenerative, meaning no net chemical reaction occurs. The general process of 
creating an interfacial charge-separated state from a photoexcited state can be thought of as 
biomimetic, as excited-state electron transfer drives the generation of useful redox 
equivalents in natural photosynthetic systems as well.3 Although early studies indicated 
sensitizers dissolved in the electrolyte solution could be used, it was quickly realized that the 
direct attachment of sensitizers to semiconductor surfaces was a more practical approach.2 
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Figure 6.1 A schematic representation of a DSSC is given. The elementary processes 
involved: (a) absorption of light by a sensitizer (filled black sphere); (b) electron transfer into 
the semiconductor conduction band; (c) reduction of the oxidized sensitizer by a charge-
transporting electrolyte (empty sphere); (d) current traveling through the external circuit and 
successively reducing the oxidized electrolyte; and (e) nonproductive BET from the 
semiconductor to the oxidized sensitizer. 
 
DSSCs are distinguished from other semiconductor-based solar cells by the 
separation of light absorption and charge transport functions between two different molecular 
components. DSSCs of the design presented above are typically referred to as Grätzel cells, 
since Michael Grätzel made significant contributions to their design by employing high 
surface area colloidal TiO2 films as the semiconductor component.1 Grätzel’s use of a high 
surface area semiconductor allowed for increased surface loading of sensitizer molecules and 
therefore higher absorbance of incident light, an absolute requirement for increased solar 
harvesting efficiency. A general description of the monochromatic current yield (ηi) possible 
for a DSSC is given by Equation 1:1 
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η௜ሺߣሻ ൌ ܮܪܧሺߣሻ ൉ ߔ௜௡௝ ൉ η௘       ܧݍݑܽݐ݅݋݊ 1 
where LHE is the light harvesting efficiency of the cell at a specific wavelength (λ), Φinj is 
the quantum yield for charge injection into the semiconductor, and ηe is the charge collection 
efficiency. The LHE is the fraction of the incident photons that are absorbed by the 
sensitizer, also commonly referred to as the absorptance (α (λ)). The LHE of a DSSC is 
related to transmittance and absorbance by Equation 2:2 
ܮܪܧሺߣሻ ൌ ߙሺߣሻ ൌ  1 െ ܫሺߣሻܫ଴ሺߣሻ ൌ 1 െ 10
ି஺ሺఒሻ       ܧݍݑܽݐ݅݋݊ 2 
where I0 is the intensity of incident light, I is the intensity of light transmitted through the 
sample, and A is the absorbance of light at a specific wavelength (λ). The efficiency of light 
absorption, and therefore the DSSC as a whole, will depend directly on the extinction 
coefficient of the sensitizer, and on the ability to adsorb high local concentrations of 
sensitizer molecules on the surface. The surface area required to bind a sensitizer is known as 
the footprint (AS).  
 Polypyridyl complexes of the transition metals FeII, RuII, OsII, and ReI have properties 
well equipped for use in DSSCs.4 As described in Chapter I, the MLCT absorbance bands for 
Ru(bpy)32+ and the related MII bipyridyl complexes have relatively high extinction 
coefficients over broad ranges of the visible spectrum. While the Ru(bpy)32+ ground state is 
relatively inert, photoexcitation produces a 3MLCT state sufficiently reducing compared to 
the conduction band of TiO2.5 Photoinjection into TiO2 typically occurs on the 
subnanosecond timescale.4 The excited-state lifetimes of the bipyridyl complexes can be tens 
or even hundreds of nanoseconds, and result in photoinjection yields that are quite high when 
sensitizer molecules are attached close to the semiconductor surface.4 
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 Any number of functional groups have been used to anchor RuII polypyridyl 
complexes to semiconductor surfaces including carboxylic acids, esters, amides, alcohols, 
and silyl chlorides.4 Carboxylic acid and phosphonic acid groups are typically considered 
superior attachment groups (Figure 6.2).4 RuII complexes containing bipyridyl ligands with 
two carboxylic acid groups serving as anchors have been the most commonly employed in 
DSSCs, and are known to exhibit high device performances (Figure 6.2a).5 Bipyridyl ligands 
containing multiple phosphonic acid groups have more recently been shown to provide 
greater surface attachment stability under conditions of irradiance in aqueous environments 
(Figure 6.2b,c).6 The phosphonic acid group also provides better surface stability over a 
broader range of pH values. 
 
 
 
 
Figure 6.2 (a) A bipyridyl ligand with two carboxylic acid groups. (b) A bipyridyl ligand 
with two phosphonic acid groups attached directly to the pyridine ring. (c) A bipyridyl ligand 
with two phosphonic acid groups attached to the pyridine ring through a methylene group. 
 C. System design 
 Phosphoserine is a naturally occurring amino acid in proteins, although it is a post-
translational modification and is not synthesized during normal translation of the genetic 
code (Figure 6.3).7 The post-translational phosphorylation of amino acids such as serine, 
threonine, and tyrosine by protien kinases is one of the most important regulatory 
mechanisms within cellular signaling pathways.7 Similar to the phosphonic acid groups used 
within the bipyridyl ligands discussed above, phosphoserine is known to provide 
coordinative binding to TiO2 surfaces when included in short peptide sequences.8 An 
(a) 
 
(b) 
 
(c) 
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attachment strategy for RuII-based sensitizers and TiO2 surfaces based on phosphoserine 
anchoring groups was designed and tested. To the best of our knowledge phosphoserine has 
not been used for the anchoring of sensitizers to semiconductor surfaces. 
Several possible advantages were anticipated with RuII-containing phosphopeptides 
as compared to traditional polypyridyl RuII complexes as sensitizers. The possible advantages 
include: (1) the ease of system redesign due to the high throughput nature of solid-phase 
peptide synthesis; (2) the ability to incorporate a number of phosphoserine groups in 
sequence in order to provide high-affinity anchoring of the RuII sensitizer; (3) the attachment 
of the RuII complexes to the phosphopeptides through a single bipyridyl ligand; (4) the ability 
to attach multiple RuII complexes to a single anchoring motif; and also (5) the tunable 
distance between the RuII bipyridyl complexes and the semiconductor surface. More 
explicitly, the ability to attach multiple RuII complexes to a single anchoring motif would 
allow for high extinction coefficient sensitizers with relatively small footprints, and would 
also allow for systematic distance dependence studies. 
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Figure 6.3 System design for the RuII-containing phosphopeptides 2pS (n = 2) and 3pS (n = 
3). The structure of both phosphoserine and azidolysine are shown. 
 
A phosphopeptide system was designed based on a single heptad repeat unit 
(KIASLKQ) from the P1 peptide sequence in Chapter II (Figure 6.3). The initial system 
design contained either two (2pS) or three (3pS) phosphoserine residues for surface 
anchoring, and a RuII bipyridyl complex (11a) attached using an azidolysine residue. The 
synthesis of and conjugation strategies for using -Fmoc--azido-L-lysine (8) are presented 
in Chapter III. RuII complexes typically gain high affinity for semiconductor surfaces when 
multiple ligands are derivatized with anchoring groups.2,4 It was hoped that using only one 
alkyne-functionalized ligand for the attachment of the phosphopeptide anchoring group to the 
RuII bipyridyl complex would allow for the chromophoric and electrochemical properties of 
the other two bipyridyl ligands to be varied more easily. 
The relative anchoring stability of the 2pS and 3pS phosphopeptides was tested by 
first adsorbing the phospopeptides onto high surface area TiO2 films, and then tracking the 
surface coverage over time using absorbance measurements. Thin-film TiO2 slides were 
115 
 
soaked for 48 hours in solutions containg 100 M phosphopeptide at pH 4 and 7 (phosphate 
buffer). The TiO2 adsorption of RuII bipyridyl complexes derivatized with phosphonic acid 
groups is known to be highly pH dependent, with more acidic media favoring higher 
adsorption levels.6c The surface coverages of the different slides were measured by 
absorbance at 452 nm. The slides were stored in identical buffers that did not contain the 
phosphopeptides so that the surface stabilities could be monitored periodically. Since the 
thickness of the TiO2 slides was somewhat nonhomogeneous, the absorbance of the 
individual uncoated slides was subtracted from the measurements and A values were 
reported (Figure 6.4). The 3pS phosphopeptide anchoring group was found to be superior to 
the 2pS anchoring group both with regard to initial loading and also long term surface 
stability. As expected the lower pH buffer provided better surface anchoring stability for the 
3pS phosphopeptide.  
 
 
 
 
 
 
116 
 
 
Figure 6.4 Relative surface stability of the 2pS and 3pS phosphopeptides on TiO2. Slides 
were coated for 48 hours in 100 M phosphopeptide solutions in 10 mM phosphate buffer, 
pH 4 or pH 7, and surface stability was evaluated in buffers that did not contain the 
phosphopeptides. 
 
 D. Photophysical measurements 
Once the 3pS phosphopeptide design had been established as a platform for attaching 
RuII-containing sensitizers, the length of the phosphopeptide anchor was investigated. It was 
unknown from the outset whether the phosphopeptide anchor would provide the intimate 
contact with the TiO2 surface required for excited-state electron transfer to occur. It was 
anticipated that if photoinjection from the phosphopeptides did occur, the length of the 
peptide structure could be used to tune both photoinjection (Figure 6.1, b) and BET (Figure 
6.1, e) rates. A second generation of phosphopeptide anchors was designed in order to test 
the influence that peptide structure had (Figure 6.5). Compared to the 3pS phosphopeptide, 
the 3pS-P3 and 3pS-P0 phosphopetides contain fewer amino acid residues between the 
phosphoserine anchor motif and the azidolysine residue used for RuII attachment. The 
general peptide sequence remains the same throughout in order to provide similar solubillity 
properties and aid in purification. A RuII complex containing a bis-phosphonated bipyridyl 
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ligand (14) was used for comparison. The complex 14 has previously been used by the Meyer 
group to study interfacial electron transfer dynamics.9  
 
Figure 6.5 Structure of the phosphopeptides used to test the effects of anchor length on 
photoinjection with TiO2. The 3pS peptide was optimized for surface coverage and stabillity. 
The second-generation phosphopeptides 3pS-P3 and 3pS-P0 have shorter peptide linkers 
between the phosphoserine anchoring motif and the RuII-containing sensitizer complex. The 
phosphonate-based complex [Ru(bpy)2((4,4’-PO3H2)2bpy)]2+ (14) was used for comparison 
when photoinjection was examined. 
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Figure 6.6 (a) Absorbance spectra are shown for the phosphopeptides 3pS (black), the bis-
phosphonated complex 14 (red), and Ru(bpy)32+ (blue). (b) Normalized emission spectra are 
shown for the phosphopeptides 3pS (black), 3pS-P0 (green), 3pS-P3 (violet). Also shown for 
comparison are the normalized emission spectra for the bis-phosphonated complex 14 (red), 
and Ru(bpy)32+ (blue). 
The RuII-containing phosphopeptides have photophysical properties very similar to 
the bis-phosphonated complex 14 when measured in solution. The absorbance spectra for the 
three phosphopeptides and 14 are typical of RuII bipyridyl complexes (Figure 6.6), displaying 
intense bands due to the -* (ligand-centered) and MLCT transitions.10 The electron 
withdrawing character of the amide substituent in the 3pS, 3pS-P0, and 3pS-P3 
phosphopeptides results in a hypsochromic shift in their emission spectra (max = 674 nm) 
(a) 
 
(b) 
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relative to Ru(bpy)32+ (max = 626 nm). The shift is similar to that observed for the bis-
phosphonated complex 14 (max = 675 nm). The three phosphopeptides also have excited-
state lifetimes () that are similar to 14 when measured in 0.1 M aqueous HClO4 (Table 6.1). 
Table 6.1. Photophysical properties of the phosphopeptides 3pS, 3pS-P0, and 3pS-P3. 
 
Absorbance 
(MLCT) 
max (nm)a 
Emission 
max (nm)b 
Lifetime 
(ns)b 
3pS 459 674 302 
3pS-P3 459 674 282 
3pS-P0 459 674 280 
14 453 675 306 
Ru(bpy)32+ 454 626 554 
aMeasured in 0.1 M HClO4. bMeasured in 0.1 M HClO4 after degassing with Ar for 30 
minutes. 
The lowest conduction band of zirconium dioxide (ZrO2) semiconductors is 
considerably higher in energy than the excited state reduction potential of most RuII bipyridyl 
complexes and therefore precludes photoinjection.11 For this reason ZrO2 films have been 
used for comparative studies where the surface-bound photophysical properties of potenitial 
sensitizers are examined in the absence of quenching due to electron injection. While the the 
solution-phase emission lifetimes for the three phosphopeptides were single exponential in 
character, their surface-bound excited-state lifetimes are biexponential (Table 6.2). The time-
resolved emission traces for each phosphopeptide displayed one component that was similar 
in lifetime to that observed in the solution phase (1) and one component that was of 
considerably longer lifetime (2). The longer lifetime component (2) had a greater amplitude 
for all three phosphopeptides. 
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Table 6.2. Photophysical properties of the phosphopeptides on ZrO2. 
 Emission max (nm)a 
1 (A1) 
ns (%)a 
2 (A2) 
ns (%)a 
˂ ˃ 
nsa 
3pS 665 280 (19) 630 (81) 470 
3pS-P3 665 290 (23) 600 (77) 410 
3pS-P0 665 280 (23) 560 (77) 380 
14 665 150 (13) 400 (87) 370 
aMeasured in 0.1 M HClO4 after degassing with Ar for 30 minutes. 
The surface-bound excited-state lifetimes of the phosphopeptides became 
triexponential after adsorption on TiO2 films (Table 6.3). Again, the emission spectra for 
each phosphopeptide displayed one component that was similar in lifetime to that observed 
in the solution-phase (1) and one component that was of considerably longer lifetime (2). 
The time-resolved emission traces for the phosphopeptides adsorbed on TiO2 displayed an 
additional component that was of considerably shorter lifetime (3) when compared to that 
observed in the solution phase. The short lifetime (3) component could be related to 
photoinjection from the RuII phosphopeptide excited state into TiO2. The relative amplitude 
of this component was less than 10% for all three phosphopeptides. The decrease in the 
average lifetimes of the phosphopeptides adsorbed on TiO2 indicate emission quenching due 
to photoinjection, although the degree of this quenching is minimal. Transient absorption 
analysis, to be reported elsewhere, indicate that the quantum yields for photoinjection (inj) 
do not exceed 12% for the phosphopeptides adsorbed onto TiO2. 
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Table 3. Photophysical properties of the phosphopeptides on TiO2. 
 Emission max (nm)a 
1 (A1) 
ns (%)a 
2 (A2) 
ns (%)a 
3 (A3) 
ns (%)a 
˂ ˃ 
nsa 
3pS 664 290 (23) 590 (76) 40 (1) 400 
3pS-P3 664 280 (35) 550 (61) 50 (3) 280 
3pS-P0 664 230 (54) 490 (37) 50 (9) 160 
14 676 b b b b 
aMeasured in 0.1 M HClO4 after degassing with Ar for 30 minutes. bValues were not 
obtained due to the instrument response. 
E. Conclusions 
The phosphopeptides designed and tested throughout Chapter VI were shown to be 
efficient anchoring modules for RuII bipyridyl complexes. The 3pS, 3pS-P0, and 3pS-P3 
phosphopeptides were compared to the previously studied bis-phosphonated complex 14 
using a number spectroscopic techniques. The complex 14 is intimately bound to the TiO2 
surface after adsorption and provides efficient photoinjection (inj = 1). The phosphopeptides 
described in Chapter VI do not provide efficient photoinjection and are unlikely to be useful 
as primary sensitizers for nanocrystalline semiconductors.  It is likely that the distance 
between the TiO2 surface and the RuII bipyridyl complexes is too large for the 
phosphopeptides to exhibit photoinjection on a timescale comparable to 14. There does 
appear to be a subtle distance dependence for the photoinjection observed in the 
phosphopeptides. The decrease in the average lifetime for each phosphopeptide roughly 
correlates with the number of amino acid residues between the RuII complex and the 
phosphoserine motif. Photoinjection yields measured by transient absorption also roughly 
correlate with this parameter. Although the 3pS, 3pS-P0, and 3pS-P3 phosphopeptides do not 
provide photoinjection yields that would make them attractive for use as primary sensitizers, 
they may be useful as secondary sensitizers capable of slowing BET (Figure 6.1, e) rates. 
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F. Experimental section 
Synthesis of phosphopeptides using -Fmoc--azido-L-lysine and -Fmoc-O-benzyl-
L-serine. Standard procedures for synthesizing peptides and azidopeptides using an 
automated synthesizer are described in detail in Chapter III. -Fmoc--azido-L-lysine (8) was 
synthesized and employed in automated coupling reactions by manual injection. -Fmoc-O-
benzyl-L-serine was purchased from Novabiochem and was also manually injected during 
automated peptide synthesis. The phosphopeptides were cleaved from the resin, and purified 
as described in Chapter III. Azidopeptide identities were confirmed by ESI-MS. M was 
calculated as 1315.61 (exact) for 2pS-N3 (C49H91N17O21P2). MS m/z observed: 1316.4 ([M + 
H+]+), 658.8 ([M + 2H+]2+); M was calculated as 1482.60 (exact) for 3pS-N3 
(C52H97N18O26P3). MS m/z observed: 1483.5 ([M + H+]+), 742.3 ([M + 2H+]2+); M was 
calculated as 1482.60 (exact) for 3pS-P3-N3 (C52H97N18O26P3). MS m/z observed: 1483.3 
([M + H+]+), 742.2 ([M + 2H+]2+); M was calculated as 1482.60 (exact) for 3pS-P0-N3 
(C52H97N18O26P3). MS m/z observed: 1483.4 ([M + H+]+), 742.2 ([M + 2H+]2+). 
Synthesis of RuII-containing phosphopeptides using the CuAAC reaction. Standard 
procedures for synthesizing RuII-containing peptides  by way of the CuAAC reaction are 
described in detail in Chapter III. RuII-containing phosphopeptides were synthesized and 
purified using identical procedures. M2+ was calculated as 1980.75 (exact) for 2pS 
(C84H120N24O22P2Ru). MS m/z observed: 990.2 ([M2+]), 660.5 ([M2+ + H+]3+); M2+ was 
calculated as 2147.75 (exact) for 3pS (C87H126N25O27P3Ru). MS m/z observed: 1073.8 
([M2+]), 716.2 ([M2+ + H+]3+); M2+ was calculated as 2147.75 (exact) for 3pS-P3 
(C87H126N25O27P3Ru). MS m/z observed: 1073.7 ([M2+]), 716.2 ([M2+ + H+]3+); M2+ was 
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calculated as 2147.75 (exact) for 3pS-P0 (C87H126N25O27P3Ru). MS m/z observed: 1073.8 
([M2+]), 716.2 ([M2+ + H+]3+). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
124 
 
References 
1O’Regan, B.; Grätzel, M. Nature 1991, 353, 737-740. 
2Ardo, S.; Meyer, G. J. Chem. Soc. Rev. 2009, 38, 115-164. 
3Gust, D.; Moore, T. A.; Moore, A. L. Acc. Chem. Res. 2001, 34, 40-48.  
4(a) Galoppini, E. Coord. Chem. Rev. 2004, 248, 1283-1297. (b) Kalyanasundaram, K, 
Grätzel, M. Coord. Chem. Rev. 1998, 77, 347-414. (c) Meyer, G. J. Inorg. Chem. 2005, 44, 
6852-6864. 
5(a) Desilvestro, J.; Grätzel, M.; Kavan, L.; Moser, J. J. Am. Chem. Soc. 1985, 107, 2988-
2990. (b) Vlachopoulos, N.; Liska, P.; Augustynski, J.; Grätzel, M. J. Am. Chem. Soc. 1988, 
110, 1216-1220. 
6(a) Gillaizeau-Gauthier, I.; Odobel, F.; Alebbi, M.; Argazzi, R.; Costa, E.; Bignozzi, C. A.; 
Qu, P.; Meyer, G. J. Inorg. Chem. 2001, 40, 6073-6079. (b) Caramori, S.; Cristino, V.; 
Argazzi, R.; Meda, L.; Bignozzi, C. A. Inorg. Chem. 2010, 49, 3320-3328. (c) Bae, E.; Choi, 
W. J. Phys. Chem. B. 2006, 110, 14792-14799. (d) Park, H.; Bae, E.; Lee, J.-J.; Park, J.; 
Choi, W. J. Phys. Chem. B 2006, 110, 8740-8749. 
7(a) Adams, J. A. Chem. Rev. 2001, 101, 2271-2290. (b) Hunter, T. Cell 1995, 80, 225-236. 
8(a) Gertler, G.; Fleminger, G.; Rapaport, H. Langmuir 2010, 26, 6457-6463. (b) Schmidt, S. 
R.; Schweikart, F.; Anderson, M. E. J. Chromatogr., B. 2007, 849, 154-162. (c) Sano, A.; 
Nakamura, H. Anal. Sci. 2004, 20, 861-864. (d) Sano, A.; Nakamura, H. Anal. Sci. 2004, 20, 
565-566. (e) Pinkse, M. W. H.; Uitto, P. M.; Hilhorst, M. J.; Ooms, B.; Heck, A. J. R. Anal. 
Chem. 2004, 76, 3935-3943. 
9Song, W.; Brennaman, M. K.; Concepcion, J. J.; Jurss, J. W.; Hoertz, P. G.; Luo, H.; Chen, 
C.; Hanson, K.; Meyer, T. J. J. Phys. Chem. C. 2011, 115, 7081-7091. 
10Juris, A.; Balzani, V.; Barigelletti, F.; Campagna, S.; Belser, P.; Von Zelewski, A. Coord. 
Chem. Rev. 1988, 84, 85-277. 
11Katoh, R.; Furube, A.; Yoshihara, T.; Hara, K.; Fujihashi, G.; Takano, S.; Murata, S.; 
Arakawa, H.; Tachiya, M. J. Phys. Chem. B. 2004, 108, 4818-4822.  
Chapter VII 
OLIGOPROLINE RECOGNITION BY A -HAIRPIN PEPTIDE 
  
A. Introduction and significance 
i. Proline is a structurally unique amino acid 
 Amongst the canonical amino acids, proline holds a distinguished position. Proline is 
the only amino acid that contains a cyclic side chain attached directly to its -amino group. 
This property makes proline the most conformationally restricted amino acid and renders it 
incapable of donating hydrogen bonds when it forms tertiary amide linkages within peptide 
structures. Proline occupies a very narrow region of the Ramachandran plot as a direct 
consequence of the pyrrolidine-containing side chain, and the conformational constraints that 
it imposes on the peptide backbone (Φ = -75º, Ψ = +145º, approximately).1 Proline typically 
plays a highly specialized role in proteins, whether it is incorporated in polyproline 
structures, or within structures containing the other proteinogenic amino acids. 
 The unique chemical properties of proline allow it to interact with the other amino 
acids in very distinctive ways. One of these distinct interactions is the aromatic-prolyl 
interaction.2 Interactions between proline and the aromatic amino acids have been well 
studied in the context of both protein folding and protein-protein interactions.2 An important 
manifestation of the aromatic-prolyl interaction is its effect on determining the cis-trans 
isomerisation state for amide bonds in many proteins. 
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Figure 7.1 (a) The s-trans and s-cis amide bond conformations for peptides are shown. Steric 
repulsions between the C substituents lead to destabilization of the s-cis amide bond 
conformation. (b) The s-trans and s-cis conformations for Xaa-Pro amide bonds are closer in 
energy due to competing steric repulsions from the C and C substituents (Xaa is any 
nonproline amino acid). 
 
 There is a significant degree of electron delocalization in amide bonds which results 
in considerable double-bond character (Figure 7.1a). This double-bond character results in a 
roughly 20 kcal·mol-1 barrier to rotation around the C-N amide bond.2a In the majority of 
amino acid peptides the s-trans conformation ( = 180°) is favored by roughly 2.5 kcal·mol-1 
relative to the s-cis conformation ( = 0°) due to the steric restrictions present in secondary 
amides (Figure 7.1a). In peptides containing Xaa-Pro tertiary amide bonds the preference for 
the s-trans conformation is considerably decreased since steric restrictions presented by the 
C and C substituents are more similar. The s-trans conformation is closer to 0.5 kcal·mol-1 
more stable compared to the s-cis conformation in these amide bonds containing proline. The 
barrier to rotation in proline-containing amide bonds is also decreased to roughly 13 
(a) 
 
(b) 
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kcal·mol-1.2a The relatively low barrier to rotation and increased energy in the s-trans 
conformation results in Xaa-Pro amide bonds adopting an s-cis conformation in more than 5% 
occurrence in natural proteins.2d This is significantly more often than any of the other 
proteinogenic amino acids which on average occupy the s-cis conformation in less than 1% 
of amide bonds. Aromatic residues directly preceding proline confer stability to the s-cis 
conformation due to favorable aromatic-prolyl interactions, with tryptophan being the most s-
cis-stabilizing non-proline residue. These interactions were first recognized through the 
analysis of protein data banks in which many aromatic residues stack against proline side 
chains. Most often, the proline H, H, or Hshow the shortest contact distances (roughly 4 
Å) with the aromatic ring (Figure 7.2a). 
 
 
 
 
 
Figure 7.2 (a) A tryptophan-proline amide bond is shown. The s-cis conformation is 
stabilized by an aromatic-prolyl interaction. (b) An aromatic-prolyl interaction between 
tryptophan and proline residues located within different protein domains. Many aromatic-
prolyl interactions are important in protein-protein recognition events. 
ii. Proline-rich motifs 
 The aromatic-prolyl interaction has also been recognized in the context of the 
interdomain contacts made between proteins (Figure 7.2b). There are many protein domains 
that recognize proline-rich motifs (PRMs) during complex signaling events (Figure 7.3).2e,f 
PRM-binding domains all contain highly conserved clusters of surface-exposed aromatic 
residues, referred to as “aromatic cradles”. PRM-binding domains typically recognize ligands 
(a) 
 
(b) 
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that are peptide segments 5-10 amino acids in length. PRM-binding domains recognize 
specific 3-6 amino acid residue “core motifs” within these ligand peptides. The core motifs 
often repeat in tandem within the ligand peptides. Currently, six distinct families of PRM-
binding domains have been distinguished based on their respective structure and ligand 
binding preferences. The SH3 domains,3 the WW domains,4 the EVH1 domains,5 the GYF 
domains,6 the UEV domains,7 and the single-domain profilin proteins8 all interact with 
specific “core motifs”. The different families recognize their respective PRMs with Kd values 
that typically range from 1 to 500 µM. Interactions of non-proline residues within the motifs 
provide specificity. PRM-binding domains are typically found in larger multidomain proteins 
and are involved in a number of cellular processes including cytoskeletal rearrangement, cell 
growth, postsynaptic signaling, and transcription.2e,f There are more than 400 PRM-binding 
domains found in the human genome, and PRMs are the most common sequence motifs in 
many simple organisms including Drosophila melanogaster and Caenorhabditis elegans.2f It 
is believed that many PRMs are associated with multiple PRM-binding domains with varying 
affinities, a property that would allow them to perform multiple signaling functions 
orthogonally.2e 
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Figure 7.3 The PRM-binding EVH1 domain from Homer 1a is shown (green) bound to its 
natural ligand peptide (red) which has the sequence TPPSPF (pdb: 1DDV).  The “aromatic 
cradle” that is required for binding is also highlighted (blue) within the EVH1 domain. The 
two aromatic residues, tryptophan and tyrosine, are shown making close contacts with 
proline residues in the ligand.  
 iii. The polyproline type II (PPII) helix 
 It is widely believed that the ubiquitous use of proline as a recognition element for 
signaling modules is a the result of the unique polyproline type II (PPII) helix structure that 
repetitive proline-rich sequences adopt in an aqueous environment (Figure 7.4). The PPII 
helix is a left-handed helical structure that lacks the intramolecular hydrogen bonds that 
stabilize the more common peptide secondary structures including α-helices and β-sheets. 
The PPII helix has a pitch greater than 9 Å and contains 3 residues per turn making it 
considerably more extended than the α-helix which has a pitch of only 5.4 Å and 3.6 residues 
per turn. The structure of the PPII helix is the result of previously mentioned conformational 
constraints imposed by the annular side chain. All amide bonds within PPII helices are in the 
s-trans conformation. The PPII helix is typically considered rigid and it is believed that the 
preorganization of recognition elements within the PPII helix reduces the entropic cost of 
binding PRM ligands.2e Since PRMs all share the PPII helix as their conserved secondary 
structure, it is not surprising that the different families of PRM-binding domains exhibit 
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structural homology as well. The previously mentioned aromatic cradles are most commonly 
found on the surface of a β-sheet and consist of two diagonal (i, j+2) aromatic residues. The 
overall shape of the PPII helix resembles that of a triangular prism, and most PRM-binding 
domains have a cleft arrangement that is complementary to this shape.2f The absence of 
intramolecular hydrogen bonding within PPII helices leaves the electron-rich proline 
carbonyl groups free to accept hydrogen bonds donated from amino acids present within 
PRM-binding domains. Hydrogen bonds to PRMs are typically donated from aromatic 
residues such as Trp or Tyr, although Asn, Thr, Ser, Gln, and His can also contribute in this 
fashion.2e,f 
 
 
 
 
 
 
Figure 7.4 The conformation of the polyproline type II (PPII) helix viewed both 
perpendicular (left) and parallel (right) to the helical axis. The helix has a pseudo C3 
rotational axis and contains three residues per turn with torsion angles that are dictated by the 
pyrrolidine-containing side chain (Φ = -78º, Ψ = +146º). The tertiary amide groups are very 
good hydrogen-bond acceptors and serve as an additional recognition element in addition to 
the aromatic-prolyl interaction.  
 
The aromatic-prolyl interactions that stabilize s-cis amide bond conformations in 
many proteins and allow PRMs to coordinate multiprotein signalling cascades are thought to 
be driven by a combination of enthalpic C-H-π interactions and the classical hydrophobic 
effect.9 Zondlo and co-workers have helped elucidate the enthalpic contribution to aromatic-
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prolyl interactions from studies on peptide model systems using 1H NMR.10 They were able 
to modulate the preference for the s-cis versus s-trans amide bond conformation in a simple 
tetrapeptide model system. The results indicated that more electron rich aromatic amino acids 
favored the s-cis conformation for enthalpic reasons and showed that tryptophan and 
deprotonated tyrosine were the most efficient in this regard. This result is interesting since 
tryptophan and tyrosine are the residues selected most often by evolutionary processes for 
binding PRMs. 
B. The tryptophan zipper peptides as models for aromatic-prolyl interactions 
i. The tryptophan zipper peptides 
 The tryptophan zipper peptides were originally reported by Cochran and coworkers 
(Figure 7.5a).11a The tryptophan zipper (trpzip) structural motif greatly stabilizes the -
hairpin conformation and was first demonstrated for a series of 12 to 16 residue peptides with 
different turn sequences. Cochran and coworkers determined an experimental energy scale 
for the stabilizing contributions of amino acid residues as nonhydrogen-bonded positions 
within -hairpin peptides.11b,c There results indicated that cross-strand tryptophan residues 
were the most stabilizing pair at nonhydrogen bonding positions and went on to develop the 
trpzip peptides as stable monomeric -structure mimics. The trpzip -hairpins all exhibit 
cooperative thermal unfolding transitions and nonzero changes in heat capacity. The Gibbs 
free energy change of unfolding (ΔGF = 0.6-1.7 kcal·mol-1) for the -hairpins are comparable 
as per-residue values to those measured for large natural proteins. NMR structures deposited 
for the trpzip peptides show an interdigitating pattern for the tryptophan side chains (Figure 
7.5b). The nearly perpendicular conformation of the side chains is not unlike that of the 
aromatic cradles discussed for PRM-binding domains. The three-dimensional disposition of 
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the aromatic residues led to the hypothesis that the trpzip peptides may serve as good model 
systems for studying aromatic-prolyl interactions. Indeed, overlay images of trpzip NMR 
structures and crystal structures of the aromatic cradles located within natural PRM-binding 
domains show a close concordance. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5 (a) The structure of a trpzip -hairpin peptide is rendered in a two-dimensional 
fashion. (b) The three-dimensional NMR structure generated for the trpzip -hairpin peptide 
is shown (pdb: 1LE1). The two tryptophan residues that form a cleft arrangement similar to 
that observed within natural PRM-binding domains are highlighted (blue) in each structural 
representation. 
 
 
 
 
 
(a)
 
(b) 
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Figure 7.6 The aromatic binding residues (tryptophan and tyrosine, gray) from the Homer 1a 
EVH1 domain bound to the natural ligand sequence (green) (pdb: 1DDV) overlaid with a 
trpzip peptide (yellow) containing a type II’ turn sequence (pdb: 1LE0). The aromatic 
residues from each structure occupy very similar conformations. 
 
ii. System design 
 It was hypothesized that the trpzip peptide scaffold originally reported by Cochran 
could be modified so that thermodynamic measurements of aromatic-prolyl interactions 
could be made via disulfide exchange experiments. Exchange reactions under 
thermodynamic equilibrium conditions have previously been employed in measuring the 
strength of non-covalent interactions between peptide segments.12 Thiol-disulfide exchange 
has proven particularly advantageous in defining important, but subtle, structural features 
during de novo protein design.12a-c When performing exchange reactions, favorable 
interactions manifest themselves as perturbations in the observed equilibrium constant (KEQ 
differs from the value expected for a statistical distribution with G = 0). Essentially a 
competition experiment, analysis is performed under “native” conditions and is highly 
beneficial for assessing relatively weak non-covalent interactions since they are measured as 
a ratio of covalent species. Other methods for assessing binding strength such as ITC or 
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fluorescence anisotropy may be too insensitive or otherwise less suited for measuring weaker 
attractive forces like the aromatic-prolyl interaction. 
 The trpzip -hairpin peptide motif was ultimately redesigned so as to be compatible 
with disulfide exchange conditions (Figure 7.7a). 12a-c The addition of Cys-Gly-Gly to the N 
terminus provides a flexible tether for thiol-disulfide exchange. The Gly-Asn turn sequence 
in Cochran’s peptide was replaced with a D-Pro-Gly sequence in order to provide the peptide 
with greater chemical stability under the experimental conditions which require equilibration 
for several days in neutral to basic media. The D-Pro-Gly sequence has been shown a 
superior promoter for -turn structures when compared to sequences containing only L amino 
acids.11b,13 Two additional Lys residues were appended to the C terminus of the -hairpin to 
encourage solubility of all disulfide species and discourage aggregation. A series of 
oligoproline peptides were designed, varying in length from five to seven Pro residues 
(Figure 7.7b). The oligoproline peptide contained a tryptophan residue for concentration 
determinations, and a flexible Cys-Gly-Gly tether for disulfide exchange measurements. 
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Figure 7.7 (a) The trpzip -hairpin peptide redesigned for disulfide exchange experiments is 
shown. The residues that have been changed from the original design are shown in red. (b) 
The oligoproline peptides used for the disulfide exchange experiments are shown. The length 
of the oligoproline segment ranges from five to seven Pro residues. (c) A simple schematic 
representation of the designed disulfide exchange experiments. 
 
(a) 
 
 
(b) 
 
 
(c) 
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 It was anticipated that, by mixing the trpzip peptide with an appropriate oligoproline 
peptide, a number of disulfide species could be produced (Figure 7.7c). The oxidized mixture 
would contain oligoproline homodimers, -hairpin homodimers, and heterodimers composed 
of each peptide. At equilibrium the relative concentration of the heterodimer would be twice 
that of either homodimer if a statistical mixture were produced (G = 0). The equilibrium 
constant (KEQ) for a statistical mixture would therefore be equal to 4 using Equation 1: 
 
ܭாொ ൌ   ሾܪ݁ݐ݁ݎ݋݀݅݉݁ݎሿ
ଶ
ሾܲݎ݋ ܪ݋݉݋݀݅݉݁ݎሿሾܪܽ݅ݎ݌݅݊ ܪ݋݉݋݀݅݉݁ݎሿ ൌ  
ሾ2ሿଶ
ሾ1ሿሾ1ሿ ൌ 4       ܧݍݑܽݐ݅݋݊ 1 
 
where [Heterodimer] is the equilibrium concentration of the heterodimer containing both an 
oligoproline peptide and a -hairpin peptide, [Pro Homodimer] is the equilibrium 
concentration of the homodimer containing two oligoproline peptides, and [Hairpin 
Homodimer] is the equilibrium concentration of the homodimer containing two -hairpin 
peptides. Any attractive or repulsive interactions between the -hairpin peptide and/or the 
oligoproline peptide would manifest as an equilibrium constant deviating from 4. The 
magnitude of the net thermodynamic driving force for the interactions (ΔG[HP]) can be 
measured using Equation 2: 
߂ܩሾு௉ሿ  ൌ  െܴܶܮ݊ ൬ܭாொ4 ൰        ܧݍݑܽݐ݅݋݊ 2 
 
where KEQ is the equilibrium constant calculated using Equation 1, R is the molar gas 
constant in units of cal·mol-1·K-1 (1.986), and T is the temperature in Kelvin (298). 
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Since the distinctive shape of the trpzip -hairpin peptide motif was hypothesized to 
be favorable for providing aromatic-prolyl interactions, a negative control was designed 
based on another -hairpin peptide motif used for molecular recognition. The WKWK -
hairpin peptide was designed as a synthetic receptor for ATP and has a binding cleft 
comprised of two tryptophan residues (Figure 7.8a).14 The NMR structure of the WKWK 
peptide indicates that the tryptophan residues present a much flatter surface when compared 
to natural PRM binding domains and the trpzip peptides (Figure 7.8b).15 The turn sequence 
for the WKWK peptide was also converted to D-Pro-Gly in order to provide greater chemical 
stability. The sequences for the peptides used throughout the disulfide exchange experiments 
are shown in Table 1. 
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Figure 7.8 (a) The WKWK -hairpin peptide redesigned for disulfide exchange experiments 
is shown. (b) The NMR structure for the WKWK peptides shows the aromatic residues 
adopts a much flatter conformation when compared to the trpzip -hairpin peptide motif. 
 
 
 
 
 
 
 
 
 
 
(a) 
 
(b) 
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Table 7.1. Primary sequences for the peptides used in disulfide exchange experiments 
Peptide Name Sequencea 
Trpzip Ac-Cys-Gly-Gly-Ser-Trp-Thr-Trp-Glu- 
D-Pro-Gly-Lys-Trp-Thr-Trp-Lys-Lys- 
Lys-NH2 
CW-Pro5 Ac-Cys-Trp-Gly-Gly-Pro-Pro-Pro-Pro- Pro-NH2 
CW-Pro6 Ac-Cys-Trp-Gly-Gly-Pro-Pro-Pro-Pro- Pro-Pro-NH2 
CW-Pro7 Ac-Cys-Trp-Gly-Gly-Pro-Pro-Pro-Pro- Pro-Pro-Pro-NH2 
CWGG Ac-Cys-Trp-Gly-Gly 
C-Pro7-W Ac-Cys-Gly-Gly-Gly-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Trp-
NH2 
WC-Pro7 Ac-Trp-Cys-Gly-Gly-Gly-Pro-Pro-Pro-Pro-Pro-Pro-Pro-
NH2 
WKWK Ac-Cys-Gly-Gly-Arg-Trp-Val-Lys-Val- 
D-Pro-Gly-Orn-Trp-Ile-Lys-Gln-NH2 
aPrimary sequences for all peptides are designated by the standard three letter amino acid 
code. Orn is ornithine. All amino acids are L amino acids, except D-Pro. 
 iii. CD analysis of trpzip -hairpin and oligoproline peptides 
 The trpzip -hairpin, oligoproline peptides, and WKWK -hairpin were analyzed 
using CD spectroscopy before disulfide exchange analysis. As desired, the oligoproline 
peptides all form PPII helices in buffer (Figure 7.9a) as indicated by intense minima at 205 
nm, with less intense maxima at 228 nm. Both spectral features are closely associated with 
the PPII helix secondary structure.16 Decreasing the number of residues within the 
oligoproline series results in a hypsochromic shift of the maxima which is likely indicative of 
a subtle decrease in the PPII helical content of the peptide (Figure 7.9a).16b 
 The CD spectrum for the trpzip peptide displays strong exciton-coupled bands at 215 
and 230 nm that are characteristic for the tryptophan zipper motif (7.9b).11a,17 CD spectra for 
the trpzip peptide were taken under reducing conditions to prevent the formation of 
homodimers. When the trpzip peptide is allowed to oxidize in the standard phosphate buffers 
used for CD analysis, the spectra show an approximately 30% decrease in the intensity of the 
exciton-coupled CD bands compared to the monomeric peptide (not shown). This 
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observation indicates that the trpzip peptide is probably distorted from the structure reported 
by Cochran when bound in the homodimer state, and also implies some interaction between 
the two trpzip peptides that compose the homodimer. The CD spectrum for the WKWK 
peptide has a minimum between 210 and 220 nm and a positive signal below 200 nm. Both 
spectral features can be attributed to an antiparallel β-structure,18 and indicate the D-Pro-Gly 
sequence is a competent nucleator of a -turn structure in this sequence.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.9 (a) CD spectra of the oligoproline peptides at 100 M are shown. All three 
oligoproline peptides show signals at approximately 205 and 228 nm characteristic to the 
PPII helix secondary structure. Spectra were recorded at 25°C in 10 mM PO43-, pH 7, buffer. 
(b) CD spectra of the trpzip and WKWK -hairpin peptides at 50 M are shown. The 
spectrum for the trpzip peptide was taken at 25°C in 10 mM PO43-, 2 mM TCEP, pH 7, 
buffer, and shows signals at 215 and 230 nm characteristic to structural motif. The spectrum 
for the WKWK peptide was taken at 25°C in 10 mM PO43-, pH 7, buffer, and shows a 
minimum at 210 nm characteristic to -structures. 
(a)
(b) 
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iv. Analysis of the disulfide exchange experiments 
 Disulfide exchange experiments were performed by mixing approximately equal 
proportions of an oligoproline peptide and the trpzip -hairpin peptide in basic aqueous 
buffer with no effort made to exclude oxygen. The presence of molecular oxygen oxidized all 
of the thiol-containing peptides to disulfide species within a matter of hours or days. As 
previously mentioned, once all of the peptide thiols were oxidized, the mixture contained a 
number of homodimer and heterodimer species. The equilibration of those species was 
monitored for several days by HPLC analysis (Figure 7.10). Although reactions were 
monitored at multiple wavelengths during the equilibration period, the absorbance at 280 nm 
was used for quantification since all of the designed peptides contained a tryptophan residue. 
 
 
 
 
 
Figure 7.10 An HPLC chromatogram at 280 nm is shown for the analysis of a typical 
disulfide exchange reaction. The equilibrated mixture contains a trpzip -hairpin homodimer 
(blue), an oligoproline homodimer (red), and a heterodimer (blue and red) containing both a 
trpzip -hairpin and oligoproline motif. 
 All three of the oligoproline peptides equilibrated with the trpzip -hairpin to give 
nonstatistical distributions of species. The CW-Pro7 peptide gave the largest relative 
concentration of heterodimer at equilibrium, implying a substantial stabilizing interaction 
between the trpzip -hairpin and the oligoproline. Likewise, the CW-Pro5 peptide gave the 
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smallest relative concentration of heterodimer species, with the concentration still being well 
above that predicted for a statistical mixture. The WKWK peptide was equilibrated with the 
CW-Pro7 peptide only, and gave a heterodimer concentration above that expected for a 
statistical mixture as well. The equilibrium constants (KEQ) calculated for the different 
disulfide exchange experiments according to Equation 1 are given in Table 2. 
Table 7.2. Equilibrium constants generated from the disulfide exchange experiments 
-hairpin Oligoproline KEQa 
Trpzip CW-Pro5 18 ± 1 
Trpzip CW-Pro6 47 ± 2 
Trpzip CW-Pro7 68 ± 3 
WKWK CW-Pro7 15 ± 2 
aEquilibrium constants (KEQ) are averaged from at least two separate trials. Error estimates 
provided are based on the peak resolution for the different trials. 
Based on the results of the disulfide exchange experiments it seemed likely that 
favorable aromatic-prolyl interactions could be measured through disulfide exchange 
experiments. It was, however, observed that during sample preparation the trpzip peptide 
formed homodimer species at an accelerated rate relative to the oligoproline and WKWK 
peptides. Coupled with the previously mentioned CD analysis, the observation of the 
accelerated homodimer formation led to the hypothesis that the trpzip peptide has a favorable 
homodimer interactions. Cochran reported no intermolecular aggregation for the trpzip 
peptides based on concentration-dependent NMR experiments and analytical 
ultracentrifugation (AUC), but a favorable intramolecular trpzip-trpzip interaction in the 
homodimer is not unreasonable given the number of tryptophan residues that could 
contribute -stacking interactions when covalently linked. These interactions could be too 
weak to manifest as an intermolecular association, while still easily being measured during a 
disulfide exchange experiment. 
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A favorable trpzip-trpzip homodimer interaction would manifest itself as a decrease 
in the observed KEQ values measured by disulfide exchange since heterodimer formation 
would have to overcome an energetic penalty corresponding to the disruption of the trpzip-
trpzip interactions. In order to test this hypothesis, the two -hairpin peptides were both 
subjected to disulfide exchange experiments with a short peptide comprised only of the linker 
sequence (CWGG) used for the oligoproline peptides. Both the trpzip and WKWK peptides 
exhibited nonstatisitcal values for KEQ when equilibrated with CWGG. For WKWK, the KEQ 
values (14 ± 1) were within error of that reported for the interaction with CW-Pro7. This 
implies that the WKWK peptide does not have any favorable aromatic-prolyl interactions. 
The nonstatisitical KEQ value measured for the -hairpin and the CW-Pro7 peptide (15 ± 2) 
are most likely due to interactions between amino acid residues in WKWK and on the tether 
sequence (CWGG).  
 The disulfide exchange experiments with the trpzip peptide and the linker sequence 
CWGG display KEQ values below 4, a result that would be expected if homodimer formation 
were thermodynamically favorable. The KEQ values for the trpzip-CWGG exchange 
experiments (1.3 ± 0.15) corresponds to a free energy change (ΔG[HP]) of 0.67 ± 0.07 
kcal·mol-1. Equation 2 was modified using the average KEQ value measured for the trpzip-
CWGG exchange experiments. The modification provides the corrected free energy change 
for heterodimer formation between the trpzip and the oligoproline peptides (ΔG*[HP]) in the 
form of Equation 3: 
߂ܩ כሾு௉ሿ ൌ  െܴܶܮ݊ ൬ܭாொ1.3 ൰        ܧݍݑܽݐ݅݋݊ 3 
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 The corrected ΔG*[HP] values for the trpzip, WKWK, and oligoproline peptides are 
given in Table 3. The ΔG*[HP] value calculated for the exchange reaction between WKWK 
and CW-Pro7 was zero since the KEQ value reported for the pair was within error of that 
reported for the WKWK-CWGG exchange reaction (14 ±1). The value (ΔG**[HP]) was 
calculated using the similarly modified Equation 4: 
߂ܩ ככሾு௉ሿ ൌ  െܴܶܮ݊ ൬ܭாொ14 ൰        ܧݍݑܽݐ݅݋݊ 4 
 
Table 7.3. Corrected values for Gibb’s free energy change of heterodimer formation 
-hairpin Oligoproline KEQa 
ΔG*[HP]b 
(kcal·mol-1) 
Trpzip CW-Pro5 18 ± 1 -1.6 
Trpzip CW-Pro6 47 ± 2 -2.1 
Trpzip CW-Pro7 68 ± 3 -2.3 
WKWK CW-Pro7 15 ± 2 0 
aEquilibrium constants (KEQ) and error estimates are the same as those reported in Table 2. 
bThe corrected Gibbs free energy change for the disulfide exchange reactions (ΔG*[HP]) were 
calculated using Equation 3. The error estimated for each was less than 0.07 kcal·mol-1 based 
on the error reported for the KEQ value measured for CWGG and the trpzip peptide. 
 The corrected ΔG*[HP] values given in Table 3 are representative of the aromatic-
prolyl interactions in these systems if the assumption is made that no other attractive forces 
are cooperatively contributing to heterodimer formation during the exchange reactions. The 
oligoproline peptides used within the experiments all contain a single tryptophan residue 
used for concentration determination and quantitation during the disulfide exchange 
experiments. Since an aromatic-aromatic interaction could contribute to heterodimer 
formation in the trpzip-CWGG exchange reaction control experiments were designed to 
probe this possibility. Based on the observation that increasing the length of the oligoproline 
peptides from CW-Pro5 to CW-Pro7 resulted in an increase in heterodimer formation, it was 
hypothesized that the trpzip peptide primarily interacts with the oligoproline peptides near 
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their C termini. The peptide C-Pro7-W has a tryptophan residue at the C terminus where 
interactions between the trpzip -hairpin and the oligoproline peptides were thought to occur 
(Table 7.1). Indeed, when the C-Pro7-W peptide is subjected to disulfide exchange 
experiments with the trpzip peptide, the observed KEQ value was extremely large and difficult 
to measure by HPLC integration (KEQ > 150). This result suggested strongly that moving the 
tryptophan residue closer to the C terminus allows binding of the residue to the -hairpin 
moiety through aromatic-aromatic interactions. The peptide WC-Pro7 has a tryptophan 
residue included on the N terminal side of the cysteine residue, displaced two residue 
positions relative to the CW-Pro7 peptide (Table 7.1). When the WC-Pro7 peptide is 
equilibrated with the trpzip -hairpin the measured KEQ value (69 ± 3) was within error of 
that reported for CW-Pro7. If the tryptophan residue in either the CW-Pro7 or WC-Pro7 
peptides significantly contributed to binding it would be highly unlikely that the peptides 
would have identical KEQ values. Therefore this suggests that the attractive interactions 
measured for the oligoproline peptides (ΔG*[HP]) are due to aromatic-prolyl interactions and 
are not due to interactions between the linker sequence and the trpzip -hairpin motif. 2D 
NMR experiments performed on the CW-Pro7-trpzip heterodimer indicated that NOE signals 
were present between Trp residues in the -hairpin structure and Pro residues in the 
oligoproline moiety. There were, however, no NOE signals present between the Trp residue 
on the oligoproline (CWGG linker) and the -hairpin. 
C. Conclusions 
The tryptophan-zipper peptide motif reported by Cochran and coworkers was shown 
to provide favorable interactions with a series of oligoproline peptides. To the best of our 
knowledge, this is the first example of a small -hairpin peptide demonstrating affinity for 
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peptides which adopt the PPII helix secondary structure. The energetics of the aromatic-
prolyl interactions in the system were measured, with the most favorable reaching -2.3 
kcal·mol-1. A related -hairpin peptide, WKWK, does not show affinity for oligoproline 
helices. This subtlety demonstrates the importance of structure when examining aromatic-
prolyl interactions in peptide model systems. Due to the structural similarities between the 
trpzip peptide family and natural PRM-binding domains, the disulfide exchange system 
described herein could be used to further understanding of how natural recognition domains 
bind to their ligand core motifs.  
D. Experimental Section 
 i. Peptide synthesis and purification 
Peptides were typically synthesized by standard automated SPPS using a Thuramed 
tetras synthesizer. Fmoc-protected amino acids were used along with a CLEAR-Amide resin 
from Peptides International, Inc.  Amino acid residues were activated with HBTU, HOBt, 
and DIPEA in DMF. Amino acids were deprotected twice with 2% DBU and 2% piperidine 
in DMF for 15 minutes each step. Amino acids were coupled using double coupling cycles of 
30-60 minutes each. The N-terminus of each peptide was acetylated using 5% acetic 
anhydride and 6% lutidine in DMF for 30 minutes. Cleavage of the peptides from the resin 
was performed in 95.0% TFA, 2.5% water, and 2.5% TIPS. TFA was evaporated with a 
stream of nitrogen and diethyl ether was added to precipitate the cleavage products. The 
peptides were extracted with water or collected as solids by centrifugation and lyophilized to 
dryness. Peptides were purified by RP-HPLC using an Atlantis Prep OBD dC-18 semi-
preparative column, with a gradient of 0-100% solvent B over 40 minutes, where solvent A 
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was 95:5 water:ACN, 0.1% TFA, and solvent B was 95:5 ACN:water, 0.1% TFA. Purified 
samples were lyophilized and the peptide sequence was confirmed by ESI-MS. 
ii. Circular dichroism measurements 
CD measurements were performed on an Aviv 62DS Circular Dichroism 
Spectrometer, using quartz cells with a path length of 0.1 cm. CD data was obtained for the 
trpzip and WKWK peptides at 50 µM concentrations in 10 mM sodium phosphate buffer, 2 
mM TCEP, pH 7. Wavelength scans were performed in triplicate and averaged. Scans were 
typically performed from 260-190 nm, although spectra for trpzip were collected up to 330 
nm at times. CD data was obtained for the oligoproline sequences at 100 μM concentration in 
10 mM sodium phosphate buffer (no TCEP), pH 7. All spectra were recorded at 25ºC (298 
K), and a 30 second averaging time was used for all scans. All scans were corrected by 
subtracting the spectrum of the respective buffer used in the experiment. The results of the 
CD experiments are reported as mean molar residue ellipticity [] with the units of 
degrees·cm2·dmol-1 and were calculated using Equation 5: 
ሾߠሿ ൌ   ሺߠ௢௕௦ሻ10 ൉ ݈ ൉ ܿ ൉ ݊        ܧݍݑܽݐ݅݋݊ 5    
where θobs is the observed ellipticity in millidegrees, c is concentration in mol·L-1, l is the 
path length in cm, and n is the number of amino acid residues in the peptide. 
 iii. Disulfide exchange experiments 
 Disulfide exchange experiments were typically initiated by mixing an oligoproline 
peptide (CW-Pro5, CW-Pro6, CW-Pro7, C-Pro7-W, or WC-Pro7) with either the trpzip or 
WKWK peptide in approximately equal proportions in 10 mM sodium phosphate buffer (pH 
8.1-8.5) with no effort made to exclude oxygen. The total peptide concnetrations were 
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typically 250 M. Peptide concentrations were determined prior to sample preparation by 
recording the absorbance of Trp at 280 nm (ε = 5690 M-1 cm-1) in 5 M GndHCl dilutions. 
LC-MS analysis of the exchange reactions was accomplished using an Agilent Series 1200 
instrument, equipped with an Agilent Zorbax Eclipse XDB-C18 column (4.6 x 50 mm, 1.8 
µm). Various gradient methods were employed (water/methanol containing 0.2% formic 
acid), ranging from 15-30 minutes at a flow rates of 0.8-1.0 mL/min (column temperature, 
35ºC). The injection volumes were typically 2.0-4.0 μL for both 100 µM and 250 µM 
exchange reactions. The reactions were monitored at 280 nm, and integrated areas were 
adjusted for the number of Trp residues. Equilibrium constants (KEQ), reported in Table 2 and 
Table 3, were calculated using Equation 1: 
 
ܭாொ ൌ   ሾܪ݁ݐ݁ݎ݋݀݅݉݁ݎሿ
ଶ
ሾܲݎ݋ ܪ݋݉݋݀݅݉݁ݎሿሾܪܽ݅ݎ݌݅݊ ܪ݋݉݋݀݅݉݁ݎሿ        ܧݍݑܽݐ݅݋݊ 1 
 
where [Heterodimer] is the equilibrium concentration of the heterodimer containing both an 
oligoproline peptide and a -hairpin peptide, [Pro Homodimer] is the equilibrium 
concentration of the homodimer containing two oligoproline peptides, and [Hairpin 
Homodimer] is the equilibrium concentration of the homodimer containing two -hairpin 
peptides. The values for ΔG[HP], ΔG*[HP], and ΔG**[HP] reported in Table 7.2 and Table 7.3 
were calculated using Equation 2, Equation 3, and Equation 4: 
 
߂ܩሾு௉ሿ  ൌ  െܴܶܮ݊ ൬ܭாொ4 ൰        ܧݍݑܽݐ݅݋݊ 2 
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߂ܩ כሾு௉ሿ ൌ  െܴܶܮ݊ ൬ܭாொ1.3 ൰        ܧݍݑܽݐ݅݋݊ 3 
 
߂ܩ ככሾு௉ሿ ൌ  െܴܶܮ݊ ൬ܭாொ14 ൰        ܧݍݑܽݐ݅݋݊ 4 
 
where KEQ is the equilibrium constant calculated using Equation 1, R is the molar gas 
constant in units of cal·mol-1·K-1 (1.986), and T is the temperature in Kelvin (298.15). A 
sample set of data and provided in Table 4. A sample calculation of ΔG[HP] for the exchange 
experiment with CWGG and the trpzip -hairpin is presented below. 
Table 7.4. Sample data set for trpzip/CWGG exchange experiment 
 
 Retention Time (min) 
Area 
(mAU*sec) 
Number of 
Trp Residues 
Corrected 
Area 
trpzip 
Homodimer 14.415 328 8 41 
trpzip-CWGG 
Heterodimer 15.872 255 5 51 
CWGG 
Homodimer 19.902 109 2 55 
 
ܭாொ ൌ   ሾ51ሿ
ଶ
ሾ55ሿሾ41ሿ        ܧݍݑܽݐ݅݋݊ 1ܾ 
ܭாொ ൌ 1.15       ܧݍݑܽݐ݅݋݊ 1ܿ 
ܭாொሺܽݒ݁ݎܽ݃݁ሻ ൌ  1.3 ሺേ0.15ሻ      ܧݍݑܽݐ݅݋݊ 1݀ 
The values reported in Table 2 and Table 3 are the average for many trials with error 
describing the absolute range of values observed, not the standard deviation of the set 
(Equation 1d). 
߂ܩሾு௉ሿ  ൌ  െܴܶܮ݊ ൬1.34 ൰        ܧݍݑܽݐ݅݋݊ 2ܾ 
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߂ܩሾு௉ሿ  ൌ  െሺ0.5921ሻܮ݊ ൬1.34 ൰        ܧݍݑܽݐ݅݋݊ 2ܿ 
߂ܩሾு௉ሿ  ൌ  0.67 ሺേ 0.07ሻ ݈݇ܿܽ ൉ ݉݋݈ିଵ       ܧݍݑܽݐ݅݋݊ 2ܿ 
iv. Sample chromatograms 
  
 
Figure 7.11 Sample chromatogram at 280 nm for the disulfide exchange experiment with the 
trpzip -hairpin and the CW-Pro5 peptide. 
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Figure 7.12 Sample chromatogram at 280 nm for the disulfide exchange experiment with the 
trpzip -hairpin and the CW-Pro6 peptide. 
 
 
Figure 7.13 Sample chromatogram at 280 nm for the disulfide exchange experiment with the 
trpzip -hairpin and the CW-Pro7 peptide. 
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Figure 7.14 Sample chromatogram at 280 nm for the disulfide exchange experiment with the 
WKWK -hairpin and the CW-Pro7 peptide. 
 
Figure 7.15 Sample chromatogram at 280 nm for the disulfide exchange experiment with the 
WKWK -hairpin and the CWGG linker sequence. 
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Figure 7.16 Sample chromatogram at 280 nm for the disulfide exchange experiment with the 
trpzip -hairpin and the CWGG linker sequence. 
 
Figure 7.17 Sample chromatogram at 280 nm for the disulfide exchange experiment with the 
trpzip -hairpin and the WC-Pro7 peptide. 
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 v. TOCSY and NOESY NMR experiments 
 TOCSY and NOESY NMR experiments were performed by Jes Park (Waters 
laboratory) using either a Varian Inova 600 MHz or Bruker Ultrashield 600 MHz Plus 
spectrometer.  2D TOCSY data were acquired between 1-5 mM peptide concentration in 50 
mM NaOAc and 0.5 mM DSS in deuterium oxide or 90% H2O and 10% D2O, adjusted in pD 
4.0 with AcOD.  TOCSY spectra were acquiered using 32 scans per increment and 128 
increments in the indirect dimension.  2D NOESY data were acquired using 64 scans per 
increment and 256 scans in the indirect dimension.  Solvent suppression was applied with the 
Varian or Bruker software.  Peptide proton assignments of the TrpZip and TrpZip-Pro7 
peptides were determined using standard methods.19   
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